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Abstract 
Sheridan, Sinead E. Cardiorespiratory Fitness, Physical Activity, Sedentary 
Behaviour and Vascular Health in Male Adolescents  
Study 1: A high cardiorespiratory fitness (CRF) level is positively associated with a 
more favorable cardiometabolic health profile in adolescents.  Limited information 
exists on the relation between CRF and vascular health in healthy adolescents.  The 
purpose of this study was to compare cardiovascular disease (CVD) risk factors and 
vascular health in healthy low fit (LF), moderate fit (MF) and high fit (HF) male 
adolescents.  LF male adolescents had significantly poorer endothelial dependent 
dilation (EDD) and cardiovascular health profile and significantly higher carotid intima 
media thickness (cIMT) compared to both MF and LF. There was a significant positive 
relation between V̇O2max and EDD and a significant inverse association between 
V̇O2max and cIMT in healthy male adolescents. 
Study 2:  The oxygen uptake efficiency slope (OUES) has been proposed as an 
objective and effort independent submaximal measure of CRF and may serve as an 
alternative to V̇O2max when assessing CRF in adolescents.  This study evaluated OUES 
and vascular health in LF, MF and HF healthy male adolescents with low, moderate 
and high CRF.  Maximal and submaximal OUES expressed relative to body weight 
were significantly higher in HF than both MF and LF.  There was a significant positive 
relation between both maximal and submaximal OUES and EDD and a significant 
inverse relation between maximal and submaximal OUES and cIMT.  In a stepwise 
 xvii 
multiple linear regression analysis that included V̇O2max, maximal OUES and 
submaximal OUES, only V̇O2max was a significant predictor of EDD. 
Study 3:  This study compared physical activity (PA) levels, sedentary behaviour, CVD 
risk factors and vascular health in LF, MF and HF apparently healthy male 
adolescents.  Time spent in moderate-to-vigorous PA (MVPA) was significantly higher 
and time spent sitting/lying was significantly lower in HF than both MF and LF.  Time 
spent in light intensity PA (LIPA) was significantly higher in HF than LF. Time in MVPA 
and LIPA were both significantly and positively related with EDD and inversely related 
to cIMT.  There was a significant inverse relation between time sitting/lying and EDD 
and a significant positive relation between time sitting/lying and cIMT.  
Conclusion: cIMT was significantly higher and EDD was significantly lower in LF than 
both MF and HF.  While OUES, PA and sedentary time were all significantly related to 
markers of vascular health, a more robust relation was observed between V̇O2max 
and vascular health. Furthermore, V̇O2max was independently related to EDD and 
cIMT.  
  
 xviii 
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 1 
Chapter I 
INTRODUCTION 
Rationale 
 Cardiovascular disease (CVD) is the leading cause of death among Europeans 
and is responsible for over 4 million deaths per year (Nichols et al., 2014).  In 2014, 
close to 50% of all deaths in Europe were attributable to CVD (Nichols et al., 2014).  
Annually, 1.48 million deaths occur before the age of 75, equating to 37% of 
premature deaths (Nichols et al., 2014).  Atherosclerosis, a slow progressive chronic, 
inflammatory, fibroproliferative disease involving large and medium-sized conduit 
arteries, is the primary underlying cause of CVD.   
 There is growing evidence that functional impairment of the endothelium, a 
physical barrier between the blood and tissues is one of the first recognizable signs of 
the development of atherosclerosis and is present prior to angiographic detection or 
clinical manifestations of CVD.  Shear stress plays a central role in regulating 
endothelial cell function.  High shear stress helps to maintain endothelium 
homeostasis by the up-regulation of endothelial derived nitric oxide synthase (eNOS) 
expression and subsequent increase in the synthesis and release of nitric oxide (NO) 
(Green et al., 2004).  In contrast, a low shear stress environment can negatively alter 
endothelium homeostasis resulting in endothelial dysfunction.  Although the 
underlying cause of endothelial dysfunction is multifactorial, a key factor is 
impairment of the bioavailability of NO (Deanfield et al., 2007).  
 2 
Although the clinical manifestations of CVD occur in middle and late 
adulthood, the atherosclerotic process begins in childhood and is accelerated by 
exposure to established CVD risk factors and their persistence over time (Berenson et 
al., 1998).  Non-invasive imaging techniques such as echo-Doppler measurement of 
carotid intima media thickness (cIMT) and flow-mediated dilation (FMD) of the 
brachial artery are now commonly used to identify sub-clinical atherosclerosis in 
asymptomatic children and adolescents (Berenson, 2002).  Impaired brachial artery 
FMD and increased cIMT are present in obese children and adolescents with 
atherosclerotic cardiovascular disease (ACVD) risk factors (Meyer et al., 2006, 
Farpour-Lambert et al., 2009).   
High levels of CRF are positively associated with a more favorable CVD risk 
factor profile in asymptomatic adolescents compared to their inactive, unfit 
counterparts (Ruiz et al., 2007, Ekelund et al., 2007, Anderssen et al., 2007).  Both 
short and long-term exercise training has proved efficacious in improving CVD risk 
factor profile, restoring endothelial function, decreasing cIMT and improving CRF in 
overweight and obese children with ACVD risk factors (Watts et al., 2004, Meyer et 
al., 2006, Farpour-Lambert et al., 2009).  Limited cross-sectional studies in children 
have found a positive relation between CRF and endothelial dependent dilation (EDD) 
(Hopkins et al., 2009, Treiber et al., 1997) and an inverse relation between CRF and 
cIMT (Silva et al., 2014).  To date, no published studies have investigated the relation 
between objectively measured CRF and brachial artery FMD and cIMT in adolescents.  
The fact that CVD risk factors cluster in children and adolescents with low levels of 
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CRF and physical activity (PA) (Anderssen et al., 2007, Andersen et al., 2006) and track 
from childhood into adulthood (Juhola et al., 2011, Steinberger et al., 2001, Nicklas et 
al., 2002) indicates that a critical window of opportunity may exist for early risk 
identification and lifestyle intervention.   
 Maximal oxygen uptake (V̇O2max) is a measure of the integrated capacity of 
the pulmonary, cardiovascular and muscular systems to uptake, transport and utilize 
oxygen at maximal exercise (Poole et al., 2008) and is considered the gold standard 
measurement of CRF.  Attainment of V̇O2max requires a plateau in oxygen uptake, 
defined as an increase in V̇O2 < 2.0 ml.kg
-1.min-1 with increasing workload during the 
final minute (min) of a maximal exercise test (Rowland & Cunningham, 1992).  The 
inability to achieve a plateau in V̇O2 during maximal exercise testing, particularly in 
overweight and obese pediatric populations has resulted in a number of secondary 
criterion being used to verify attainment of V̇O2max.  These include respiratory 
exchange ratio (RER) > 1.0, heart rate (HR) >200 bpm and volitional fatigue (RPE 18-
20) (Breithaupt et al., 2012). Exercise performance at submaximal intensities may be 
better tolerated and more reflective of the intensity of ambulatory activities 
undertaken by adolescents (Akkerman et al., 2010).  The oxygen uptake efficiency 
slope (OUES), derived from the linear relation between oxygen uptake and the 
logarithm of minute ventilation (V̇E) during incremental exercise has been proposed 
as an objective and effort independent submaximal measure of CRF (Baba et al., 
1996).  OUES is positively related to V̇O2max in both healthy normal weight (Marinov 
et al., 2007) and obese children and adolescents (Breithaupt et al., 2012, Marinov et 
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al., 2003) and in children with congenital heart disease  (Baba et al., 1996).  In 
apparently healthy middle-aged adults, OUES is inversely associated with large artery 
stiffness (Arena et al.,  2009).  To date, no published studies have examined the 
relation between OUES and vascular health in children and adolescents.  
 Low levels of PA are independently associated with increased cardiometabolic 
disease risk factors in children and adolescents (Andersen et al., 2006,  Ekelund et al., 
2006, Ekelund et al., 2007) while findings from studies examining the independent 
relation between sedentary behaviouor and cardiometabolic disease risk factors in 
this cohort have been equivocal (Tremblay et al., 2014). To date, the relation 
between both objectively measured PA and sedentary behaviour and sub-clinical 
atherosclerosis in adolescents is unknown.  In the only study to examine objectively 
measured PA and vascular function in children, time spent in moderate to vigorous 
levels of physical activity (MVPA) was positively related to brachial artery FMD 
(Hopkins et al., 2009).  A recent study found no relation between sedentary 
behaviour and brachial artery FMD in pre-pubertal children (Hopkins et al., 2012).  
Currently, 81% of Irish children and 88% of Irish adolescents do not meet the PA 
recommendations of 60 min of daily MVPA (Woods et al., 2010). In addition, it is 
estimated that European children aged 12-18 years spend on average 9 h per day or 
71% of their waking hours in sedentary behaviours (Ruiz et al., 2011).  
 To date, no published studies have simultaneously evaluated the effect of 
CRF, PA and sedentary behaviour on sub-clinical atherosclerosis in adolescents.  The 
purpose of the following series of studies was to determine the influence of CRF, PA 
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and sedentary behaviour on CVD risk factors and vascular health in apparently 
healthy male adolescents. 
Study Aims 
1. To compare CVD risk factors, endothelial function and cIMT in LF, MF 
and HF healthy male adolescents and examine the relation between 
V̇O2max and vascular health. 
2. To determine the value of the OUES as an objective measure of CRF in 
adolescents and to examine its relation with vascular health.  
3. To examine the influence of PA and sedentary behaviours on vascular 
health in healthy male adolescents and to compare PA and sedentary 
behaviours in LF, MF and HF healthy male adolescents. 
 
Hypotheses  
1. LF adolescents will have a significantly poorer CVD risk factor profile and 
significantly greater sub-clinical atherosclerotic CVD than MF and HF 
adolescents and V̇O2max will be positively related to vascular health. 
2. The OUES will be a suitable and valid objective measure of CRF in adolescents 
and will be positively related to vascular health.   
3. PA will be positively related to vascular health and sedentary behaviour will 
be inversely related to vascular health, PA behaviours will be significantly 
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lower and sedentary behaviours will be significantly higher in LF than MF and 
HF healthy male adolescents.  
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Chapter II 
Chapter II 
REVIEW OF LITERATURE 
Cardiovascular Disease  
Cardiovascular disease (CVD) collectively refers to diseases of the heart and 
the circulatory system and includes coronary artery disease (CAD), peripheral arterial 
disease (PAD), cerebrovascular disease, rheumatic heart disease, congenital heart 
disease, aortic aneurysm, pulmonary embolism and deep venous thrombosis.  
Approximately 17.5 million deaths worldwide were attributed to CVD in 2012 (WHO, 
2015).  It is estimated that by 2030 almost 23.6 million people will die annually from 
CVD (WHO, 2015).  In Europe, over 4 million people die from CVD each year with an 
estimated cost of €192 billion per year (Nichols et al., 2012)  In Ireland, a total of 6% 
of the healthcare budget in 2009 was spent on the treatment of CVD (McGee, 2010). 
Blood Vessel Structure 
 Arterial blood vessels are comprised of three distinct layers called the intima, 
media and adventitia (figure 2.1).  The intima contains endothelial cells that rest on a 
basement membrane.  The media layer consists primarily of smooth muscle cells 
(SMC) and is bordered by the internal and external elastic lamina.  The adventitia is 
the outermost layer of the blood vessel. 
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Figure 2.1.  Structure of large and medium sized arteries 
Pathophysiology of Atherosclerosis  
 Atherosclerosis, the most common cause of CVD, is a chronic inflammatory 
vascular disease occurs in response to alterations in lipid homeostasis and 
endothelial cell injury.  The disease is characterized by progressive lipid accumulation 
and the proliferation of smooth muscle and connective tissue within the sub-
endothelial space of primarily large, and medium sized systemic arteries (Libby et al., 
2010).  A long incubation period exists between the initial development of 
atherosclerosis and clinical manifestations.  
 Vascular endothelial cells are not only targets, but are also the effectors that 
actively participate in inflammatory processes associated with arteriosclerosis.  
Healthy endothelial cells are selectively permeable and are primarily antithrombotic, 
anti-inflammatory and antioxidant due in part, to their production and release of NO.  
High circulating levels of low density lipoprotein cholesterol (LDL-C) and their 
subsequent oxidation and accumulation in the subendothelial matrix has been 
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identified as a major triggering event in the initiation of atherosclerosis.  LDL-C 
normally diffuses passively through endothelial cell junctions, and its retention in the 
vessel wall involves interactions between the LDL-C constituent Apo lipoprotein B 
(ApoB) and matrix proteins including proteoglycans and other intimal 
glycosaminoglycans (GAGs), which have a high affinity for Apo B.  This entrapment 
increases the residence time of LDL-C in the artery and renders them more 
susceptible to oxidation.   
 Oxidized LDL-C (oxLDL) inhibits the production of NO and stimulates the 
overlying endothelial cells to produce endothelial leukocyte adhesion molecules 
(ELAMs), chemotactic proteins such as monocyte chemotactic protein-1 (MCP-1), and 
growth factors such as macrophage colony-stimulating factor (M-CSF), resulting in 
the recruitment of monocytes to the vessel wall and their subsequent proliferation 
and differentiation into macrophages.  Soluble vascular cell adhesion molecule-1 
(sVCAM-1) is responsible for the recruitment of monocytes and T-lymphocyte by 
binding to its cognate ligand VLA4 on the leukocyte.  Other adhesion molecules that 
play a role in the development of atherosclerosis include soluble intercellular 
adhesion molecule-1 (sICAM-1), P-selectin and E-selectin.   
 The monocytes and T-lymphocytes recruited to the sub-intima space are 
responsible for the progression of the atherosclerotic lesions and their subsequent 
complications.  In response to stimulation by macrophage derived IL-1 and TNF- 
endothelial cells increase their permeability, produce more adhesion molecules and 
become more thrombogenic.  T-lymphocyte derived INF-ϒ stimulates macrophages 
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and SMC to express scavenger receptors that bind and internalise oxLDL resulting in 
the formation of lipid-rich arterial foam cells.  These nascent atherosclerotic lesions 
are the precursor of more complex plaques.  They are called foam cells because of 
the foamy appearance under the microscope, due accumulation of lipid droplets 
within the cytoplasm.  Vascular smooth muscle cells lose their ability to contract and 
develop the capacity to proliferate, migrate and to synthesise and secrete 
extracellular matrix proteins (EMP).  Over time, SMCs migrate to the sub-endothelial 
layer where they undergo mitosis and synthesize and release collagen to from a 
fibrous cap.  Macrophages and lymphocytes may also be present in the fibrous cap.   
 Macrophages and SMC within foam cells become necrotic and rupture.  Their 
fat content accumulates and a fibrotic lipid core, a site of chronic inflammation, is 
formed.  Fibrous plaques eventually increase in size and undergo calcification to 
become advanced lesions.  The dense fibrous cap may weaken overtime resulting in 
hemorrhage within the plaque and ultimately plaque rupture.  Thrombosis may result 
in partial or full occlusion of the artery, the clinical consequence being myocardial 
ischemia, infarction or sudden death. 
Origin of Atherosclerosis  
Although the clinical manifestation of CVD occurs in middle and late 
adulthood, evidence of atherosclerotic disease is evident from autopsy studies in 
children and young adults (Enos et al., 1953, McNamara et al., 1971, McGill et al., 
2000).  The onset of atherosclerosis in childhood was first documented by Holman et 
al., (1957) who reported that grossly visible fatty streaks were present in the aorta 
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and coronary arteries of US children after the ages of 3 and 10 years respectively, and 
that these lesions advanced to fibrous plaques by young adulthood (Holman, 1957).  
Stary et al., (1989) found that 65% of 12 to 14 year old children had coronary artery 
lesions containing foam cells and lipid droplets, and an additional 8% had developed 
more advanced pre-atheroma or atheroma stage of atherosclerosis (Stary et al., 
1989).  A nation-wide pathology study of atherosclerosis in Japanese youth found 
that fatty streaks were present in the aortas of 29% of children <1 year old and 3.1% 
in the coronary arteries of children aged between 1 and 9 years of age (Tanaka et al., 
1988). 
The findings of pathology studies are consistent with the findings from in-vivo 
studies examining atherosclerosis in youth (Berenson, 2002, Goar et al., 1992 ,  
Morrison et al., 2010, Tuzcu et al., 2001).  An intravascular ultrasound study on the 
characterization of atherosclerosis in young heart transplant recipients found that 
coronary artery plaques >0.5 mm were present in 17% of 262 asymptomatic heart 
donors under the age of 20 years (Tuzcu et al., 2001).  More recently, studies using 
non-invasive ultrasonography to evaluate atherosclerotic plaque development, have 
found increased intima media thickness (IMT) of the carotid arteries of both children 
and young adults (Berenson, 2002, Morrison et al., 2010). 
Cardiovascular Disease Risk Factors 
Epidemiological studies in adults have identified a number of individual 
characteristics known as risk factors that predict the probability of an individual 
developing clinical manifestations of CVD (Dawber et al., 1950).  These risk factors are 
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commonly classified as modifiable and non-modifiable.  Non-modifiable risk factors 
include age, race, gender and family history.  Hypertension, smoking, low levels of 
high density lipoprotein cholesterol (HDL-C), high levels of LDL-C, glucose intolerance, 
obesity and a sedentary lifestyle are the most common modifiable risk factors.  More 
recently, elevated levels of high sensitivity serum C-reactive protein (hsCRP), 
interleukin 6 (IL-6) and TNF- α have been associated with the development of CVD.  
Risk factors for CVD track from childhood into adulthood (Juhola et al. 2011, 
Laurer  et al., 1989,  Steinberger et al. 2001) and are strong predictors of sub-clinical 
atherosclerosis in early adulthood (Davis et al., 2001, Li et al., 2003; Raitakari et al., 
2003).  The extent of sub-clinical atherosclerosis increases as the number of 
childhood risk factors increase (Berenson, 2002, Raitakari et al., 2003).  The American 
Heart Association (AHA) guidelines for the primary prevention of ACVD in children 
and adolescents encourage the screening of modifiable risk factors to identify those 
at high risk for future CVD (Kavey et al., 2003). 
Risk Factors and Early Atherosclerosis  
Large prospective observational studies examining the relation between 
childhood CVD risk factors and the development of early atherosclerosis found a 
strong association between both antemortem and postmortem CVD risk factors and 
atherosclerotic changes in the aorta and coronary arteries of young individuals.  The 
Bogalusa Heart Study, a long-term epidemiological study of CVD risk factors in 
individuals from 2 to 38 years of age, examined the relation between antemortem 
risk factors and the development of aortic and coronary atherosclerosis in 204 young 
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individuals who died from accidental causes (Berenson et al., 1998).  Almost 100% of 
children between the age of 2 and 15 years had evidence of fatty streaks in the aorta 
on gross examination.  Coronary fatty streaks were present in 50% of children 
between 2 and 15 years and increased to 85% between 21 and 39 years of age.  The 
prevalence of raised fibrous plaque in the aorta increased with age, particularly after 
15 years, and was evident in 60% of study participants between the age of 26 and 39 
years.  Similarly, the prevalence of raised fibrous plaque in the coronary arteries 
increased from 8% in children under-15 years to 69% in 26 to 39 years old adults.  
There was a significant relation between the prevalence and extent of atherosclerotic 
lesions in the aorta and coronary arteries and systolic blood pressure (SBP), diastolic 
(DBP), body mass index (BMI) total cholesterol (TC), LDL-C and triglycerides (TG). 
The Pathological Determinants of Atherosclerosis in Youth (PDAY) study 
investigated the relation between postmortem risk factors and the extent of flat fatty 
streaks, raised fatty streaks and raised lesions in the aorta and right coronary artery 
of individuals between the age of 15 and 34 years who died of non-cardiovascular 
causes (McGill et al., 2000).  Raised fatty streaks were detected in the abdominal 
aorta in 20% of 15 to 19 year old adolescents and increased to 40% between the age 
of 30 and 34 years.  The presence of raised fatty streaks was 10% and 30% in the 
same two age cohorts.  The percentage of intimal surface involvement of raised fatty 
streaks was positively associated with hypertension, obesity, impaired glucose 
tolerance, high levels of non-HDL-C and low HDL-C (McGill et al., 2000). 
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Clustering of CVD Risk Factors  
Individual CVD risk factors correlate with each other and the co-existence of 
multiple risk factors in an individual is known as clustering (Berenson, 2002).  
Clustering of CVD risk factors is associated with the presence of early atherosclerotic 
lesions in adolescents and young adults.  Berenson (2002) found a curvilinear relation 
between the severity of atherosclerotic disease in children and the number of CVD 
risk factors (Berenson, 2002).  Autopsy and antemortem risk factor data on 
asymptomatic individuals aged between 2 and 39 years who died from non-
cardiovascular events, indicate a significant relation between the number of CVD risk 
factors and the presence and extent of atherosclerotic lesions in the aorta and 
coronary arteries.  The extent of fatty streaks and fibrous plaque in the coronary 
arteries was 8.5 and 12 times higher in individuals with greater than 4 CVD risk 
factors than those with no risk factors. IMT of the common carotid artery (CCA), 
carotid bulb and internal carotid artery is also related to the number of CVD risk 
factors in young asymptomatic adults between the age of 20 and 38 years (Berenson 
2002). 
Tracking of CVD Risk factors  
The progression and increasing severity of atherosclerosis is not only 
associated with the presence and extent of CVD risk factors but also their persistence 
over time (Berenson et al., 1998).  CVD risk factor levels for an individual tend to 
persist or track over time in a given rank within the distribution of the population 
(Berenson & Srnivasan, 2005).  Elevated blood pressure (BP), TC, HDL-C, ratio 
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(TC:HDL-C), plasma insulin, and BMI have been found to track from childhood to 
adulthood (Laurer and Clarke, 1988, Laurer et al., 1989, Juhola et al., 2011, Nicklas et 
al., 2002, Steinberger et al.,2001).  
Multiple risk factors tend to track better than individual risk factors (Nicklas et 
al., 2002) and the tracking of multiple risk factors is stronger with advancing age 
(Juhola et al., 2011).  Nicklas et al., (2002) tracked TC: HDL-C, SBP and insulin from 
childhood to adulthood over a 14 to 20 year period and found a significant 
association between the composite risk index score of the 3 risk factors between year 
1 and year 8.  The association was weaker when the risk factors were analyzed 
individually (Nicklas et al., 2002). 
Childhood Risk factors and Subclinical Atherosclerosis in Adulthood  
Epidemiological studies utilizing non-invasive imaging have found that 
childhood CVD risk factors, in particular elevated LDL-C and BMI, contribute to the 
development of sub-clinical atherosclerosis in young adults (Davis et al., 2001, Li et 
al., 2003, Raitakari et al., 2003).  Risk factor measurements obtained during childhood 
are stronger predictors of pre-clinical atherosclerosis than measurements obtained 
during young adulthood.  Raitakari et al., (2003) examined the relation between CVD 
risk factors measured at 3 and 18 years of age and between 24 and 39 years 
(Raitakari et al., 2003).  Adult cIMT was significantly associated with childhood LDL-C, 
SBP, BMI and smoking.  The number of risk factors including elevated levels of LDL-C, 
SBP, BMI and cigarette smoking measured in 12-18 year old adolescents was 
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significantly related to cIMT measured between the ages of 33 and 39 years and 
remained significant, after adjusting for the number of adult risk factors.  
The extent of pre-clinical atherosclerosis increases as the number of 
childhood CVD risk factors increase.  While controlling for current CVD risk factors, 
Juonala et al., (2010) found that there was a significant relation between the number 
of childhood risk factors and the 6 year change in adult cIMT (Juonala et al., 2010).  A 
recent analysis of 4380 participants in 4 longitudinal cohort studies found that risk 
factor measurements (high [highest quintile] TC, TG, BP and BMI) obtained at, or 
after 9 years of age are predictive of sub-clinical atherosclerosis in adulthood.  In 
addition, the extent of pre-clinical atherosclerosis increased as the number of 
childhood risk factors increased (Juonala et al., 2010). 
Until recently, information on the role of CVD risk factors in the development 
of sub-clinical atherosclerosis was limited to observations from pathological studies 
and risk factor profiles.  While a profile of CVD risk factors is useful in predicting 
cardiovascular events, measurement of functional and structural markers of sub-
clinical atherosclerosis by non-invasive imaging techniques such as echo-Doppler 
studies of the carotid arteries or FMD of the brachial artery provides a powerful 
approach to determine the extent and severity of asymptomatic disease, and 
potential future risk in young populations (Berenson, 2002). 
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Vascular Biology  
Endothelial Function 
Vascular Endothelium – Structure  
 The vascular endothelium is a 0.2 to 4.0 µm-thick monolayer of squamous 
endothelial cells that line the entire vasculature and form a permeable biological 
interface between circulating blood elements and the various systems in the body.  
Once viewed as an inert barrier between the blood and tissues, the endothelium is 
now recognized as a key regulator of vascular homeostasis by acting as an active 
signal transducer for circulating influences that modify the vessel wall phenotype 
(Deanfield et al., 2007).  It plays an important role in regulating vascular tone, smooth 
muscle cell (SMC) proliferation, inflammation, haemostasis, platelet aggregation and 
thrombus formation.  A normal healthy endothelium maintains vascular haemostasis 
by synthesizing and releasing an array of biological substances in response to various 
physical, chemical and mechanical stimuli (Vita, 2011).  Due to its location, the 
endothelium is subject to injury from mechanical forces and processes related to CVD 
risk factors.  
Vascular Smooth Muscle Contraction 
The primary role of vascular smooth muscle is to regulate blood vessel tone. 
Vascular smooth muscle contraction (VSMC) is regulated by the 
phosphorylation/dephosphorylation of the 20-kDa myosin light chain (MLC).  MLC is 
phosphorylated by the Ca2+-calmodulin-activated myosin chain light kinase (MLCK) 
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and dephosphorylated by the Ca2+ independent myosin light chain phosphatase 
(MLCP) (Sauzeau et al., 2000).  Increases in cytosolic [Ca2+] induced by either 
electromechanical coupling or pharmacomechanical coupling mechanisms result in 
MLCK activation and consequent phosphorylation of MLC.  Cytosolic [Ca2+] is 
increased by an influx of Ca2+ from the extracellular space through both voltage and 
receptor operated Ca2+ channels or by the controlled release of Ca2+ from 
intracellular storage sites.  
Binding of agonists such as norepinephrine, angiotensin II and endothelin to 
the Gq protein linked receptor, increases cytosolic [Ca2+] through opening of Ca2+ 
surface membrane operated channels or the stimulation of phospholipase C.  
Phospholipase C catalyzes the hydrolysis of phosphatidylinositol 4.5-bisphosphate to 
inositol 1, 4, 5-triphosphate (IP3) and diacylglycerol (DAG).  The binding of IP3 to its 
specific receptor on the sarcoplasmic reticulum results in the controlled release of 
Ca2+ into the cytosol (Webb, 2003).  Cytosolic Ca2+ binds with calmodulin forming a 
calcium-calmodulin complex, which activates MLCK.  MLCK phosphorylates MLC in 
the presence of ATP resulting in cross-bridge formation between myosin head and 
actin filaments and subsequent VSMC. 
In addition to the Ca2+ dependent activation of MLCK, MLC phosphorylation is 
further regulated by changes in the sensitivity of the contractile apparatus to [Ca2+] 
(Sauzeau et al., 2000).  MLCP removes the high-energy phosphate from the myosin 
light chain, resulting in vascular smooth muscle relaxation (Webb, 2003).  Increased 
Ca2+ sensitivity of the contractile apparatus inhibits the activity of MLCP by Rho-
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kinase, allowing increased MLC phosphorylation and tension at a constant Ca2+ 
concentration (Sauzeau et al., 2000). 
 
Figure 2.2: Vascular smooth muscle contraction 
P3, inositol 1,4,5-triphosphate; DAG, diacylglycerol; Ca
2+
, calcium; MLC, myosin light chain; P, 
phosphate; ATP, Adenosine Triphosphate.  An increase in free intracellular [Ca
2+
] can result from 
increased flux of [Ca
2+
] into the cell through calcium channels or by the release of [Ca
2+
] from internal 
stores (e.g., SR).  The cytosolic [Ca
2+
] binds to a calcium-binding protein called calmodulin.  Calcium-
calmodulin activates MLCK, an enzyme that phosphorylates MLC in the presence of ATP.  MLC 
phosphorylation leads to cross-bridge formation between the myosin heads and the actin filaments 
resulting in smooth muscle contraction. Increased Ca
2+
 sensitivity of the contractile apparatus inhibits 
the activity of MLC phosphatase by Rho-kinase, allowing increased MLC phosphorylation and tension 
at a constant Ca
2+
 concentration (Diagram as in Webb 2003) 
Vascular Smooth Muscle Relaxation 
Vascular smooth muscle cell relaxation occurs as a result of a decrease in 
cytosolic [Ca2+] and/or an increase in MLCP activity (Sauzeau et al.,2000).  During 
relaxation, receptor and voltage-operated calcium channels in the vascular smooth 
muscle plasma membrane close, resulting in a reduced Ca2+ entry into the cell.  
Calcium is also re-sequestered to the sarcoplasmic reticulum by Ca2+,Mg2+-ATPases or 
removed from the cell by Ca2+Mg2+-ATPases and Na+/Ca2+ exchangers in the plasma 
membrane (Webb, 2003).  
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The vascular endothelium also assists in the regulation of SMC relaxation by 
synthesizing and releasing vasoactive substances in response to mechanical or 
humoral stimuli.  Furchgott and Zawadzki (1980) first demonstrated that a healthy 
intact endothelium was necessary to induce vascular smooth muscle cell relaxation in 
isolated rabbit aorta in response to acetylcholine (ACh) (Furchgott & Zawadzki, 1980).  
The endothelium-dependent response to exogenously administered ACh was 
attributable to the production and diffusion of the hydrophobic, diatomic gas NO, 
produced by the enzyme eNOS in response to changes in shear forces or binding of a 
variety of endothelial cell receptor agonists. 
 Shear stress, the force exerted by blood flow on vascular endothelial cells ( 
Davies et al., 2005) increases NO production by the phosphorylation of eNOS.  In 
particular, shear stress activates specialized Ca2+- activated K+ channels on the 
endothelial surface resulting in K+ efflux and Ca2+ influx (Sandoo et al., 2010).  
Cytosolic Ca2+ attaches to calmodulin, which activates eNOS resulting in the synthesis 
of NO from L-arginine.  Once synthesized, NO diffuses across the endothelium into 
the adjacent vascular smooth muscle where it binds and activates guanylyl cyclase 
resulting in the conversion of guanosine triphosphate (GTP) to cyclic guanosine 
monophosphate (cGMP).  cGMP inhibits calcium influx into the smooth muscle cell 
and decreases calcium-calmodulin stimulation of MLCK, which in turn decreases 
phosphorylation of MLC resulting in a reduction in smooth muscle tension 
development and inducing vasodilation. 
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Figure 2.3: Vascular smooth muscle relaxation 
ACh=acetylcholine; BK, bradykinin; ATP, adenosine triphosphate; ADP, adenosine diphosphate; SP, 
substance P; Ca
2+
, calcium; K
+
,
 
potassium; SOCa
2+, 
store-operated calcium channel; ER, endoplasmic 
reticulum,; eNOS, endothelial derived nitric oxide synthase; L-arg, L-arginine; NO, nitric oxide; GC, 
guanylyl cyclase; GTP, guanosine triphosphate; cGMP, cyclic guanosine monophosphate; MLCK, 
myosin light chain kinase.  Increases in hemodynamic shear result in [Ca
2+
] efflux from the 
endoplasmic reticulum into the cytoplasm.  [Ca
2+
] binds to calmodulin and activates eNOS resulting in 
the synthesis of NO from, L-arginine.  The NO molecule diffuses abluminally into the adjacent vascular 
smooth muscle, where it binds GC, leading to activation of the enzyme, and the production of cGMP.  
This intercellular signaling molecule leads to the inhibition of [Ca
2+
] influx into the smooth muscle cell, 
and decreases calcium-calmodulin stimulation of MLCK.  This in turn decreases the phosphorylation of 
MLC, decreasing smooth muscle tension development and causing vasodilation.  In addition, when 
Ca
2+ 
stores of the ER are depleted a signal is sent to the SOCa
2+ 
channel which allows extracellular Ca
2+ 
into the endothelial cell. (Diagram as in Sandoo et al., 2010) 
Vascular Endothelial Dysfunction  
Impairment to the normal function of the vascular endothelium is termed 
endothelial dysfunction and represents one of the earliest events in the pathogenesis 
of atherosclerosis (Anderson et al., 1995).  Endothelial dysfunction is related to CVD 
progression (Halcox et al., 2002) and is predictive of CV events (Suwaidi et al., 2000, 
Halcox et al., 2002).  A key manifestation of endothelial dysfunction is a reduction in 
the bioavailability of vasodilators, most notably NO, resulting in impaired EDD 
 22 
(Flammer et al., 2012).  Endothelial dysfunction is also characterized by proliferative, 
pro-inflammatory and pro-coagulant states that favour all stages of atherogenesis 
(Anderson, 1999).   
An alteration in the redox balance in endothelial cells leads to increased 
superoxide anion production and oxidative stress that degrades NO (Kofler et al.,  
2005).  This can occur by three distinct mechanisms.  Firstly, superoxide can react 
with NO to form peroxynitrite anions resulting in consumption of NO and loss of its 
activity.  Secondly, reactive oxygen species (ROS) increase the concentration of 
asymmetric dimethylaminohydrolase (ADAMA) an endogenous inhibitor of eNOS and 
finally, superoxide anions can result in uncoupling of eNOS due to degradation of 
tetrahydrobiopterin (BH4). 
Assessment of Endothelial Function 
Quantitative coronary angiography, venous occlusion plethysmography, and a 
cold pressor test are invasive tests that are commonly used to assess endothelial 
function.  Quantitative coronary angiography measures the vasomotor response to 
intracoronary administration of Ach or other endothelial dependent agonists such as 
bradykinin and substance P (Halcox et al., 2002).  Venous occlusion plethysmography 
involves measuring changes in forearm resistance and blood flow following the 
infusion of endothelial dependent and endothelial independent dilators such as ACh 
and sodium nitroprusside, respectively (Spieker et al., 2002).  The cold pressor test is 
used to assess endothelial dependent coronary vasomotor function.  Submersion of 
an extremity in ice water for 90 sec induces sympathetic stimulation and subsequent 
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EDD, which is measured using quantitative angiography (Zeiher et al., 1991).  The 
invasive nature of these methods limits their widespread use to assess endothelial 
function in children and adolescents.   
Advances in non-invasive techniques, in particular ultrasound imaging, has 
allowed for the assessment of endothelial function in asymptomatic children and 
adolescents with or without CVD risk factors (Järvisalo & Raitakari, 2005).  The most 
commonly used non-invasive techniques for assessing endothelial function in 
children and adolescents are brachial artery FMD and peripheral arterial tonometry.   
Brachial Artery Flow Mediated Dilation (FMD) 
 Flow mediated dilation (FMD) of the brachial artery is the most widely used 
non-invasive technique to measure endothelial function in both adults and children.  
High-resolution ultrasonography is used to measure brachial artery blood flow 
velocity and vessel diameter at rest and in response to reactive hyperemia following 
a brief period of arterial occlusion.  The change in artery diameter is normally 
expressed as a percentage change from baseline diameter.  Shear stress induced 
brachial artery FMD is believed to occur in response to an increased release of 
endothelial derived NO.  Brachial artery FMD can be used as a surrogate for coronary 
artery function due to the similarity in vasomotor response of both the coronary 
arteries to pharmacological agents and the brachial artery to hemodynamic shear 
stress (Anderson et al., 1995, Takase et al., 1998).  Brachial artery FMD is related to 
the extent and severity of coronary atherosclerosis (Neunteufl et al., 1997) and is an 
independent predictor of CV events in adults (Gokce et al., 2003). 
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 Pharmacological agents such as glyceryl-trinitrate (GTN) cause vasodilation by 
acting directly on vascular smooth muscle cell and are therefore commonly used to 
assess endothelial-independent dilation (EID).  Measuring EID serves as a control for 
FMD measurement to ensure that low percentage change in FMD is as a result of 
impaired endothelial function and not a reflection of underlying smooth muscle 
dysfunction (Järvisalo & Raitakari, 2005).  Relatively few studies have measured EID in 
children due to the potential side effect of GTN. 
Peripheral Arterial Tonometry   
The measurement of endothelial function in children and adolescents using 
peripheral arterial tonometry (PAT) has recently grown in popularity (Mahmud et al., 
2009, Metzig et al., 2011, Tryggestad et al., 2012).  PAT measures microvascular 
endothelial function.  It involves the measurement of pulsatile arterial volume 
changes by finger plethysmography (Flammer et al., 2012).  Probes are placed on one 
fingertip on both hands and are subsequently inflated to produce as sub-diastolic 
counter-pressure equal to approximately 70 mm Hg.  Pressure differences secondary 
to dilating arterioles in the fingers are measured.  Similar to brachial artery FMD, a 
pressure cuff is placed on the arm.  The BP cuff is inflated above SBP and deflated 
after 5 min to induce reactive hyperemia (Flammer et al., 2012).  The reactive 
hyperemia index defined as the ratio of the mean pulse amplitude between 90 and 
150 sec after deflation divided by a pre-occlusion period 210 sec before occlusion is 
calculated.  This ratio is then divided by the same ratio for the control arm and 
multiplied by a baseline correction factor.  In contrast to FMD, the response is only 
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partially mediated by NO (Bruyndonckx et al., 2013).  Other mediators that contribute 
to vasodilation include prostacyclin (PGI2) and endothelial derived hyperpolarizing 
factor (Bruyndonckx et al., 2013). 
Normative Brachial Artery FMD Values  
FMD responses vary considerably between studies primarily due to different 
populations, location of measurement, duration of occlusion and other technical 
aspects related to measurement (Bots et al., 2005).  An analysis of 16,680 individuals 
from 412 study groups found that mean FMD response varied from 0.20 to 19.2% in 
healthy populations, -1.3% to 14.0 % in coronary heart disease (CHD) populations and 
0.75 to 12.0% in individuals with type 1 diabetes mellitus (T1DM) (Bots et al., 2005). 
A number of studies have found no change in endothelial function in healthy 
asymptomatic children throughout childhood (Kaufman et al., 2007, Tounian et al., 
2001, Woo et al., 2004, Meyer et al., 2006).  Mean FMD response in healthy non-
obese children and adolescents is typically 8% to 11% (Järvisalo et al., 2002, Järvisalo 
et al., 2004, Woo et al., 2004).  However, large variability exists between studies 
(Fernhall & Agiovlasitis, 2008).  
Limited population based studies involving children, differences in technical 
aspects relating to FMD measurement between studies and a large range of FMD 
values makes it challenging to define abnormal FMD responses in children (Fernhall & 
Agiovlasitis, 2008).  Jarvisalo et al., reported a mean FMD response of 8.7% in healthy 
asymptomatic 11 year old children (Järvisalo et al., 2004) and 7.7% in healthy children 
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between the age of 9 and 16 years (Järvisalo et al., 2002).  Similarly, Celermajer et al., 
(1992) reported a mean percentage change in FMD of 8.0% in healthy 8 to 16 year 
old children and adolescents (Celermajer et al., 1992).  Woo et al., (2004) measured 
brachial artery FMD in 36 non-obese healthy children and reported a mean FMD 
response of 9.7% (Woo et al., 2004).   
The majority of pediatric studies investigating endothelial function in children 
and adolescents report FMD as being reduced or impaired, with relatively few studies 
defining what percentage change in FMD response constitutes impairment.  Impaired 
FMD response has been pre-defined in healthy and disease-based adult populations 
as a peak FMD response of ≤ 8% from baseline (Kitta et al., 2009, Corretti et al., 2002, 
Gokce et al., 2003) with some studies, particularly in patients with CAD, defining 
impaired FMD as < 5.5% (Kitta et al., 2009).  Meyer et al., (2006) defined impaired 
FMD as < 5.5% in obese children (Meyer et al., 2006) while others used a value > 3.3% 
in children with T1DM (Järvisalo et al., 2004) based on the bottom 10th percentile for 
healthy 9 to 16 year olds (Järvisalo et al., 2002).  
Endothelial Function and Puberty  
Measurement of endothelial function in children and adolescents can be 
confounded by anthropometric and physiological changes that occur with puberty 
(Bruyndonckx et al., 2013).  During puberty, there is an increase in the circulating 
levels of the steroid hormones, estrogen and dehydroepiandrosterone sulphate 
(DHEAS) (Bhangoo et al., 2011).  Both of these hormones bind to their specific 
receptors on the vascular endothelium and upregulate eNOS concentration and 
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activity, resulting in an increase in NO and subsequent enhanced EDD (Duckles & 
Miller 2010).  Bhangoo et al., (2011) found that endothelial derived NO mediated 
vasodilation, measured by PAT was significantly higher in children who were at mid 
(Tanner II-III) and late stages of puberty (Tanner IV-V) than pre-pubertal children 
(Tanner 1) (Bhangoo et al., 2011).  Endothelial derived NO mediated vasodilation was 
significantly correlated with estrogen, DHEAS and age (Bhangoo et al., 2011). In 
contrast, a recent large cross-sectional study examining the effect of pubertal 
development on EDD found no difference in the percentage change in brachial artery 
FMD across the pubertal Tanner stages (Marlatt et al., 2013).  The equivocal findings 
may be related to the inherent differences between large conduit and small arteries.  
Endothelial Function and CVD Risk Factors in Children 
Impaired endothelial function is present in children and adolescents with 
ACVD risk factors including overweight (Woo et al., 2004), obesity ( Meyer et al., 
2006, Kapiotis et al., 2006, Zhu et al., 2005, Yilmazer et al., 2010, Peña et al., 2006, 
Tounian et al., 2001, Aggoun et al., 2008, Farpour-Lambert et al., 2009), T1DM 
(Järvisalo et al., 2004, Singh et al., 2003, Wiltshire et al., 2002, Babar et al., 2011, 
Glowinska-Olszewska et al., 2013), T2DM (Naylor et al., 2011) and familial 
hypercholesterolemia (FH) (Celermajer et al., 1992, de Jongh et al., 2002,  Vlahos et 
al., 2014, Sorensen et al., 1994). 
Childhood obesity, a key independent risk factor for CVD is associated with 
impaired endothelial function and greater arterial stiffness from as early as the first 
decade of life (Singhal, 2005).  The effect of obesity on vascular function is partly 
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mediated by the prolonged exposure of arteries to high circulating insulin levels and 
adipokines (Singhal, 2005).  Several cross-sectional studies (Table 2.1) have found that 
obese children and adolescents have lower FMD compared to their healthy normal 
weight counterparts (Meyer et al., 2006, Kapiotis et al., 2006, Zhu et al., 2005, 
Yilmazer et al., 2010, Peña et al., 2006, Tounian et al., 2001, Aggoun et al., 2008, 
Farpour-Lambert et al., 2009).  A number of these studies have found a strong 
association between the percentage change in FMD and BMI (Zhu et al., 2005, 
Yilmazer et al., 2010, Peña et al., 2006, Woo et al., 2004, Aggoun et al., 2008), weight 
(Peña et al., 2006), waist circumference (Yilmazer et al., 2010), body fat (Aggoun et 
al., 2008), TC (Zhu et al., 2005), LDL-C (Zhu et al., 2005), Apo-B (Zhu et al., 2005), BP, 
(Aggoun et al., 2008), apolipoprotein A1 (ApoA1) (Tounian et al., 2001) and fasting 
insulin concentration (Tounian et al., 2001). 
Some studies have found that both EDD and EID were lower in obese than 
lean children (Tounian et al., 2001, Peña et al., 2006, Aggoun et al., 2008, Farpour-
Lambert et al., 2009), whereas others have reported no difference in the percentage 
change in EID between these two groups (Woo et al., 2004, Karpoff et al., 2009).  The 
impaired EID may be due to functional changes in vascular smooth muscle cells in 
response to obesity such as decreased activity of intracellular guanylyl cyclase, cyclic 
GMP or calcium dependent relaxation or accelerated inactivation of NO by increased 
oxidative stress.  In these studies, BMI (Peña et al., 2006, Aggoun et al., 2008), weight 
(Peña et al., 2006), body fat (Aggoun et al., 2008) and BP (Aggoun et al., 2008) were 
inversely associated with the percentage change in EID.  
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Table 2.1.   Cross-sectional studies comparing EDD and EID responses in overweight/obese and healthy children and adolescents  
Author (y) Age (y) Cohort %FMD %GTN 
Tounian et al., 
(2001) 
Obese 12.6 /Healthy 
12.0 
Obese (n=42)/Healthy (n=21) matched for 
age and puberty 
sig  in obese vs. healthy 
(5.0 vs. 9.0%) 
sig in obese  
vs. healthy 
(15.6 vs. 23.0%) 
Woo et al., (2004) 10.3 ± 0.9 OW (n=36)/Healthy (n=36) matched for age 
and gender 
sig  in obese vs. healthy 
(6.6 vs. 9.7%) 
 in obese  vs. 
healthy 
(19.6 vs. 20.6 %) 
Zhu et al., (2005) 12.0 (7-12) Obese (n=43)/Healthy (n=28) matched for 
age 
sig  in obese vs. healthy 
(10.9 vs. 18.8%) 
___ 
Kapiotis et al., 
(2006) 
Obese 12.0 ± 
2.9/Healthy 12.0 ± 5.0 
Obese (n=77)/Healthy (n=15) matched for 
age 
sig  in obese vs. healthy 
(7.7 vs. 11.1%) 
___ 
Meyer et al., (2006) 
Obese 13.7/Healthy 
14.7 
Obese (n=32)/Healthy (n=20) matched for 
age 
sig  in obese vs. healthy 
(5.8 vs. 9.3 %) 
___ 
Meyer et al., (2006b) 
Obese 14.2 ± 1.9 
/Healthy 14.7 ± 2.2 
Obese (n=67)/Healthy (n=35) matched for 
age 
sig  in obese vs. healthy 
(4.1 vs. 10.7%) 
___ 
Pena et al., (2006) 
Obese 13.3/Healthy 
14.1 
Obese (n=58)/non-obese (n=53)/T1DM 
(n=159) All matched for age 
sig  in obese/T1DM 
vs. healthy 
(4.9 /3.8 vs.7.8%) 
sig  in 
obese/T1DM 
vs. healthy 
(21.7 /20.5 vs. 
27.7%) 
Aggoun et al., (2008) 
Obese 8.9 ± 
1.5/Healthy 8.3 ± 1.5 
Obese (n=48)/Healthy (n=23) matched for 
age 
sig  in obese/T1DM 
vs. healthy 
(4.5 vs. 8.3 %) 
sig in obese  
vs. healthy 
(19.0 vs. 25.8 %) 
Karpoff et al., (2009) 11.6 ± 0.6 
Obese (n=12)/Healthy (n=13) matched for 
age and PA levels 
sigin obese  vs. healthy 
(4.6 vs. 8.8 %) 
 in obese  vs. 
healthy 
(17.4 vs. 20.4%) 
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Author (y) Age (y) Cohort %FMD %GTN 
Yilmazer et al., 
(2010) 
Obese 11.5/Healthy 
9.8 (7-16) 
Obese (n=77)/Healthy (n=40) matched for 
age 
sig in obese vs. healthy 
(9.7 vs. 14.8%) 
___ 
Farpour-Lambert et 
al., (2009) 
8.9 ± 0.5 Obese (n=44)/Healthy (n=22) matched for 
age 
sig in obese vs. healthy 
(4.1 vs. 7.8%) 
sig in obese  
vs. healthy 
(17.1 vs. 25.0% ) 
%FMD, percent change in diameter following flow mediated dilation; %GTN, percent change in diameter following glyceryl trinitrate mediated 
dilation; sig, significant  
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Cross-sectional studies have found that FMD is significantly lower in children 
with T1DM and T2DM than healthy controls (Table 2.2) (Järvisalo et al., 2004, Singh et 
al., 2003, Wiltshire et al., 2002, Głowińska-Olszewska et al., 2013, Babar et al., 2011, 
Naylor et al.,2011).  Järvisalo et al., (2004) reported that 36% of children with T1DM 
had endothelial dysfunction defined as a peak FMD of  3.3% (Järvisalo et al., 2004) 
below the 10th percentile cutoff for healthy children aged 9-16 years (Järvisalo et al., 
2002).  Among the CVD risk factors measured in these studies, blood glucose (Singh 
et al., 2003) duration of diabetes (Singh et al., 2003), TC (Singh et al., 2003) LDL-C  
(Singh et al., 2003) and circulating levels of endothelial progenitor cells (CD34, 
CD309) (Glowinska-Olszewska et al., 2013) and glycated hemoglobin (HBA1c) (Babar 
et al., 2011) were inversely associated with percentage change in FMD. In each of the 
studies, there was no difference in EID between children with T1DM and healthy 
controls (Järvisalo et al., 2004, Singh et al., 2003, Glowinska-Olszewska et al., 2013, 
Babar et al., 2011).  
Naylor et al., (2011) compared brachial artery FMD responses in adolescents 
with T2DM, obese non-insulin resistant adolescents, and healthy lean controls.  FMD 
was significantly decreased in adolescents with T2DM than lean healthy controls. 
Although FMD in the obese non-insulin resistant group was intermediate between 
T2DM and lean healthy controls subjects, there was no significant difference 
between the obese and T2DM group (Naylor et al., 2011). 
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Table 2.2.  Cross sectional studies comparing EDD and EID responses in children and adolescents with T1DM and T2DM and 
healthy children and adolescents 
Author (y) Cohort  Age (y) %FMD %GTN% 
Jarvisalo et al., (2004) T1DM (n=45)/healthy 
(n=30) matched for age 
11 ± 2 sigin T1DM  vs. healthy 
(4.4 vs. 8.7 %) 
  in T1DM vs. 
healthy 
(9.7 ± 5.0 vs. 11.5 ± 
4.5%) 
Babar et al., (2011) 
T1DM (n=21)/healthy 
siblings (n=15) matched for 
age 
8.3 ± 0.3 (T1DM) 
7.6 ± 0.3 (healthy 
siblings) 
sigin T1DM  vs. healthy 
 (7.1 vs. 9.8 %) 
___ 
Singh et al., (2003) 
T1DM (n=31)/healthy 
(n=35) matched for age 
15.0 ± 2.4 (T1DM) 
15.7 ± 2.7 (healthy) 
sigin T1DM  vs. healthy 
(4.2 vs. 8.2 %) 
 
  in T1DM vs. 
healthy 
(17 vs. 18 %) 
Glowinska-Olszewska 
et al., (2013) 
T1DM (n=52)/healthy 
(n=36) matched for age 
14.5  
sig in T1DM vs. healthy 
(6.9 vs. 10.5%)  
___ 
Wiltshire et al., (2002) 
T1DM (n=36)/healthy 
(n=20) matched for age and 
gender 
13.7 ± 2.3 
sigin T1DM  vs. healthy 
 (5.2 vs. 9.1%) 
  in T1DM vs. 
healthy 
(19.5 vs. 23.3 %) 
Naylor et al., (2011) T2DM (n=15)/Healthy 
(n=13) matched for age 
14 sigin T2DM  vs. healthy 
 (8.0 vs. 10.4%) 
___ 
T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus;  %FMD, percent change in diameter following flow mediated 
dilation; %GTN, percent change in diameter following glyceryl trinitrate mediated dilation; sig, significant  
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Impaired endothelial function has been found in children as young as 7 years 
with FH (Table 2.3) (Sorensen et al., 1994).  In the first published study to examine 
endothelial function in children using non-invasive ultrasound, Celermajer et al., 
(1992) measured brachial artery FMD in children with FH between the age of 8 and 
16 years and found that FMD was significantly reduced or absent compared to 6 
aged-matched healthy controls.  There was no difference in EID between the groups 
(Celermajer et al., 1992). Others, (de Jongh et al., 2002, Vlahos et al., 2014, Sorensen 
et al., 1994) have also found significantly lower brachial artery FMD responses in 
children and adolescents with FH compared to healthy controls.  FMD was found to 
be inversely related to TC in both healthy children and those with FH and was 
inversely related to ApoA1 level in hypercholesterolemic children (Sorensen et al., 
1994). 
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Table 2.3.  Cross sectional studies comparing EDD and EID responses in children and adolescents with familial 
hypercholesterolemia and healthy children and adolescents  
Author (y) Age (y) Cohort %FMD %GTN 
Sorensen et al., (1994) 7-17 FH (n=30)/healthy (n=30) 
matched for age and gender 
sigin FH vs. healthy 
(1.2 vs. 7.5 %) 
sigin FH vs. healthy 
(12.4 vs. 10.0 %) 
de Jongh et al., (2002) 9-18 FH (n=50)/Healthy (n=19) 
matched for age 
sigin FH vs. healthy 
 (11.7 vs. 15.6%) 
___ 
Celermajer et al., (1992) 8-16 FH (n=10)/Healthy (n=6) sigin FH vs. healthy in FH vs. healthy 
 
Vlahos et al., (2014) 12 
 
FH (n=30)/Healthy (n=30) 
matched for age and gender 
sig in FH vs. healthy 
(6.2 vs. 9.5 %) 
____ 
FH, familial hypercholesterolemia; %FMD, percent change in diameter following flow mediated dilation; %GTN, percent 
change in diameter following glyceryl trinitrate mediated dilation; sig, significant. 
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Exercise/Physical Activity and Endothelial Function  
Regular exercise training and moderate to high levels of PA reduce the risk of 
CVD (Blair & Morris, 2009).  In a landmark study, Morris et al., (1953) found 
significantly lower rates of CVD in physically active bus conductors than sedentary 
bus drivers.  The conductors climbed approximately 600 steps per day (Morris et al., 
1953).  Similarly, physically active postmen were found to have a significantly lower 
rate of CHD than sedentary office clerks and telephone operators (Morris 1953 et al., 
1953).  The Harvard alumni study, one of the first large scale studies of self-reported 
PA and chronic disease found that adults who expended <2000 kcal per week had a 
64% increased risk of MI compared to those who expended >2000 kcal.wk-1 
(Paffenbarger et al., 1978).  
The mechanisms for the beneficial effect of exercise on CVD risk are 
multifactorial.  The Nurses’ Health Study found that among 27,000 women, those 
who expended >1500 kcal.wk-1 in PA had a 40% overall reduction in CVD risk than 
women who expended <200 kcal.wk-1 (Mora et al., 2007).  Only 59% of the risk 
reduction for CVD could be attributed to the effects of PA on traditional risk factors, 
indicating that that other putative mechanisms such as alterations in the autonomic 
nervous system and a direct effect of exercise on the vascular wall may also be 
responsible for the risk reduction (Joyner & Green, 2009).  
Autonomic dysfunction is associated with CVD.  Exercise training improves 
heart rate variability by enhancing vagal tone.  Enhanced endothelial function 
associated with exercise favors vasodilation and contributes to enhanced peripheral 
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baroflex function by limiting the increases in vascular stiffness associated with age 
and CVD risk factors (Joyner & Green, 2009).  Furthermore, positive interactions 
between enhanced endothelial function and sympathetic outflow limit the effects of 
high levels of baseline sympathetic outflow on BP. 
Endothelial Function and Cardiorespiratory Fitness - Cross Sectional Studies 
A number of cross-sectional studies have investigated the relation between 
CRF and endothelial function in healthy children (Hopkins et al., 2009, Treiber et al., 
1997).   Hopkins et al., (2009) examined the relation between brachial artery FMD, 
percentage body fat and V̇O2peak in 129 healthy asymptomatic 10 year old children
  
(Hopkins et al., 2009).  Brachial artery FMD was normalized for shear rate area under 
the curve (%FMD/SRAUC).  Overall, there was a significant relation between 
%FMD/SRAUC and percentage body fat and V̇O2peak.  However, when participants 
were classified into tertiles according to both percentage change in FMD (%FMD), 
and %FMD%/SRAUC there was no relation between V̇O2peak and %FMD or 
%FMD%/SRAUC.  There was a significant difference in V̇O2peak between the lower and 
upper tertile for %FMD%/SRAUC.  A cross-sectional study examining the relation 
between CRF, body fat and femoral artery FMD in asymptomatic healthy 11 to 14 
year olds found that FMD was inversely related to percentage body fat and positively 
related to CRF (Treiber et al., 1997).  In stepwise multiple regression analysis, CRF and 
SBP response to exercise accounted for 31% of the variance in femoral EDD (Treiber 
et al., 1997).   
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Aortic elasticity, another marker of vascular health is positively related to 
estimated V̇O2max in 17 year olds (Pahkala et al., 2013).  Reed et al., (2005) found 
that performance on a 20 m multistage shuttle run test (20 MST) accounted for 15% 
and 7% of the variance in large and small artery compliance in 9 to 11 years old 
children.  Arterial compliance was 34% greater in the highest CRF quartile than the 
bottom two quartiles (Reed et al., 2005).  
Endothelial Function, cIMT and Cardiorespiratory Fitness - Training Studies  
A number of studies have investigated the effect of short-term training on CRF 
and obesity-related vascular dysfunction in children and adolescents (Table 2.5) 
(Watts et al., 2004, Watts et al., 2005, Murphy et al., 2009).  Compared to age and 
weight-matched non-exercising controls, 12 weeks of aerobic-active video-gaming 
improved brachial artery FMD by 22% in overweight 10 year old children with 
impaired endothelial function (Murphy et al., 2009).  Using a crossover study design, 
Watts et al., (2004) evaluated the effect of circuit training (CT) on brachial artery FMD 
in obese adolescent boys and girls (Watts et al., 2004).  A matched group of lean boys 
and girls who did not train were recruited for cross-sectional comparisons.  The CT 
sessions were performed three times per week for 8 weeks and consisted of a 
combination of cycle ergometry and resistance training (RT).  Baseline brachial artery 
FMD was 67% lower in obese than lean adolescents and normalized relative to the 
lean group following eight weeks of CT.  Submaximal exercise HR responses were 
significantly lower in obese adolescents at matched workloads post training, 
indicating an improvement in CRF.   
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Figure 2.4.  Effect of circuit training on brachial artery FMD in obese adolescents in 
comparison to lean age-matched controls (Watts et al., 2004). 
In a prepubescent cohort of lean and obese boys and girls matched for age 
and physical activity levels, Watts et al., (2005) found that brachial artery FMD was 
105% higher in the lean children (Watts et al., 2005).  Despite no change in BMI, body 
fat, and HR responses at matched workloads, brachial artery FMD increased by 23% 
in the obese group following 8 weeks of monitored aerobic training (Watts et al., 
2005).  Brachial artery FMD did not however, normalize after training relative to the 
age and PA matched lean control group.  Since EID was not assessed in either study 
(Watts et al., 2004, Watts et al., 2005) it is not possible to determine whether the 
improvement in EDD was due to improved endothelium-dependent function or 
improvements in vascular smooth muscle sensitivity.  Using a randomized control 
design Kelly et al., (2004) found no change in brachial artery FMD or GTN mediated 
EID following 8 weeks of endurance training program in 11-year old overweight 
children (Kelly et al., 2004).  Despite a 6% increase in V̇O2max and a significant 
decrease in SBP, BMI and abdominal fat, Farpour-Lambert et al., (2009) also found no 
change in brachial artery FMD or GTN mediated EID in obese pre-pubertal children 
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following 3 and 6 months of moderate intensity exercise training.  Both arterial 
stiffness and cIMT decreased significantly at 6 months (Farpour-Lambert et al., 2009).   
Exercise interventions ranging from 6 to 12 months in duration have been 
found to improve CRF, restore endothelial function and decrease cIMT in overweight 
and obese youth and children (Meyer et al., 2006b, Woo et al., 2004, Tjonna et al., 
2008) and with T1DM (Seeger et al., 2011) Meyer et al., (2006b) found a significant 
improvement in radial artery FMD accompanied by a significant decrease in cIMT 
after 6 months of aerobic exercise training in 15 year old obese adolescents. The 
improvements in vascular health were related to reductions in BMI, body fat mass, 
waist-to-hip ratio, SBP, fasting insulin, TG, LDL-C/HDL-C ratio, hsCRP and fibrinogen ( 
Meyer et al., 2006b). 
Tjonna et al., (2008) compared the effect of a 12 month high-intensity aerobic 
interval training (AIT) program and a multi-treatment program on endothelial 
function and CVD risk factors in 14 year old overweight adolescents.  The multi-
treatment group had activity sessions and group meetings involving a physician, 
psychologist, physiotherapist, clinical nutritionist and physiologist.  Improvements in 
V̇O2max and endothelial function were significantly greater in the AIT than the multi-
treatment group at both 3 and 12 months.  Furthermore, AIT was more effective than 
the multi-treatment intervention in reducing traditional CVD risk factors (Tjonna et 
al., 2008).  In children aged 11 years with T1DM, eighteen weeks of exercise training 
resulted in a 6.8% and 39% increase in V̇O2peak and brachial artery FMD, 
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respectively.  There were no significant change in cIMT, BMI and waist circumference 
post training (Seeger et al., 2011). 
Endothelial Function - Diet and Exercise 
Two studies have assessed the combined effect of diet and exercise on 
obesity-related vascular dysfunction and cIMT in youth (Woo et al., 2004, Kelishadi et 
al. 2008).  Kelishadi et al., (2008) examined the effect of a 6 week exercise and diet 
intervention on endothelial function, cIMT and CVD risk factors in obese children 
ranging in age from 12 to 18 years (Kelishadi et al., 2008).  Participants performed 60 
min of aerobic based MVPA 3 d.week-1 for 6 weeks while adhering to a recommended 
diet.  Following the 6-week intervention, brachial artery FMD was significantly 
greater than baseline and there was no change in cIMT.  Training induced changes in 
CVD risk factors including BMI, waist circumference, fat mass, oxLDL, 
malondialdehyde, hsCRP, insulin and HOMA-IR were inversely related to the mean 
percentage change in FMD after adjustment for age and sex.  
Woo et al., (2004) compared the effect of 6 weeks and subsequently 1 year of 
dietary modification or a combined diet and exercise program on endothelial 
function, cIMT and CVD risk factors in overweight children aged 9-12 years.  Both 
group consumed a 900-1200 kcal hypo-caloric diet (Woo et al., 2004).  In addition, 
the exercise group undertook two weekly 75 min bouts of circuit-based exercise 
combining resistance, aerobic and agility training.  Although brachial artery FMD 
increased significantly in both groups after 6 weeks, the improvement was greater in 
the combined diet and exercise group than the diet only group.  Further 
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improvements in EDD were found in both groups from 6 weeks to 1 year.  Both 
interventions resulted in a significant decrease in the waist-to-hip ratio and TC level.   
Endothelial Function – Physical Activity 
In 13 year-old boys, maximum FMD and area under the dilation curve 40-180 
sec after hyperemia were found to be directly associated with self-reported leisure 
time physical activity (LTPA) (Pahkala et al., 2008).  These associations remained 
significant after adjusting for baseline brachial artery diameter, BMI, HDL-C, LDL-C, 
TG, hsCRP and SBP.  A difference in MVPA between sedentary and active boys of 
approximately 40 MET/h wk-1 was associated with a 1% unit difference in maximal 
FMD. 
Objectively measured time spent in moderate and high intensity PA has also 
been found to be significantly related to %FMD and %FMD corrected for shear rate 
(%FMD/SRAUC) in pre-pubertal healthy children (Hopkins et al., 2009).  Participants 
were split into tertiles according to FMD% and %FMD/SRAUC.  While MVPA and 
vigorous physical activity (VPA) were significantly related to %FMD/SRAUC across the 
entire cohort, the strongest relation was found between PA and FMD in the lowest 
%FMD/SRAUC tertile.  Seasonal decreases in objectively measured high intensity PA 
have also been associated with a decrease in brachial artery FMD in 11 year old 
children (Hopkins et al., 2011).  Abbott et al., (2002) found that PA was related to the 
percentage change in brachial artery FMD in normal weight 5 to 10 year old children 
and FMD was significantly lower in the least active tertile compared to the most 
active tertile (Abbott et al., 2002). 
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In a longitudinal study, self-reported LTPA measured as MET/h wk-1 in 13 to 
17 years adolescents was independently related to both maximum brachial artery 
FMD and total FMDAUC response (Pahkala et al., 2011).  Maximum FMD increased in 
the sedentary adolescents who increased their LTPA from <5 MET/h wk-1 to >30 
MET/h wk-1 between the age of 13 and 17 years compared with those who remained 
sedentary during that time.  
Endothelial function – Sedentary Behaviour  
To date only one published study has examined objectively measured 
sedentary behavior and endothelial function in healthy children.  Hopkins et al., 
(2012) measured baseline brachial artery FMD and total sedentary time over 7 days 
using a uniaxial accelerometer in 116 healthy children aged 10.7 years in summer and 
again 6 months later. At baseline, there was no association between FMD and 
sedentary time. While a significant decrease in brachial artery FMD and a significant 
increase in sedentary behaviour was observed between the seasons, the lack of 
association between brachial artery FMD and objectively measured total sedentary 
time remained  (Hopkins et al., 2012). 
Mechanisms for Exercise-induced Improvements in Endothelial Function  
Exercise induced improvements in vascular function are attributed to a 
combination of enhanced vasodilatory capacity and arterial remodeling, risk factor 
modification and a reduction in ROS. Improvements in vasodilatory capacity normally 
proceed structural remodeling (Green et al., 2004).  Repetitive increases in vascular 
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wall shear stress that accompany regular exercise training are associated with an 
increased up-regulation of eNOS expression (Green et al., 2004).  This subsequently 
increases the synthesis and release of NO and improves endothelial function.  
Improvements in endothelial function may also be mediated through CVD risk factor 
modification.  Compared with sedentary controls, lower cholesterol levels were 
related to an enhanced forearm dilation response to ACh in highly trained athletes 
(Kingwell et al., 1996). 
Improvements in endothelial function in response to exercise training may 
occur independent of changes in traditional CVD risk factors.  Green et al., (2003) 
found that 8 weeks of exercise training in adults with CV risk factors did not 
significantly alter plasma lipids, BP, blood glucose, waist-to-hip ratio or BMI despite 
an improvement in endothelial function in conduit and resistance vessels (Green et 
al., 2003).  Similarly, improvements in brachial artery FMD following 8 weeks of 
aerobic exercise training were not associated with changes in BMI, BP and plasma 
lipids in obese children and adolescents (Watts et al., 2005).  
Improvements in endothelial function may also be mediated by a reduction in 
ROS and a restoration of NO bioavailability (Durand & Gutterman, 2014).  Repeated 
up-regulation of eNOS in response to exercise training may increase the half-life of 
NO by reducing its degradation by free radicals (Fukai et al., 2000), or by directly 
inhibiting free radical production (Adams et al., 2005).  Paradoxically, 12 weeks of 
exercise training, 5-7 times per week for 30 min at 75% V̇O2max increased oxidative 
stress but failed to improve ACh mediated forearm vasodilation in healthy young 
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men, whereas training at 50% V̇O2max improved the vasodilatory response to ACh in 
the absence of oxidative stress (Goto et al., 2003).  These findings indicate that there 
may be an intensity threshold beyond which exercise negatively impacts endothelial 
function due to increased generation of ROS. 
Carotid Intima Media Thickness 
Carotid intima media thickness (cIMT) is the distance between the lumen 
intima interface and the media adventitia interface of the carotid artery wall 
(Pignoliet al., 1986).  It is a commonly used index of arterial structure and is 
measured using ultrasonography.  cIMT is regarded as valid indicator for generalised 
atherosclerosis as it is associated with atherosclerosis in other areas of the arterial 
tree (Bots & Grobbee, 2002). 
The validity of ultrasonographically determined cIMT as a non-invasive 
surrogate marker for atherosclerotic CVD has been well established (Bots & Grobbee, 
2002). Compared with angiography, measurement of cIMT using B-mode 
ultrasonography demonstrates greater sensitivity in detecting early atherosclerosis 
(Bots & Grobbee, 2002).  The measurement of cIMT is increasingly used for risk 
stratification and as a surrogate end point in clinical trials to assess the efficacy of 
interventions against atherosclerosis.  As vascular events in young individuals are 
rare, cIMT is an attractive end point in epidemiological and intervention studies in 
young asymptomatic populations (Lorenz et al., 2007). 
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cIMT – Measurement  
The measurement of cIMT is routinely undertaken at the near and/or far wall 
of arterial segments including the carotid bulb, internal carotid artery and the CCA.  
Images of the CCA are easier to obtain and are highly reproducible compared to other 
carotid arterial segments (Nambi et al., 2012).  Furthermore, IMT at the CCA is 
associated with adverse CV events (Fernhall & Agiovlasitis, 2008).  The majority of 
pediatric studies examining the relation between CVD risk factors and cIMT have 
measured IMT of the CCA far wall (Urbina et al., 2009).  Compared with histological 
examination, CCA far wall measurements more accurately represent the thickness of 
the intima media complex than near wall measurements (Urbina et al., 2009).  
Furthermore, Espeland et al., (1999) found a stronger relation between CVD risk 
factors and far wall cIMT than near wall cIMT measurements (Espeland et al., 1999). 
Large follow-up trials including the Atherosclerosis Risk in Communities (AIRC) 
study and the Rotterdam study found that cIMT is an independent predictor of future 
clinical vascular events such as stroke and MI in asymptomatic adults (O’Leary et al., 
1999, Bots et al., 1997).  A meta-analysis of longitudinal studies examining the 
relation between cIMT and future CV events found that a 0.1 mm increase in cIMT 
was associated with an 18% and 15% increase in age and sex-adjusted relative risk for 
future stroke and MI, respectively (Lorenz et al., 2007).  The addition of cIMT to 
traditional risk factor score has been found to improve CHD risk prediction in middle-
aged and older adults (Nambi et al., 2012).  
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cIMT Values in Healthy Children 
Based on arbitrary-chosen cut-off points, normal values for cIMT in adults 
range between 0.5-1.2 mm.  Increased cIMT is associated with both CAD and with 
several CVD risk factors (Le et al., 2010).  The presence of carotid plaque is 
demonstrated by cIMT values > 1.2 mm (Bots & Grobbee, 2002).   
Normative cIMT values for children and adolescents are limited (Le et al., 
2010).  Normal cIMT mean values in healthy children and adolescents have been 
reported to range between 0.32 mm to 0.50 mm (Urbina et al., 2009).  Doyon et al., 
(2013) recently published the first pediatric sex and age reference values for cIMT 
based on the measurement of 1155 healthy European children between the age of 6 
and 18 years (Doyon et al., 2013).  The 50th percentile of cIMT increased in boys from 
0.37 mm at 6 years of age to 0.41 mm at 18 years of age (Doyon et al., 2013).  In 
contrast, Sass et al., (1998) found that cIMT was not affected by age or gender until 
after 18 years in a large cohort of 10 to 25 year olds.  After the age of 18 years, cIMT 
increased significantly in males compared to females of similar age (Sass et al., 1998). 
Vascular Aging 
The Framingham Risk score is a gender-specific algorithm used to estimate 
the 10-year CV risk of an individual.  CVD risk is calculated on points awarded 
depending on the presence of a number of risk factors including age, BP, diabetes, 
smoking and cholesterol levels.  More recently, the SCORE-CARD evaluation system 
was introduced which is based on data from a large number of European countries.  
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Risk factors including age, gender, smoking and TC are used in the prediction model.  
Scoring systems such as The Framingham Risk Score and the SCORE-CARD are 
strongly influenced by chronological age and do not consider that the atherosclerotic 
burden of individuals with the same chronological age and similar risk profiles can 
greatly differ (Stein et al., 2004). 
The concept of “Vascular aging” (VA) has more recently been integrated with 
existing risk stratification paradigms into CHD risk assessment.  VA evaluates cIMT 
measurements against percentile charts for race and gender matched adult 
population (Stein et al., 2004).  Although normative values in children are currently 
limited, VA estimation, and the ability to relate cIMT measurements to adult 
measurements may serve as a useful adjunct to stratify children at risk of developing 
premature atherosclerosis (Le et al., 2010).  In the only published study to estimate 
VA in children, Le et al., (2010) reported that 75% of children aged 6-19 years with 
obesity and CVD risk factors including dyslipidemia, hypertension, insulin resistance 
and tobacco exposure had advanced VA, defined as having a mean cIMT similar to 
that of a race and sex-matched 45 year old (Le et al., 2010).  The average cIMT was 
0.07 mm higher in children with advanced VA compared to children with age 
appropriate cIMT.  
cIMT and CVD Risk Factors  
Observational studies have reported increased cIMT in children with obesity 
(Zhu et al., 2005,  Yilmazer et al., 2010,  Iannuzzi et al., 2004,, Meyer et al.,2006, Woo 
et al., 2004, Reinehr et al., 2006, Stabouli et al., 2012), FH (Pauciullo et al., 1994, 
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Tonstad et al., 1996, Virkola et al., 1997, Wiegman et al., 2004), hypertension (Lande, 
et al., 2006, Litwin et al., 2006, Litwin et al., 2004), T1DM (Jarvisalo et al., 2004, 
Jarvisalo et al., 2002 , Pozza et al., 2007) and T2DM (Naylor et al., 2011, Urbina, et al., 
2009) compared to healthy children.  Among the risk factors examined in children, 
cIMT is positively associated with age (Stabouli et al., 2012), level of obesity (Stabouli 
et al., 2012), BMI and waist circumference (Yilmazer et al., 2010), glucose and hsCRP 
(Reinehr et al., 2006), TC, LDL-C, Apo-B (Zhu et al., 2005), homocysteine, LDL-C and 
ApoA1 (Litwin et al., 2004), hyperinsulinemia and hypertriglyceridemia (Yilmazer et 
al., 2010), SBP (Stabolui et al., 201,2 Litwin et al., 2004) 24 h SBP (Litwin et al., 2006) 
and pulse pressure (Stabolui et al. ,2012, Litwin et al., 2004, Litwin et al., 2006). 
cIMT and Obesity  
Childhood obesity is associated with and increased risk of atherosclerotic 
disease in adulthood (Must et al., 1992).  The adverse effect of obesity on the 
structure of large conduit arteries appears to be mediated in part by exposure to risk 
factors particularly SBP and insulin resistance (Iannuzzi et al., 2004).  A number of 
cross-sectional studies in children and adolescents have found that, after adjustment 
for potential confounders, cIMT is increased in children who are overweight (Woo et 
al., 2004) or obese (Iannuzzi et al., 2004, Reinehr et al., 2006, Meyer et al., 2006,  Zhu 
et al., 2005, Yilmazer et al., 2010) compared to healthy lean age-matched controls.  A 
small number of studies however, failed to find a significant difference in cIMT 
between obese and healthy children and adolescents (Tounian et al., 2001, Aggoun et 
al., 2008, Farpour-Lambert et al., 2009). 
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Overweight/obese children with increased cIMT have also significantly greater 
arterial stiffness (Iannuzzi et al., 2004, Yilmazer et al., 2010) and lower FMD (Yilmazer 
et al., 2010, Woo et al., 2004).  Children with elevated IMT defined as IMT > 0.48 mm 
also have significantly lower physical fitness levels (Meyer et al., 2006) Others have 
found no significant difference in cIMT between obese children and adolescents with 
impaired endothelial function and healthy age- matched controls (Tounian et al., 
2001,  Aggoun et al., 2008, Farpour-Lambert et al., 2009).  Farpour-Lambert et al., 
(2009) found no significant difference in IMT of the CCA in prepubertal obese children 
and in lean age-matched healthy controls despite obese children having significantly 
lower EDD, EID, V̇O2 max and PA levels and significantly higher BP, BMI, body weight, 
abdominal fat, insulin resistance indexes, hsCRP and arterial stiffness (Farpour-
Lambert et al., 2009).  The disparate findings may be due in part to the fact that 
arterial stiffness was not advanced enough to produce IMT and that changes in 
vascular function occur much earlier than structural changes (Cote et al., 2013).  
Furthermore, the effect of age, puberty and body fat distribution on cIMT in children 
remains uncertain (Cote et al., 2013). 
cIMT and Hypertension  
cIMT has emerged as a potential marker of hypertensive vascular damage 
(Lande et al., 2006).  Increased cIMT has been found in obese hypertensive children 
(Lande et al., 2006,  Litwin et al., 2006,  Litwin et al., 2004, Stabouli et al., 2012). 
Some studies have however, failed to demonstrate an increased cIMT in hypertensive 
children and adolescents after adjusting for BMI while others did not find BP to be an 
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independent predictor of cIMT (Litwin et al., 2006,Litwin et al., 2004,  Stabouli et al., 
2012). 
cIMT and Type 1 Diabetes Mellitus 
A number of cross-sectional studies have compared CCA IMT in children and 
adolescents with T1DM and healthy controls.  The majority of these studies found 
that CCA IMT was significantly higher in children with T1DM than healthy controls 
(Järvisalo et al., 2004, Jarvisalo et al., 2002, Rodriguez et al., 2007, Pozza et al., 2007 
(Głowińska-Olszewska et al., 2013).  Järvisalo et al., (2002) also found that children 
with T1DM and impaired brachial artery FMD had significantly higher far wall CCA 
IMT than children with T1DM and normal FMD (Järvisalo et al., 2002).  One study 
found no significant difference in CCA IMT between children with T1DM and low FMD 
and their healthy siblings (Babar et al., 2011).  Diabetic state (Jarvisalo et al., 2002, 
Järvisalo et al., 2004), age at onset of diabetes (Pozza et al., 2007), daily insulin dose 
(Pozza et al., 2007), SBP (Jarvisalo et al., 2002, Rodriguez et al., 2007, Pozza et al., 
2007), TC (Pozza et al., 2007), LDL-C (Jarvisalo et al., 2002, Rodriguez et al., 2007, 
Järvisalo et al., 2004) and brachial artery FMD (Järvisalo et al., 2004) were 
independently related to CCA IMT in children with T1DM. 
cIMT and Type 2 Diabetes Mellitus  
Only two published studies have examined cIMT in children and adolescents 
with T2DM (Naylor et al., 2011, Urbina, et al., 2009).  CCA far wall IMT was 
significantly higher in children with T2DM than both lean aged-matched healthy 
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controls and obese non-insulin resistant controls (Naylor et al., 2011).  Urbina et al., 
(2009) compared IMT of the CCA, carotid bulb and ICA in lean, obese and T2DM 
individuals between the ages of 10 and 24 years.  Individuals with T2DM had 
significantly higher IMT of the CCA than both lean and obese controls and 
significantly higher IMT of the ICA and carotid bulb than lean controls (Urbina et al., 
2009). 
cIMT and Familial Hypercholesterolemia  
Findings from cross-sectional studies comparing cIMT in children and 
adolescents with FH and healthy children have been equivocal with some studies 
reporting increased cIMT in children with FH (Virkola et al., 1997,  Pauciullo et al., 
1994, Wiegman et al., 2004,  Kusters et al., 2014, Tonstad et al., 1996) while others 
have found no difference in cIMT between the two groups (Vlahos et al., 2014, Riggio 
et al., 2010).  In a recent study, Vlahos et al., (2014) found that brachial artery FMD 
was significantly lower and TC, LDL-C, ApoB and ApoA1 levels were significantly 
higher in 12-year-old children with heterozygous FH than healthy age and gender-
matched controls.  However, there was no difference in cIMT between the two group 
(Vlahos et al., 2014).  Similarly, Riggio et al., (2010) found no difference in cIMT 
between children with FH, untreated hypercholesterolemia and primary 
hypercholesterolemia and age and sex-matched controls (Riggio et al., 2010). 
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cIMT – Cardiorespiratory Fitness 
A number of cross-sectional studies have found an inverse association 
between CRF and cIMT in obese and normal weight children and adolescents (Table 
2.4) (Meyer et al., 2006, Kim et al., 2011, Silva et al., 2014, Melo et al., 2014).  Low 
levels of CRF were found to be associated with increased IMT of the CCA and carotid 
bifurcation in obese 9 to 16 year old children with impaired radial artery FMD ( Meyer 
et al., 2006).  More recently, Silva et al., (2014) also found that IMT of the CCA was 
inversely associated with objectively measured V̇O2max in obese and non-obese 10 to 
16 year old boys and girls (Silva et al., 2014).  Kim et al., (2011) found that estimated 
V̇O2max was inversely related with maximum cIMT in 17-year-old Korean males with 
an average BMI of 21 kg.m2 (Kim et al., 2011).  This relation was no longer significant, 
after adjusting for BMI.  In a sample of children aged 11-13 years, Melo et al., (2014) 
also found a significant inverse relation between estimated V̇O2max and cIMT 
independent of MVPA and sedentary behaviour.  Estimated V̇O2max was however, no 
longer associated with cIMT after adjusting for waist circumference (Melo et al., 
2014).  These findings suggest that perhaps the effect of CRF on cIMT is mediated by 
adiposity.  
In contrast, a number of cross-sectional studies involving approximately 800 
children and adolescents have failed to find a significant relation between CRF and 
cIMT (Pahkala et al., 2013, Ried-Larsen et al., 2013).  Although Pahkala et al., (2013) 
found that estimated V̇O2max, was independently and inversely associated with 
aortic IMT and young elastic modulus, a measure of arterial elasticity, there was no 
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relation with cIMT (Pahkala et al., 2013).  The equivocal findings may be related to 
the fact that some studies measured V̇O2max while in others, it was estimated.   
 
 54 
Table 2.4.  Cross-sectional studies examining the relation between CRF and cIMT in healthy children and adolescents  
Author (year) Age (y) Cohort Measurement of CRF Results 
Meyer et al., (2006) 13.7  2.1 (obese ) 
14.7  2.2 (healthy)  
 
32 obese /20 healthy V̇O2max  
Maximal CE test  
Low levels of CRF positively 
associated with increased 
cIMT  
Silva et al., (2014) 10-16 35 obese/18 healthy  
m/f=28/7 
V̇O2max  
Maximal TM test  
V̇O2max was inversely 
associated with cIMT  
Kim et al., (2011) 16.96  0.23 225 healthy males  Estimated V̇O2max 
One mile run test  
V̇O2max was inversely 
associated with cIMT 
Melo et al., (2015) 11-13  265 healthy  
m/f= /130135 
Estimated V̇O2max 
Maximal CE  test  
V̇O2max inversely associated 
with cIMT  
Ried-Larsen et al., 
(2013) 
15.6  0.4 336 healthy  
m/f=179/219 
Estimated V̇O2max 
Maximal CE test 
No association between 
V̇O2max and cIMT  
Pahkala et al., 
(2013) 
17 years m/f=189/179 
Fitness tertiles; m(LF=63, 
MF=63, HF=63) 
f (LF=60, MF=59, HF=60) 
Estimated V̇O2max 
Maximal CE test 
No association between 
V̇O2max and cIMT 
CRF, cardiorespiratory fitness; V̇O2max, maximal oxygen uptake; m/f, male/female; LF, low fit; MF, moderately fit; HF, high fit; CE, cycle 
ergometer; TM, treadmill 
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cIMT- Physical Activity 
Findings from studies that have evaluated the relation between PA and cIMT 
in children and adolescents have been equivocal  (Ried-Larsen et al., 2013, Ried-
Larsen et al., 2014, Pahkala et al., 2011).  PA intensity, measured using accelerometry 
was not associated with cIMT in a large sample of 16 year old Danish adolescents 
(Ried-Larsen et al., 2013).  Similarly, a 6 year prospective study found no association 
between exposure to, or changes in minutes spent in higher PA intensities between 
the age of 8 and 10 years and cIMT during adolescence (Ried-Larsen et al., 2014).  In 
contrast, studies that have employed self-reported measures to assess PA have found 
inverse associations between PA and IMT.  Pahkala et al., (2011) using a prospective 
study design found that after adjusting for age, sex, BMI, HDL: TC, SBP, hsCRP and 
brachial artery diameter, LTPA assessed by questionnaire was inversely associated 
with aortic IMT (aIMT) in the same cohort measured at 13, 15 and 17 years of age.  
Sedentary adolescents who increased their LTPA from <5 to >5 METS h/.wk-1 
between 13 and 17 years had a significantly decreased progression of aIMT than 
those who maintained LTPA at <5 METS/h.wk-1.  Individuals who remained physically 
active had a significantly lower rate of aIMT progression than those who remained 
sedentary (Pahkala et al., 2011). These equivocal findings may be due to the inherent 
differences in methods employed to measure PA. 
CIMT- Sedentary Behaviour  
To date, only one published study has examined the association between 
objectively measured sedentary behavior and cIMT in 265 children aged 11-13 years 
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(Melo et al., 2014). Using 100 counts per min as a sedentary cut-point,, 4 days of total 
sedentary time measured using an Actigraph uniaxial accelerometer was not 
associated with CCA far wall IMT with or without adjustment for waist circumference 
(Melo et al., 2014). In contrast, waist circumference was positively associated with 
cIMT suggesting that adiposity may perhaps be a stronger determinant of cIMT in 
children and adolescents.  
Aortic Intima Media Thickness  
Autopsy studies have found that changes in vascular structure occur in the 
intima of abdominal aorta prior to the coronary and carotid arteries (McGill et al., 
2000).  Measurement of aIMT may therefore provide a better index of preclinical 
atherosclerosis.  Compared to cIMT, measurement of aIMT has been found to 
provide greater sensitivity in identifying subclinical atherosclerosis in high risk 
children (Jarvisalo et al., 2001).  While both aIMT and cIMT measurements were 
higher in children with T1DM and hypercholesterolemia than healthy controls, the 
increase in IMT was relatively greater in the aorta than the carotid artery (Jarvisalo et 
al., 2001).  A study examining both aIMT and cIMT found a significant increase in 
aIMT only, in children with T1DM compared to healthy controls.  Measures of aIMT 
were significantly related to CVD risks factors (Harrington et al., 2010).  Among 
adolescents, Dawson et al., (2009) found a stronger association between CVD risk 
factors and aIMT than cIMT (Dawson et al., 2009).  
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Table 2.5: Studies examining the effect of exercise training on flow mediated dilation, cIMT, CVD risk factors and CRF in children and 
adolescents  
 
Author 
 
Cohort Age(Y)  Intervention FMD cIMT  
 
CVD risk factors 
 
CRF 
Watts et al., 
(2004) 
Obese Ex (N=19)  
Obese CTL( N = 
20) 
14.3 ± 1.5 ET + RT 60 min 3d/wk/8wk  ___  BF, Lipids, 
homocysteine, 
HBA1c, BP 
 
Watts et al., 
(2004) 
Obese Ex (N=14)  
Obese CTL (N = 7) 
8.9 ± 0.4 ET 60 min 3d/wk/8wk  _____  HbA1c  BW, 
BMI, BF, lipids, 
homocysteine, 
glucose, BP 
 
Kelly et al., 
(2004) 
OW Ex (N=10)  
OW CTL (N = 20) 
10.9 ± 0.4 ET 30-50 min 4d/wk/8wk  ____  HDL-c vs. con  
Murphy et al., 
(2009) 
OW Ex (N=23)  
OW CTL (N= 12) 
7-12 ET 10-30 min 5d/wk/12wk  ____  BW, MAP  
Fapour Lambert 
et al., (2009) 
Obese Ex (N=22)  
Obese CTL (N = 
22) 
8.5 ± 1.5 ET 60 min/3d/wk/12wk 
ET 60 min/2d/wk/6mo 
 at 3 
& 6 mo  
 at 
3 mo 
at 6 
months  
 BP, BMI, BF  
Meyer et al., 
(2006) 
Obese Ex (N=33)  
Obese CTL (N = 
34) 
14.7 ± 2.2 ET 60 min/2d/wk + 
90min/1d/wk/6mo 
 vs. con   BMI, BF, W:H, 
insulin, insulin 
resistance, TG, 
LDL: HDL, 
fibrinogen, hsCRP 
 
Tjonna et al., 
(2009) 
OW AIT (N=20)  
OW MTG (N = 22) 
14.0 ± 0.3 AIT: 4x4 min/2d/wk/3mo    
MTG: Group Meeting 2d/wk/ 
AIT 
(6.3%) 
MTG  
(3.9) 
 
____ AIT:  BMI, BF, 
SBP, DBP, MAP, 
insulin, glucose, 
HOMA, HbA1c  
HDL-c 
 
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 MTG:  SBP, 
insulin, HOMA, 
HbA1c  HDL-c 
Seeger et al., 
(2011) 
T1DM Ex (N=9) 10.9 ± 1.5 ET 30-60 min 2d/wk/18wk    BMI, WC 
 
 
Kelishadi et al., 
(2008) 
Obese Ex+ Diet 
(N=35) 
12-18 ET 60 min 3d/wk/6wk    BMI, BF, WC, 
W:H,TC, LDL-C, 
TG, Insulin, 
HOMA-IR, hsCRP, 
oxLDL-c, MDA 
___ 
Woo et al., 
(2004) 
Obese Ex + Diet 
(N=41)  
 Obese Diet(N = 
41) 
9-12 y  ET 75min 2d/wk/6wk   Ex +Diet: W:H, 
TC,LDL-c, 
LDL:HDL, glucose.         
Diet:  
W:H,TC,HDL-c, 
LDL:HDL 
___ 
Woo et al., 
(2004) 
Obese Ex + Diet 
(N=22)  
 Obese Diet(N = 
41) 
9-12 y  ET 75min 1d/wk/1yr   Ex +Diet: BF, 
LDL-c, HDL-c, 
LDL:HDL Diet:  
TC,HDL-c, 
LDL:HDL 
___ 
FMD, flow mediated vasodilation; CRF, cardiorespiratory fitness; Ex, exercise group; CTL; control group; ET, endurance training; RT, 
resistance training; BF, body fat; BP, blood pressure; OW, overweight; BW. Body weight; BMI, body mass index; W: H, waist-to-hip ratio; 
WC, waist circumference; MAP, mean arterial pressure; hsCRP, High sensitivity C-reactive protein; SBP, systolic blood pressure; DBP, 
diastolic blood pressure; triglycerides; TC, total cholesterol; AIT, aerobic interval training, MTG; multidisciplinary approach; OxLDL-c, 
oxidized LDL-cholesterol; MDA , malondialdehyde; HbA1c,glycosylated hemoglobin, HOMA, Homeostasis model assessment of insulin 
resistance; 
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Inflammation and CVD  
  Although traditional CVD risk factors such as age, male sex, 
hypercholesterolemia, hypertension, and smoking, account for most of the risk of 
coronary heart disease approximately one-third of individuals with ≤ 1 risk factor 
develop CHD, 15% to 20% occur in individuals with none of the major traditional risk 
factors and close to 50% occur in individuals with no overt evidence of 
hyperlipidemia (Khot et al., 2003, Greenland et al., 2003). 
 The role of inflammation in the propagation of atherosclerosis and susceptibility 
to CV events is well established (Ridker et al., 2000).  In response to endothelial 
damage, a complex intracellular network of T-lymphocytes, macrophages and smooth 
muscle cells secrete an array of growth factors and pro-inflammatory cytokines that 
mediate functional and structural changes in the vasculature (Kofler et al., 2005).  
Upon activation, endothelial cells also secrete vascular adhesion molecules to which 
circulating leukocytes adhere.  High circulating levels of pro-inflammatory cytokines 
including IL-1, IL-6 and TNF-α, further add to the expression of adhesion molecules 
(Bruyndonckx et al., 2013), increase oxidative stress, down-regulate eNOS bioactivity 
and cause endothelial cell apoptosis (Kofler et al., 2005). 
  A number of systemic inflammatory proteins have been identified as potential 
indicators of subclinical atherosclerosis and have been used in the prediction of risk 
of CV events including hsCRP, serum amyloid A (SAA), cytokines such as IL-6, and 
adhesion molecules such as soluble intracellular adhesion molecule-1 (sICAM-1) 
 60 
(Ridker et al., 2000).  A number of these markers have been found to impair 
endothelial function either directly by reducing NO production or indirectly by 
increasing ROS generation.  
High Sensitivity C-Reactive Protein (hsCRP) 
  High sensitivity C-reactive protein (hsCRP) is an acute phase reactant and non-
specific marker of inflammation produced predominantly in hepatocytes in response 
to several cytokines.  Of the wide array of inflammatory biomarkers that have been 
studied, CRP has received the most attention for its use in screening and risk.  
Systemic low-grade inflammation, as assessed by measuring serum concentrations of 
hsCRP, has been found to be an independent risk factor of future cardiovascular 
events in a large number of studies involving both men and women.  Although hsCRP 
is associated with increased CVD risk, definitive randomized evidence for its role as a 
causative factor in atherothrombosis is lacking (Yousuf et al., 2013) 
  As a predictor of this risk, high sensitivity measurements are needed, and 
hsCRP assays have been developed.  Circulating hsCRP values > 3.0 mg.L-1, 1.0-3.0 
mg.L-1 and < 1.0-mg.L-1 are associated with a high, moderate and low risk of CVD, 
respectively (Ridker, 2005).  Phenotypes that portent accelerated atherosclerosis, 
including obesity, metabolic syndrome and insulin resistance, are associated with 
elevated levels of hsCRP. CRF and adiposity may influence CVD risk through their 
effects on inflammation.   
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  Circulating hsCRP levels are significantly higher in overweight than normal 
weight children and adolescents (Peña et al., 2006, Kapiotis et al., 2006, Meyer et al., 
2006,  Peña et al., 2010, Akinci et al., 2008, Farpour-Lambert et al., 2009, Jarvisalo et 
al., 2002).  hsCRP has also been associated with impaired brachial artery FMD and 
increased CIMT in healthy children and adolescents (Jarvisalo et al., 2002).  
  In the first study to evaluate hsCRP levels in a population-based sample of 
apparently healthy children, Cook et al., (2000) found that adiposity was the 
important determinant of hsCRP levels among the characteristics measured in English 
and Welsh children aged 9-11 years (Cook et al., 2000).  The fall in hsCRP levels with 
increasing levels of PA was only of borderline significance.  This may be due in part to 
the crude nature of the PA questionnaire employed in the study.  In contrast, resting 
HR, which is a reasonable marker of aerobic fitness in children, was significantly 
related to hsCRP levels.  HsCRP was correlated with several CVD risk factors, but only 
fibrinogen, HDL-C, resting HR and SBP remained statistically significant after 
adjustment for the confounding effect of adiposity.  Adiposity was independently 
related to all CVD risk factors independent of hsCRP.  Adjustment for hsCRP had little 
effect on the relation between adiposity and CVD risk except for that with fibrinogen, 
indicating that while adiposity has effects on hsCRP, the effect of adiposity on some 
CVD risk factors is via a separate pathway.  The study findings suggest that, with the 
possible exception of fibrinogen, hsCRP does not mediate the effects of obesity.  
 Other studies have found evidence of a state of low-grade systemic 
inflammation in overweight children.  In a sample of 3512 children from the NHANES 
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III, a higher prevalence of elevated hsCRP was found in overweight than normal 
weight children, even after controlling for disease and other factors known to 
influence hsCRP concentrations (Visser et al., 2001).  Another NHANES III study 
involving 2846 boys and girls 3 to 17 years of age found that among the measured 
socio-demographic and CVD risk factors, BMI was the most consistent and strongest 
predictor of hsCRP concentration (Ford, 2003).  A recent study involving healthy 
preschool boys and girls between the age of 3 to 5 years, found that obese children 
presented with inflammatory and metabolic alterations (Carmona-Montesinos et al., 
2015).  Preschool children who were classified as obese had significantly higher 
circulating levels of hsCRP, TG, LDL-C and glucose levels as well as decreased levels of 
HDL compared with eutrophic children.  
  Currently, limited information exists on the role of CRF on hsCRP in children 
and adolescents.  Among US children 12 to 16 years of age, percent body fat 
correlated positively and physical fitness and inversely with hsCRP concentration. 
However, 8 months of physical training had little effect on CRP concentrations 
despite weight loss and improved fitness (Barbeau et al., 2002).  Sun et al., (2014) 
found that higher childhood CRF is associated with lower levels of hsCRP and 
fibrinogen 20 years later when the participants were young adults.  Higher childhood 
adiposity and an increase in adiposity from childhood to adulthood were associated 
with higher adult hsCRP levels, independent of fitness (Sun et al., 2014). With the 
majority of studies demonstrating a positive relation between measures of adiposity 
on hsCRP and a limited studies examining the mediating role of CRF in this 
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relationship, adiposity appears to be a stronger determinant of hsCRP.  However, the 
inverse relation observed between hsCRP and CRF suggests that CRF may play a 
protective role on low-grade inflammation through reductions in adiposity.  
Serum Amyloid A (SAA) 
 Similar to hsCRP, serum amyloid (SAA) is an acute phase protein synthesized 
in the liver in response to infection, injury, inflammation or stress.  Specifically, its 
expression is upregulated in response to pro-inflammatory cytokines including 
interleukin-1 beta (IL-1β), IL-6 and TNF-α.  Circulating SAA associates predominately 
with HDL-C.  It displaces ApoA1, the major Apo lipoprotein of HDL-C, particularly 
during the acute phase response and alters reverse cholesterol transport.  
  Elevated levels of SAA have been found to predict CVD events (Johnson et al., 
2004, Ridker et al., 2000) even better than hsCRP (Kosuge et al., 2007). Obese 
children and adolescents have increased levels of SAA compare to their lean healthy 
counterparts (Gomez-Ambrosi et al., 2008).   
Interleukin-6 (IL-6)  
  Interleukin-6 is a cytokine that has both pro-inflammatory and anti-
inflammatory properties (Scheller et al., 2011). In addition to inflammation, IlL-6 is 
involved in the regulation of metabolism, neural and regenerative processes (Scheller 
et al., 2011.)  As a proinflammatory cytokine, IL-6  stimulates the production of acute-
phase proteins, including hsCRP, in the liver (Ridker et al., 2000). Higher adipose 
tissue content of IL-6 has been associated with higher serum hsCRP concentrations in 
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obese persons. The release of interleukin-6 from adipose tissue may induce elevated 
hsCRP concentrations in individuals with excess body fat.  In addition to the 
stimulation of acute phase proteins, IL-6 also stimulates the production of 
angiotensin II in vascular smooth muscle cells and the subsequent production of ROS 
(Wassmann et al., 2004).   Increased production of ROS results in decreased NO 
production, an uncoupling of eNOS and paradoxical increased ROS generation 
(Landmesser et al., 2003).  Higher levels of circulating IL-6 have been found in obese 
children with lower FMD and increased cIMT compared to healthy children (Kapiotis 
et al., 2006, Murphy et al., 2009).  
TNF-  
 Tumor necrosis factor alpha (TNF-α), a pro-inflammatory cytokine is primarily 
produced by activated macrophages in adipocytes.  Its production contributes to the 
further expression of adhesion molecules including sICAM-1 and IL-6 and MCP-1 
which promote diapedisis of monocytes from the circulation to adipose tissue 
(Bruyndonckx et al., 2013). High levels of TNF-α are positively associated with 
impaired EDD through their increased stimulation of the production of ROS and 
decreased bioavailability of NO (Zhang et al., 2009). In addition, TNF-α is associated 
with insulin resistance with deficiencies in TNF-α or its receptors associated with 
increased insulin sensitivity (Hotamisligil, 1999).   
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Interleukin 1 (IL-1)  
  The interleukin 1 gene family consists of 3 proteins involved in systemic 
inflammation; interleukin-1 (IL-1), interleukin-1 beta (IL-1β) and IL-1 receptor 
antagonist (IL-1ra).  Both IL-1 and IL-1ra are produced by endothelial cells, smooth 
muscle cells and macrophages and are mediators for the secretion of (IL-1β) a pro-
inflammatory cytokine that is associated with CVD risk factors including obesity 
diabetes mellitus, hypertension, smoking and dyslipidemia (Fearon & Fearon, 2008). 
In addition, increased levels of IL-1 result in the secretion and expression of IL-6 and 
other cytokines, activation of endothelial and smooth muscle cell proliferation, 
macrophage activation and increased vascular permeability (Fearon & Fearon, 2008). 
Elevated circulating levels of cytokines of the IL-1 family have been found in 
overweight adolescents (Jung et al., 2010). 
Vascular Adhesion Molecules  
  Soluble intracellular adhesion molecule 1 (sICAM-1) and soluble vascular 
adhesion molecule 1 (sVCAM-1) are transmembrane glycoprotein members of the 
immunoglobulin (Ig) gene superfamily (Fotis et al., 2012) that participate in 
atherosclerosis by stimulating monocyte accumulation in the arterial intima.  
Increased levels of sICAM-1 have been reported in overweight/obese children 
compared to healthy children (Jarvisalo et al., 2002, Desideri et al., 2005, Caballero et 
al., 2008) whereas others have found no difference in sICAM-1 or sVCAM-1 between 
obese and healthy children (Kapiotis et al., 2006, Peña et al., 2010). Brachial artery 
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FMD was inversely related to sICAM-1 in healthy and obese adolescents (Jarvisalo et 
al., 2002, Glowinska-Olszewska et al., 2007). 
INF-γ  
  Interferon gamma (IFN-γ) is a pro-inflammatory cytokine that is synthesized 
by T-cells and released locally in the blood vessel intima in response to vascular injury 
(Vaddi et al., 1994).  Together with TNF-α, IFN-γ increases the i) expression of 
intracellular adhesion molecules (Vaddi et al., 1994), ii) activity of plasminogen 
activator inhibitor and iii) synthesis of tissue plasminogen activator (Schleef et al., 
1988). 
 Risk factors for CVD risk including obesity and the metabolic syndrome (MetS) 
are associated with a low-grade pro-inflammatory status in childhood (Christodoulos 
et al., 2012, Kapiotis et al., 2006) and are associated with the development of insulin 
resistance, atherosclerosis and other obesity comorbidities (Metzig et al., 2011). 
Inflammation, Endothelial function and cIMT  
  Among obese children, brachial artery FMD was found to be 40% lower and 
cIMT was 8% higher than healthy normal weight controls.  Circulating hsCRP, IL-6 and 
E-selectin were also significantly higher in the obese children than the healthy 
controls (Kapiotis et al., 2006).  Although circulating hsCRP was positively associated 
with BMI, IL-6, sICAM-1, sVCAM-1 and E-selectin in obese children there was no 
relation between hsCRP and brachial artery FMD or cIMT.  There was no difference in 
sICAM-1 and sVCAM-1 between the groups.  In contrast, hsCRP was found to be a 
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significant and independent predictor of brachial artery FMD and cIMT in healthy 
children aged 10.5 years (Jarvisalo et al., 2002).  Compared to children with hsCRP 
levels under the detection limit (<0.1 mg/L), children with higher hsCRP (≥ 0.1 to ≤0.7 
mg.L-1) or (> 0.7 mg.L-1) both had significantly lower brachial artery FMD and 
significantly higher cIMT (Jarvisalo et al., 2002).  
 Others have also found significantly higher hsCRP levels in obese children with 
impaired EDD and EID than normal weight children (Peña et al., 2010, Farpour-
Lambert et al., 2009). Children with normal endothelial function but at risk for being 
overweight also have significantly higher levels of hsCRP (Akinci et al., 2008,  Farpour-
Lambert et al., 2009, Meyer et al., 2006). Elevated levels of E-selectin, 
thrombomodulin and fibrinogen are also present in obese children and adolescents 
with impaired EDD and with low V̇O2max (Meyer et al., 2006). The majority of studies 
that have reported increased levels of circulating inflammatory markers have been 
conducted in overweight/obese children and adolescents suggesting that excess body 
fat may prerequisite for the expression and release of inflammatory markers since 
adipocytes partially mediate the inflammatory response.  While a number of studies 
have reported a significant association between inflammatory markers and vascular 
health in children and adolescents with impaired EDD and increased cIMT, others 
have found no association (Kapiotis et al., 2006). This may be due to differences in 
the cohort between studies and also may be that the measurement of inflammatory 
markers are perhaps not as sensitive of a marker of vascular health in children and 
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adolescents  compared to the direct measurement of vascular health using non-
invasive ultrasound. 
Exercise and Inflammation  
  Regular exercise exerts a positive anti-inflammatory effect (Pedersen, 2006).  
The release of IL-6 by the muscle fibers during exercise stimulates the production of 
anti-inflammatory cytokines IL-1ra and IL-10 and inhibits the production of the pro-
inflammatory cytokine, TNF-α (Pedersen, 2006). A number of studies have examined 
the effect of exercise training alone or in combination with diet on markers of 
inflammation and vascular health (Table 2.6).  Six months of aerobic exercise training 
3 times a week for 60 min decreased BMI, waist-to- hip ratio, cIMT, hsCRP and 
fibrinogen and improved brachial artery FMD in 67 obese adolescents (Meyer et al., 
2006).   
  Nitric oxide generation can be assessed by measuring the serum levels of 
nitrite/nitrate (NOx). In contrast, ADMA an endogenous inhibitor of nitric oxide 
synthase (NOS), may be related to reduced biosynthesis of NO and ACVD.  The closely 
related compound symmetric dimethylarginine (SDMA) does not inhibit NOS, but 
may compete with arginine for cellular uptake, thereby limiting substrate availability 
for NOS.  In overweight 12 year olds, 10-30 min of aerobic dance 5 days a week for 12 
weeks significantly increased V̇O2peak, NOx and adiponectin levels, and significantly 
improved brachial artery FMD compared to non-exercise controls (Murphy et al., 
2009).  There were no significant within group or between group differences in the 
ADMA, SDMA or pro-inflammatory cytokines at any time.  Similarly, 3 months of high-
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intensity aerobic interval training twice a week for 3 months significantly increased 
NO production, V̇O2max, brachial artery FMD and significantly decreased percentage 
body fat in obese 14-year-old adolescents (Tjønna et al., 2009).  There was no 
significant difference in adiponectin levels following the exercise program.  Using a 
randomized cross-over study design Kelly et al., (2004) also found a significant 
improvements in V̇O2peak, HDL-C and brachial artery FMD/SRAUC in 20 overweight 
children aged 11 years following an 8 week exercise program consisting of stationary 
cycling  (Kelly et al., 2004). These improvements occurred independent of changes in 
body weight and body composition and hsCRP.  
  In contrast, Farpour-Lambert et al., (2009) found that despite a significant 
reduction in BMI and body fat, aerobic exercise training three times a week for 3 
months had no effect on brachial artery FMD, cIMT and hsCRP in pre-pubertal obese 
children (Farpour-Lambert et al., 2009).  Similarly, 40 min of aerobic based training 
three times per week for 12 weeks improved CRF and insulin sensitivity in the 
absence of weight loss, percentage body fat and changes in adiponectin, IL-6, hsCRP, 
sICAM-1 and sVCAM-1 in 19 overweight and obese girls aged 13 years (Nassis et al., 
2005).  In a younger cohort of overweight children with a mean age of 10.8 years 
Kelly et al., (2007) found that four weekly 30-50 min sessions of supervised stationary 
cycling at 50-80% V̇O2max for 8 weeks improved V̇O2max but had no effect on body 
weight, body fat, hsCRP, IL-6, adiponectin, leptin, resistin or 8-isoprostane (Kelly et 
al., 2007). Collectively the majority of the studies that have examined the effect of 
exercise training on vascular health and inflammation have reported improved 
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vascular health and weight loss but an inconsistent decrease of inflammatory 
markers while others have demonstrated improvements of vascular health 
independent of changes in body weight. 
Exercise, Diet and Inflammation  
  In obese children and adolescents aged 12-18 years, a combined 6-week 
exercise and dietary intervention increased brachial artery FMD and reduced hsCRP 
and markers of oxidative stress including oxLDL (malondialdehyde (MDA) and 
conjugated diene (CDE) (Kelishadi et al., 2008).  Circulating insulin, HOMA-IR, body 
weight, BMI, percentage body fat, waist circumference also improved significantly, 
but subcutaneous fat did not change.  After adjusting for age and gender, the 
exercise induced improvements in insulin, HOMA-IR BMI, waist circumference, fat 
mass, LDLox, MDA, hsCRP were inversely related to improvements in brachial artery 
FMD (Kelishadi et al., 2008).   
  Similarly, a 2 week high-fibre low-fat diet combined with 2.0 -2.5 h of daily 
aerobic exercise significantly reduced the circulating levels of 8-isoprotaglandin 
F2alpha, a maker of oxidative stress, myeloperoxidase (MPO) and the inflammatory 
markers sICAM-1, E-selectin, hsCRP and total matrix metalloproteinase-9 in 
overweight children and adolescents aged 8-17 years (Roberts et al., 2007).  
Additionally, there was a significant decrease in the production of superoxide 
hydrogen peroxide, MCP-1 and a concomitant increase in NO production.  
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Table 2.6: Studies examining the effect of exercise on markers of inflammation, flow mediated dilation, cIMT, CVD risk factors and CRF 
in children and adolescents  
 
Author 
 
 
Cohort 
 
Age (Y) 
 
Intervention 
 
Inflammation  
 
FMD 
 
cIMT 
 
CVD risk factors 
 
CRF 
Watts et al., 
(2004) 
Obese Ex (N=19)  
Obese CTL (N = 20) 
14.3 ± 1.5 ET + RT 60 min 3d/wk/8wk  
homocysteine  
 ___  BF, Lipids, 
homocysteine, 
HBA1c, BP 
 
Watts et al., 
(2004) 
Obese Ex (N=14)  
Obese CTL (N = 7) 
8.9 ± 0.4 ET 60 min 3d/wk/8wk  
homocysteine 
 _____  HbA1c  BW, 
BMI, BF, lipids, 
homocysteine, 
glucose, BP 
 
Kelly et al., 
(2004) 
OW Ex (N=10)  
OW CTL (N = 20) 
10.9 ± 0.4 ET 30-50 min 4d/wk/8wk  
hsCRP 
 ____  HDL-c vs. con  
 
 
Murphy et al., 
(2009) 
 
 
OW Ex (N=23)  
OW CTL (N= 12) 
 
 
7-12 
 
 
ET 10-30 min 5d/wk/12wk 
 adiponectin vs. 
con, sig in IL-6 in 
females Ex vs.CTL 
 in hsCRP, 
TNF- α 
 
 
 
 
 
 
____ 
 
 
 BW, MAP 
vs.con 
 
 
 
Nassis et al., 
(2005) 
OW/OB girls  
(N=19 girls only) 
13 years  ET 40 min/3d/wk/12wk  hsCRP, IL-6, 
adiponectin, 
sICAM-1, sVCAM-
1 
 
___ ___  insulin 
sensitivity  
body weight, 
body fat  
 
Fapour 
Lambert et al., 
(2009) 
Obese Ex (N=22)  
Obese CTL (N = 22) 
8.5 ± 1.5 ET 60 min/3d/wk/12wk 
ET 60 min/2d/wk/6mo 
 hsCRP  at 3 
& 6 mo  
 at 3 
mo at 6 
months  
 BP, BMI, BF vs 
con 
 
 
Meyer et al., 
(2006) 
 
Obese Ex (N=33)  
Obese CTL (N = 34) 
 
14.7 ± 2.2 
 
ET 60 min/2d/wk + 
90min/1d/wk/6mo 
 
 hsCRP, 
fibrinogen  vs con 
 
 vs. con 
 
 
 
 BMI, BF, W:H, 
insulin, insulin 
resistance, TG, 
 
 
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LDL: HDL vs.con 
 
Tjonna et al., 
(2009) 
 
OW AIT (N=20)  
OW MTG (N = 22) 
 
14.0 ± 0.3 
 
AIT: 4x4 min/2d/wk/3mo    
MTG: Group Meeting 
2d/wk/ 
 
 in 
adiponectin  
 
AIT 
(6.3%) 
MTG  
(3.9) 
 
 
 
____ 
 
AIT:  BMI, BF, 
SBP, DBP, MAP, 
insulin, glucose, 
HOMA, HbA1c  
HDL-c 
MTG:  SBP, 
insulin, HOMA, 
HbA1c  HDL-c 
 
 
 
Kelly et al., 
(2007) 
OW EX=9 
OW con=10 
OW Ex 
10.8 ± 0.67 
OW con 11.0 
±0.71 
 
ET 30-50 min 4d/wk/8wk hsCRP, IL-6, 
adiponectin 
leptin, resistin 
_ __  body 
weight, body fat 
 
Kelishadi et 
al., (2008) 
Obese Ex+ Diet (N=35) 12-18 ET 60 min 3d/wk/6wk  hsCRP    BMI, BF, WC, 
W:H,TC, LDL-C, 
TG, Insulin, 
HOMA-IR, hsCRP, 
oxLDL-c, MDA 
___ 
Roberts et al., 
(2007) 
OW Ex + Diet (n=19) 8-17 ET 180-210 
min/7d/wk/2wk 
 hsCRP, sICAM-
1, E-selectin, 
MMP-9 
* NO    ______ 
FMD, flow mediated vasodilation; CRF, cardiorespiratory fitness; Ex, exercise group; CTL; control group; ET, endurance training; RT, 
resistance training; BF, body fat; BP, blood pressure; TG, triglycerides, OW, overweight; BW. Body weight; BMI, body mass index; W:H, 
waist-to-hip ratio; WC, waist circumference,; MAP, mean arterial pressure; hsCRP, C-reactive protein; SBP, systolic blood pressure; DBP, 
diastolic blood pressure;; TC, total cholesterol; AIT, aerobic interval training, MTG; multidisciplinary approach oxLDL-c, oxidized low 
density lipoprotein cholesterol; , IL-6, interleukin-6;  sICAM, soluble intracellular adhesion molecule; sVCAM-1, soluble vascular adhesion 
molecule;  MMP-9, matrix metalloproteinase;  HOMA, homeostatic model assessment of insulin resistance;  HbA1c, glycated 
hemoglobin; wk, week; d, day; TNF- α , tumor necrosis factor alpha; MDA, malondialdhyde.
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Cardiorespiratory Fitness and inflammation in Children and Adolescents  
 CRF has a protective role in the development of CVD and low-grade inflammation.  
Currently little is known about the mediating effect of adiposity on the relation between 
CRF, CVD and inflammation in children (Christodoulos et al., 2012).  In univariate analysis, a 
stronger association has been found between body fat and the MetS than between CRF and 
MetS.  Christodoulos et al., (2012) found a significant relation between CRF and both MetS 
and hsCRP in 112 healthy children aged 11.4 years.  Children with low CRF estimated using a 
20 MST had significantly higher MetS risk and hsCRP levels than children with high CRF. The 
relation between CRF and both MetS and hsCRP was attenuated after adjusting for 
measures of adiposity including waist circumference and BMI (Christodoulos et al., 2012). 
 Similarly, a cross-sectional study involving of 142 prepubertal children aged 9-10 
years examined the association of hsCRP, fibrinogen and complement factors C3 and C4 
with CRF, PA and body fat  Ruiz et al., 2007).  After controlling for sex, age and pubertal 
development, hsCRP and C3 were inversely associated with estimated V̇O2max and 
positively associated with body fat.  However, the association between V̇O2max and hsCRP 
and C3 were no longer significant after adjustment for body fat.  In contrast, both hsCRP and 
C3 were positively associated with body fat after controlling for sex, age and pubertal status. 
When both CRF and body fat were included in the regression model, only the association 
between body fat and hsCRP and C3 remained significant. There was no significant relation 
between objectively measured total time spent in physical activity and in MVPA and VPA 
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and inflammatory markers despite a significant relation between total time in PA, MVPA and 
VPA and V̇O2max. 
A cross-sectional study involving 197 children aged 10-15 found that obese children 
had significantly higher skinfold thickness, LDL-C, fibrinogen, ferritin, IL-6 and TNF- α and 
lower HDL-C than non-obese children (Halle et al., 2004).  When the children were divided 
into 4 groups based on CRF (< 5 MET, ≥ 5 MET) and BMI (BMI <22.5 kg.m2 or BMI ≥22.5 
kg.m2) the Unfit/High BMI group had the highest concentrations of IL-6 and TNF-α than the 
other groups. There was no significant difference in IL-6 and TNF-α between the Fit/High 
BMI and Fit/Normal BMI groups. These findings suggest that inflammatory markers are 
increased in obese children and that CRF attenuates this association. Furthermore, TNF- α 
values were significantly higher in the unfit children independent of BMI demonstrating the 
importance of CRF rather than obesity in reducing this marker of inflammation.  
Sedentary Behaviour, inflammation and endothelial function biomarkers in children  
In 164 healthy 7-10 year old children, Gabel et al., (2015) found that each additional 
hour per week of TV viewing was associated with 4.4% increase in hsCRP and 0.6% increase 
in sVCAM-1 after adjustment for sex, waist circumference, MVPA and diet (Gabel et al., 
2015).  There was no association between total sedentary time and markers of 
inflammation and endothelial dysfunction. Furthermore, there was no significant relation 
between sedentary bouts between 5-10 min or >10 min and any of the markers of 
inflammation and endothelial dysfunction.  Self-reported TV viewing time but not 
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objectively measured sedentary time, was found to be positively associated with sICAM-1, 
sVCAM-1, L-selectin and E-selectin concentrations, after controlling for sex, age, pubertal 
status, MVPA, BMI and total sedentary time in 183 adolescents aged 13 to 17 years 
(Martinez-Gomez et al., 2012).  In addition, those that watched TV for ≥ 3h per day had 
significantly higher concentrations of cellular adhesion molecules compared to those who 
watched TV for ≤ 1 h per day.   
Saunders et al., (2013) compared the effect of 8 h of uninterrupted sitting (SIT), 8 h 
of sitting interrupted with a 2 min light intensity walk every 20 min and 8 h of sitting 
interrupted with a 2 min of light intensity walk break every 20 min as well as 2 x 20 min of 
MVPA on circulating levels of insulin, glucose, TG, HDL-C and LDL-C in 11 healthy males and 
8 healthy females aged 10-14 years. There was no significant difference in CMD risk factors 
across the three experimental conditions (Saunders et al., 2013).  Of the limited studies that 
have examined the relation between sedentary behaviour, the majority have reported a 
positive relation between sedentary behaviour and inflammatory makers in children. 
However, these studies used self-reported measures such as TV viewing time to assess 
sedentary behavior. More objective measures of sedentary behaviour are required to 
further investigate the association between sedentary behaviour and inflammation in 
children and adolescents.  
Cardiorespiratory Fitness  
Cardiorespiratory fitness (CRF), also termed cardiovascular fitness or aerobic 
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capacity, is the ability to perform large-muscle, whole-body exercise at moderate to high 
intensities (Saltin et al, 1973).  It reflects the overall ability of the cardiovascular and 
respiratory systems to support skeletal muscle activity through high rates of aerobic 
metabolism (Pate et al., 2012).  Low CRF levels are associated with an increased risk of CVD 
(Blair et al., 1989, Sandvik et al., 1993), certain site specific cancers (Lee et al., 2002, 
Breithaupt et al., 2012, Peel et al., 2009) and premature mortality from all causes (Blair et 
al., 1989, Blair et al., 1995).  
Determinants of Cardiorespiratory Fitness  
Although information on the role of the genotype on CRF is limited, findings from the 
HERITAGE family study involving 700 healthy, sedentary men and women found that 
approximately 50% of the intra-individual variance in CRF was explained by genetic factors 
(Bouchard et al., 1999, Rankinen et al., 2010).  Maximal aerobic capacity values are generally 
attained between the ages of 20-30 years, (Fleg et al.,  2005, Jackson et al., 2009) after 
which they begin to decline at a rate of 3% to 6% per decade during the third and fourth 
decades and 20% per decade after 70 years in both healthy men and women (Fleg et al., 
2005).  Age associated decreases in PA and increases in weight gain exacerbate the process 
(Fleg et al., 2005). 
Measurement of Cardiorespiratory Fitness 
CRF is usually expressed in metabolic equivalents (METs) or maximal oxygen uptake 
(V̇O2max) measured during exercise testing.  Maximal oxygen consumption (V̇O2max) 
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attained during a graded maximal exercise test is considered the gold standard 
measurement of CRF and represents the integrated capacity of the pulmonary, 
cardiovascular and muscle systems to uptake, transport and utilize oxygen, respectively 
(Poole et al., 2008).  It reflects the exercise intensity beyond which V̇O2 fails to increase 
further.  This leveling off or plateau in oxygen uptake with increasing workload during the 
final minute of exercise has been used as the primary criterion for determining V̇O2 max 
(Taylor et al., 1955).  However, a number of other secondary criteria are used to verify 
attainment of V̇O2max.  In children and adolescents, these include respiratory exchange 
ratio (RER) > 1.0, heart rate (HR) >200 bpm and volitional fatigue (Breithaupt et al., 2012). 
Maximal oxygen consumption can be expressed as the absolute volume of oxygen 
consumed per unit of time (L.min-1) or relative to body mass (ml.kg-1.min-1).  It can be 
measured directly from expired gas analysis or estimated through various maximal or 
submaximal laboratory and field-based exercise tests.  The most commonly used laboratory 
tests include treadmill walking and/or running and cycle ergometry.  Commonly used field-
tests for estimating CRF include distance or timed runs and graded paced shuttle run tests.   
The 20 MST developed by Leger et al., (1988) is a commonly employed field test for 
estimating CRF in youth.  The test consists of a number of 1 min stages called levels and 
comprises of a number of 20 m laps, called shuttles.  The participants running velocity is 
controlled by an audio “bleep” which signals the completion of a stage.  Stage 1 starts at a 
speed of 8.0 km.h-I, stage two starts at 9.0 km.h-I after which the speed increases by 0.5 
km.h-I at the end of each stage (Léger et al., 1988) .  The test has excellent validity and 
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reliability for measuring CRF in youth (Léger et al., 1988, Boreham et al., 1990).  In youth, 
performance in the 20MST is more highly correlated with both relative V̇O2max and CVD risk 
factors than field based measures such as the 12-min Cooper run and 1.5 mile run (Pate et 
al., 2012).  Improved performance in the 20 MST in children and adolescents is also 
associated with improvements in a number of CVD risk factors including BP, insulin 
resistance and body weight (Reed et al., 2008, Puder et al., 2011,  Kim et al., 2005). 
Cardiorespiratory Fitness and All-cause and CVD Mortality  
Epidemiological studies have found an inverse relation between CRF and both all-
cause and CVD mortality in both asymptomatic men and women independent of other 
conventional risk factors (Blair et al., 1989, Gulati et al., 2003, Kokkinos et al., 2008).  In an 
epidemiological study involving 40,451 men and 12,831 women ranging in age from 20 to 
100 years, Blair et al., (1989) found that men and women in the highest quintile for CRF had 
a 43% and 53% lower risk for all-cause mortality and a 47% and 70% lower risk of CVD 
mortality, respectively (Blair et al., 1989). 
In addition to healthy individuals, high levels of CRF in individuals with CVD risk 
factors including overweight, obesity, MetS, and diabetes mellitus have been found to be 
cardioprotective, and largely negate the adverse effects of traditional risk factors on 
subsequent CVD and mortality (Blair et al., 1996,  Lyerly et al., 2008,  Lyerly et al., 2010, 
Church et al., 2004).  In these studies, individuals with CVD risk factors and high levels of CRF 
had lower mortality than those with CVD risk factors and low levels of CRF. 
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Improvements in exercise capacity have been associated with substantial reductions 
in CVD and all-cause mortality in both healthy asymptomatic (Gulati et al., 2003,  Lee et al., 
2011, Kodama et al., 2009) and clinical populations (Meyer et al., 2002).  A recent-meta 
analysis of 33 studies found that a 1 MET increase in CRF was associated with a 13% 
reduction in all-cause mortality and a 15% reduction in CV events (Kodama et al., 2009).  In 
addition, individuals with low CRF had a significantly higher risk of all-cause mortality and 
CVD events than individuals with moderate and high CRF.  A small increase in CRF in 
individuals in the lowest CRF quintile was associated with a substantial reduction in CVD 
events and all-cause mortality (Kodama et al., 2009).  Similarly, Lee et al., (2011) found that 
a 1 MET increase in CRF between two examinations separated by an average of 6.9 years 
was associated with a 15% reduction in all-cause and a 19% reduction in CVD mortality (Lee 
et al., 2011).  A major limitation of these epidemiological studies is the use of a single 
baseline CRF measurement.   
A number of prospective studies in men have found an inverse association between 
changes in CRF and mortality risk (Blair et al., 1995, Erikssen et al., 1998). Blair et al., (1995) 
measured CRF on two occasions over a period of 4.9 years in almost 10,000 healthy and 
unhealthy men aged 20-82 years who were followed for an average of 5.1 years (Blair et al., 
1995).  Men who improved their CRF classification from unfit to fit between the two 
examinations had a 44% reduction in mortality risk compared to men who remained unfit at 
both visits.  Individuals who had a low level of CRF on both visits had the highest risk of 
mortality compared to men who had a high level of CRF at both visits.  Each one-minute 
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increase in maximal treadmill time performance was associated with a 7.9% reduction in 
mortality risk (Blair et al., 1995).  Improvements in CRF over a 7 year period in 2014 healthy 
men who were 40-60 years of age at baseline was associated with a significantly lower risk 
of all-cause mortality during a 15 year up follow-up, regardless of the initial CRF level and 
independent of changes in body weight (Erikssen et al., 1998). 
Findings from studies in adults regarding the relative contributions of CRF and 
obesity to mortality are equivocal.  Some studies have found that CRF eliminates the 
detrimental effects of obesity on mortality (Lee et al., 1999,  Sui et al., 2007, McAuley et al., 
2010) while others have found that although high CRF can substantially ameliorate the risk 
of obesity, it cannot eliminate it (Stevens et al., 2004). 
Mechanisms linking CRF and Reduction in All-Cause and CVD mortality  
Putative biological mechanisms proposed to explain the positive effect of CRF on 
both all-cause and CVD mortality include the direct effect of CRF on the vasculature or 
indirectly through risk factor modification.  Improvements in CRF that accompany regular 
exercise training are associated with enhanced endothelial vasomotor function.  Repetitive 
increases in vascular wall shear stress during exercise are associated with an increased up-
regulation of eNOS expression (Green et al., 2004).  This subsequently increases the 
synthesis and release of NO and improves endothelial function.  Exercise induced 
improvements in endothelial function may also be mediated through CVD risk factor 
modification (Kingwell et al., 1996). 
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Risk Factor Modification  
Studies in adults have found that improvements in CRF are associated with 
improvements in insulin sensitivity (Leite et al., 2009), blood lipid and lipoprotein profile 
(Arsenault et al., 2007), body composition (Arsenault et al., 2007), inflammation (Aronson et 
al., 2004, Church et al.,, 2002,  Kuo et al., 2007) and BP (Carnethon et al., 2005).  In addition, 
others (LaMonte et al., 2005, Hassinen et al., 2008) have shown an inverse association 
between CRF and the risk of developing MetS in adults.  
Cardiorespiratory Fitness and CVD risk in Youth  
High levels of CRF are associated with a more favorable cardiovascular health profile 
in children (Ruiz et al., 2007, Ekelund et al., 2007, Anderssen et al., 2007). A number studies 
have examined the relation between CRF and CVD risk factors in children and adolescents 
(Table 2.7). Some of these studies have examined this relation independent of adiposity 
(Shaibi et al., 2005, Ekelund et al., 2007, Rizzo et al., 2007) while others have failed to take 
adiposity into account (Andersen et al., 2007, Ruiz et al., 2007, Bailey et al., 2012).    Of 
these studies, some have found a relation between CRF and CVD risk independent of 
adiposity (Ekelund et al., 2007, Ruiz et al., 2007, Eisenmann et al., 2007) while others have 
failed to find a significant relation between CRF and CVD risk factors independent of 
adiposity (Shaibi et al., 2005, Rizzo et al., 2007) (Table 2.7) suggesting that the association 
between CRF and CVD risk in children and adolescents may be mediated by adiposity.   
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Andersen et al., (2007) examined the relation between CRF and clustered CVD risk in 
a large sample of boys and girls between the age of 9 and 15 years and found that after 
adjusting for country, age, sex, socio-economic status, pubertal stage, family history of CVD 
and diabetes there was a significant inverse relation between estimated V̇O2max expressed 
relative to body mass and the clustering of CVD risk factors.  Compared to those in the 
highest quartile for CRF, the odds ratio for the clustering of metabolic risk factors was 10.4 
for girls and 15.8 for boys in the lowest CRF quartiles (Anderssen et al., 2007).  Similarly, Ruiz 
et al., (2007) examined the association between CRF and cardiometabolic disease (CMD) risk 
factor clustering in 873 children aged 9 and 15 years and found that the CRF level associated 
with low metabolic risk classification was 37.0 ml.kg-1.min-1 and 42.1 ml.kg-1.min-1 in 9-10 
year old boys and girls, respectively (Ruiz et al., 2007).  Using health related CRF threshold 
values proposed by Ruiz et al., Bailey et al., (2012) found that CMD risk was significantly 
higher in unfit compared to fit boys and girls aged 10-14 years and that CRF was inversely 
associated with clustered CMD risk (Bailey et al., 2012) 
To date, only one published study has examined the association between directly 
measured V̇O2max and CVD risk factors in children and adolescents (Shaibi et al., 2005).  The 
relation between V̇O2max and MetS was examined in 11-year-old overweight Latino boys 
and girls with a family history of T2DM (Shaibi et al., 2005).  MetS was defined as having 
three or more of the following risk factors; abdominal obesity, high BP, low HDL-C, high TG 
and impaired glucose tolerance.  Absolute V̇O2max was not significantly correlated with any 
of the MetS risk factors after adjusting for gender, age, total fat mass and fat free mass.  
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Furthermore, there was no significant difference in absolute V̇O2max values between 
children with no risk factors or those with one, two, three or more risk factors.  In contrast, 
V̇O2max expressed relative to both body mass and fat free mass (FFM) decreased as the 
number of risk factors for MetS increased.  Children with no MetS risk factors had a 
significantly higher V̇O2max relative to body weight and FFM than those with two, three or 
more MetS risk factors (Shaibi et al., 2005).  These findings suggest that the relation 
between CRF and cardiometabolic health is a function of body composition.  
As part of the European Youth Heart Study, Ekelund et al., (2007) examined the 
association between CRF with CVD risk factors in boys and girls between the age of 9 and 10 
years and 15 and 16 years and found that CRF estimated from an incremental cycle 
ergometer test was significantly associated with clustered risk and remained independently 
associated after adjustment for adiposity (Ekelund et al., 2007).  In contrast, after 
controlling for body fat, Rizzo et al., (2007) found no significant association between CRF 
estimated from a cycle ergometer test and metabolic risk score in boys and girls between 
the age of 9 and 15 years (Rizzo et al., 2007).  
As part of the Aerobics Center Longitudinal Study, Eisenmann et al., (2007) 
investigated differences in CVD risk factors across four cross-tabulated groups of CRF and 
BMI (HF/Low BMI, LF/Low BMI, HF/High BMI and LF/High BMI) in 16 year old boys and girls 
(Eisenmann et al., 2007).  The HF/Low BMI boys had significantly lower TC, LDL-C and TC: 
HDL-C values than LF/High BMI boys.  The LF/Low BMI males had a lower SBP and mean 
arterial pressure than both HF/High BMI and LF/High BMI males.  LF/High BMI females had 
 84 
higher TG levels than their LF/Low BMI counterparts.  In both males and females, the 
LF/High BMI groups had the highest MetS score.  In males, MetS score for HF/Low BMI and 
LF/Low BMI group were similar suggesting body fatness may be more associated with MetS 
than CRF.  While inherent differences exist in the findings between studies, it would appear 
that the association between CRF and CVD risk in children and adolescents appears to be 
mediated in part by adiposity.  
  
 85 
Table 2.7: Cross-sectional studies examining the relation between CRF and clustering of cardiometabolic disease risk factors in healthy children 
and adolescents 
Author Cohort Measurement of CRF  
Measure of Clustered 
Metabolic risk 
Confounders adjusted for  Findings 
Shaibi et al., (2005) n (m/f)=91/72 
Age: 11 yr 
 
Maximal TTM  
V̇O2max (L
.min-1) 
V̇O2max (ml
.kg-1.min-
1)V̇O2max ml
.kg-1.FFM-
1.min-1) 
 
WC, TG, HDL-C, BP, fasting 
glucose, No. of components 
of the MetS (0,1, 2 or ≥ 3) 
Sex, age, fat mass and 
FFM 
No association between 
V̇O2max (L
.min-1) and 
number of MetS risk factors. 
V̇O2max (ml
.kg-1.min-1) and 
V̇O2max ml
.kg-1.FFM-1.min-1) 
inversely associated with 
number of risk factors 
(p<0.001)  
Ekelund et al, (2007) n (m/f)= 838/908 
Age: 9 yr and 15 yr 
Maximal CE test (W kg 
FFM-1.min-1) 
WC, BP, glucose, insulin  
HDL-C, TG zMS, non-Ob zMS 
Sex, age, study location, 
birth weight, pubertal 
status, smoking, maternal 
BMI, parental SES, PA, 
waist circumference 
(when zMS is the 
outcome) 
 
Significant associations 
between zMS and CRF and 
between non-OB zMS and 
CRF 
Rizzo et al., (2007) n (m/f)= 264/265  
Age: 9 yr and 15  yr 
Maximal CE test 
(estimated ml O2
.
 kg 
-1 
.min-1 ) 
Insulin, glucose, TG, TC, HDL-
C, BP, sum of skinfolds zMS, 
non-OB zMS 
Pubertal status, height, 
SES and parental smoking 
and PA 
CRF inversely associated 
with zMS in 9 and 15 year 
old girls and boys. No 
association between non-OB 
zMS and CRF in 9-year-old 
boys and girls.  Inverse 
association between non-OB 
zMS and CRF in 15 year old 
girls and boys  
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Ruiz et al., (2007) n (m/f)=429/444  
Age: 9-10 yr 
Maximal CE test 
(estimated ml O2
.
 kg 
-1 
.min-1 ) 
Insulin, glucose, HDL-C, TG, 
skinfolds, BP, zMS <75th 
percentile= lower risk 
 Inverse association between 
CRF quartiles with zMS. Girls 
CRF > 37 ml O2
.
 kg 
-1 .min-1 
increased OR of a low zMS 
score compared to girls ≤ 37 
ml O2
.
 kg 
-1 .min-1  Boys CRF > 
42.1 ml O2
.
 kg 
-1 .min-1 
increased OR of a low zMS 
score compared to boys < 
42.1 ml O2
.
 kg 
-1 .min-1   
Anderssen et al., (2007) n=(m/f) 1391/1454  
Age: 9 and 15 years 
Maximal CE test (W 
kg) 
TC: HDL-C, sum of 4 
skinfolds, SBP, TG, HOMA, 
zMS, non-Ob zMS 
Pubertal status, SES, 
family history if CVD and 
diabetes, country, age 
and sex 
OR (ascending quartiles of 
fitness) for having risk 13.0, 
4.8 and 2.5. Similar 
association when age, group 
sex and country where 
adjusted  
 
Eisenmann et al., (2007) n=(m/f) 296/188  
Age: 8-18 yr 
Maximal TTM (min) Glucose, MAP, HDL-C, TG, 
WC, zMS 
Age standardized BMI 
and CRF 
In both males and females, 
no significant difference in 
zMS between high fit/low 
BMI and low fit/low BMI 
 
Bailey et al., (2012) n=(m/f) 41/59 
Age: 10-14 
Maximal CE  
(estimated ml O2
.
 kg 
-1 
.min-1 ) 
WC, BP TC: HDL-C ratio, TG’S, 
glucose  
Age, sex, ethnicity, and 
socioeconomic status 
Clustered CMD risk 
significantly higher in unfit 
than fit boys and girls. CRF 
was inversely associated 
with clustered CMD risk. 
CE, cycle ergometer; TM, treadmill; CMD, cardiometabolic disease; FFM, fat free mass; zMS, standardized metabolic risk score; non-Ob zMS, standardized metabolic risk 
score excluding adiposity; OR, odds ratio; MetS, metabolic syndrome; SES, socioeconomic status; m/f, male/female; MAP, mean arterial pressure; MetS, metabolic 
syndrome; WC, waist circumference; TC: HDL-C, total cholesterol HDL-C ratio, HOMA; homeostasis model assessment; TG, triglycerides; TC, total cholesterol; BP, blood 
pressure 
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Cardiorespiratory Fitness Classification in Youth  
A number of cut-off values for optimal CRF values for cardiometabolic health 
in youth have been proposed (Table 2.8).  Ruiz et al., (2007) found that a CRF level of 
> 37.0 ml.kg1.min1 and > 42.1 ml.kg1.min1 in adolescent girls and boys respectively, 
was associated with an increased odds ratio of having a lower metabolic risk (Ruiz et 
al., 2007).  In another sample of 4500 children, CRF values of < 37.4 ml.kg1.min1 and < 
33.0 ml.kg1.min1were used to identify 9 and 15 year old girls at metabolic risk.  Higher 
cut-off values of < 43.6 ml.kg1.min1 and < 46.0 ml.kg1.min1 were used to identify 9 and 
15 year old boys, at metabolic risk (Adegboye et al., 2011).  Similarly, Lobelo et al., 
(2009) found that optimal CRF values for identifying children with high CVD risk was < 
44.1 ml.kg1.min1 and < 40.3 ml.kg1.min1 in 12-15 year old and 16-19 year old boys, 
respectively, and < 36.0 ml.kg1.min1 and <35.5 ml.kg1.min1 among 12-15 and 16-19 
year old girls, respectively (Lobelo et al., 2009).  These optimal CRF were similar to 
age and gender-specific CRF values for adolescents known as healthy zones proposed 
by FITNESSGRAM (The Cooper Institute for Aerobic Research, 2004).  
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Table 2.8: Proposed CRF classification in children and adolescents 
Author Cohort Measure of CRF Proposed optimal CRF values  
Ruiz et al., (2005) n=873  
Age: 9-10 yr 
Maximal CE test 
(estimated ml O2
.
 kg 
-1 
.min-1 ) 
 
 V̇O2max ml
.kg1.min1 
Males: >42.1 ml.kg1.min1 
Females: >37.0 ml.kg1.min1 
Associated with an increased odds ratio of having a 
lower metabolic risk than those with CRF below these 
levels 
Lobelo et al, 2009 n =1247 
Age: 12-18 years  
Submaximal TM test  
(estimated ml O2
.
 kg 
-1 
.min-1 ) 
V̇O2max ml
.kg1.min1 
Males 12-15 years : <44.1 ml.kg1.min1 
Males 16-19 years: < 40.3 ml.kg1.min1 
Females 12-15 years : <36.0 ml.kg1.min1  
Females 12-15 years : <35.5 ml.kg1.min1  
Optimal CRF values for identifying individuals with 
high risk 
 
Adegboye et al, (2011) n=4500 TM test  
(Estimated ml O2
.
 kg 
-1 
.min-1) 
V̇O2max ml
.kg1.min1 
Males 9 years: <43.6 ml.kg1.min1 
Males 15 years: < 46.0 ml.kg1.min1 
Female 9 years: <37.4 ml.kg1.min1  
Females 15 years: <35.0 ml.kg1.min1  
Optimal levels for identifying individuals at high risk  
V̇O2max, maximal oxygen uptake; CRF, cardiorespiratory fitness; CE, cycle ergometer; TTM, treadmill; 
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Cardiorespiratory Fitness in Adolescence and CVD risk factors in Adulthood 
A number of longitudinal studies have examined the relation between CRF in 
adolescence and CVD risk factors in adulthood (Twisk et al., 2000, Ferreira et al., 
2002, Hasselstrom et al., 2002, Andersen et al., 2004, Eisenmann et al., 2005).  
Maximal oxygen uptake and maximal slope determined from a graded treadmill 
exercise test in 13-16 males and females were both significantly and inversely related 
to sum of four skinfolds, waist circumference and total cholesterol at 32 years of age 
(Twisk et al., 2000).  In contrast, Andersen et al., (2004) found no significant relation 
between V̇O2max measured between the age of 16-19 years and adult clustered CVD 
risk (TC: HDL-C, TG, SBP and body fat) measured 8 years later in males and females 
(Andersen et al., 2004).  Using the top fitness quartile as a reference, the odds ratio 
at baseline for having ≥ 2 risk factors was 3.1, 3.8 and 4.9 for quartiles two, three and 
four, respectively.  At the second examination the odds ratio was 0.7, 3.5 and 4.9 for 
quartiles two, three and four, respectively. The probability for “a case” i.e (≥ 2 risk 
factors) at baseline to be a case at the second examination was 6.0.  
In a similar age cohort, Hasslestrom et al., (2002) found that the change in 
CRF between adolescence and adulthood measured over an 8-year period rather 
than the level measured in adolescence was more strongly related to both the total 
number and the changes in CVD risk factors in adulthood (Hasslestrom et al., 2002).  
The V̇O2max score in adolescence was significantly related to V̇O2max 8 years later in 
both men and women and to circulating TG levels and % body fat in women.  The 
change in V̇O2max over the 8-year period was related to TC, TG, waist girth, V̇O2max, 
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PA, HDL-C and risk score in adult men and TG, PA and percentage body fat in adult 
women at follow up .  There was also a significant relation between changes in 
V̇O2max and changes in TC, TG and HDL-C in men and between the changes in 
V̇O2max and changes in SBP, TG, risk score and % body fat in women.  
To examine the relation between both CRF and body fatness during 
adolescence and CVD risk factors in adulthood, Eisenmann et al., (2005) evaluated 
CRF and body fat at 15.8 years and again at 26.6 years in 48 men and women 
(Eisenmann et al., 2005).  Adolescent treadmill time was associated with adult BMI, 
waist circumference and % body fat, and changes in body fat.  The change in 
treadmill time was associated with the change in body fat.  There was no significant 
relation between treadmill time during adolescence and BP, TC, HDL-C, TG and 
glucose in adulthood.  Adolescent waist circumference was significantly related to 
adult BP.  BMI, percentage body fat and waist circumference in adolescence was 
significantly related to adult treadmill time.  Change in waist circumference was 
significantly related to the change in both treadmill time and HDL-C.  The change in 
BMI was significantly related to the change in both BP and HDL-C.  Twisk et al., (2000) 
measured CRF on 6 occasions between the ages of 13-27 years in 181 individuals and 
examined the longitudinal relation between CRF and CVD risk factors in adulthood. 
There was an inverse relation between V̇O2max and TC: HDL-C and the sum of four 
skinfolds in adulthood (Twisk et al., 2000).  
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Tracking of CVD Risk Factors from Adolescence to Adulthood  
Prospective studies have found that CRF tracks better than PA from 
adolescence into adulthood (Twisk et al., 1997, Kemper et al., 1990, Soric et al., 
2014).  A recent study tracked CRF and body fatness in 50 individuals from 15 years of 
age into middle adulthood (37-43 yr) and found that the tracking of V̇O2peak was low 
to moderate (r=0.30) (Soric et al., 2014).  Similarly, Twisk et al., (1997) reported 
moderate stability (r=0.31) for the tracking of CRF over a 15 year period from 13 
years to 27 years in 181 apparently healthy individuals (Twisk et al., 1997).  Kemper 
et al., (1990) tracked serum cholesterol, BP, % body fat, V̇O2max, smoking, PA, type A 
behaviour in 93 males and 107 females annually between 13 and 21 years of age and 
found that that CRF had the high stability (Kemper et al., 1990). 
Limitations of Maximal Exercise Testing  
Cardiopulmonary exercise testing (CPET) is widely used in to assess the 
response to exercise in both healthy and disease-based populations.  Although 
V̇O2max is recognized as the gold standard measurement of CRF, a true plateau in 
V̇O2 during CPET is seldom attained particularly in overweight and obese pediatric 
populations.  The application of V̇O2max testing may therefore be limited to healthy, 
trained and motivated individuals.   The ability to attain V̇O2 peak during CPET is 
strongly influenced by the individual’s effort, motivation, the experience of the tester 
and the exercise protocol.  Norman et al., (2005) found that 24% of overweight and 
12% of normal weight adolescents did not achieve V̇O2 peak during a graded maximal 
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exercise test (Norman et al., 2005).  Furthermore, maximal exhaustive exercise 
testing does not mimic the submaximal daily activities of children.   
Ventilatory Anaerobic Threshold 
 During incremental exercise, lactic acid, a product of anaerobic glycolysis, 
readily dissociates into lactate and hydrogen ions.  Buffering of the hydrogen ions in 
the blood by sodium bicarbonate, results in the formation of carbonic acid, which is 
further broken down into carbon dioxide and water.  The disproportionate increase 
in arterial carbon dioxide production is detected by central and peripheral 
chemoreceptors, stimulating an increase in pulmonary ventilation.  The exercise 
intensity at which V̇E increases disproportionally in relation to oxygen consumption 
during incremental exercise is called the ventilatory anaerobic threshold (VAT) and is 
a commonly used submaximal measure of CRF.   
A number of methods are commonly used to determine the VAT.  The V-slope 
method examines the change in the relation between V̇CO2 and V̇O2.  Specifically, it 
involves identifying the breakpoint in which V̇CO2 begins to increase more rapidly 
than V̇O2.  Alternatively, the ventilatory equivalents method defines VAT as the 
exercise intensity at which the ventilatory equivalent of oxygen (V̇E/V̇O2) increases 
without a concurrent rise in the ventilatory equivalents of carbon dioxide (V̇E/V̇CO2).  
A major limitation of the VAT is that its measurement is largely dependent on the 
exercise protocol and is often not identifiable (Akkerman et al., 2010).  Furthermore, 
the subjective nature of its measurement means that VAT is subject to inter-
evaluator variability (Akkerman et al., 2010).  
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Oxygen Uptake Efficiency Slope  
The oxygen uptake efficiency slope (OUES) is an objective and effort 
independent submaximal measure of cardiopulmonary reserve (Baba et al., 1996).  It 
represents the rate of increase in V̇O2 in response to a given V̇E during incremental 
exercise, indicating how effectively oxygen is taken in by the lungs, transported and 
used in the periphery (Baba et al., 1996).  The OUES therefore integrates 
cardiovascular, musculoskeletal and respiratory function during incremental exercise 
into a single index (Hollenberg & Tager, 2000).  Physiologically, the OUES is influenced 
by the onset of exercise induced metabolic acidosis which is determined by a variety 
of factors including blood flow distribution to the working muscles, muscle mass, 
oxygen extraction and utilization, physiologic pulmonary dead space and the arterial 
PCO2 set point (Hollenberg & Tager, 2000).   
Calculation of OUES  
OUES is derived from the linear relation of V̇O2 (y-axis) versus the logarithm of 
V̇E (x-axis) during incremental exercise (Baba et al., 1996).  It is calculated using the 
equation; V̇O2=a logV̇E + b; where V̇O2 represents oxygen uptake (ml.min
-1), the 
constant ‘a’ represents the rate of increase in V̇O2 in response to an increasing V̇E 
(OUES), log V̇E is the common logarithm of V̇E and the constant ‘b’ represents the 
intercept (figure 2.1) (Bongers, 2013).  The logarithm transformation of V̇E results in 
the linearization of the relation of V̇O2 versus V̇E during incremental exercise making 
the OUES theoretically effort independent (Mezzani et al., 2009).  A number of 
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studies involving both healthy and disease based populations have reported similar 
maximal  
 OUES and submaximal OUES values (using 50%-75% of exercise data) 
calculated from maximal exercise tests indicating that OUES is independent of effort 
during exercise (Hollenberg & Tager, 2000,  Baba et al., 1996, Baba et al., 1999, 
Davies et al., 2006).  OUES is highly reproducible (Baba et al., 1999) and is 
significantly correlated with other exercise parameters including V̇O2max (r=0.94), 
V̇O2peak (r=0.91-0.92) and VAT (r=0.86)  (Akkerman et al  et al., 2010).  Given its 
strong positive correlation with V̇O2max (Baba et al., 1996, Davies et al., 2006, 
Bongers et al.,  2012, Breithaupt et al., 2012), the OUES may be of clinical utility and 
may be used in addition to, or as a substitute for V̇O2max in the assessment of CRF in 
populations unable to perform maximal exercise.  
 
 
 
 
 
 
Figure 2.5.  Calculation of oxygen uptake efficiency slope (OUES) 
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Prognostic Value of OUES  
OUES has been found to have prognostic value in both CAD (Coeckelberghs et 
al., 2015) and HF populations (Davies et al., 2006, Arena et al., 2007).  In a recent 
study, Coeckelberghs et al., (2015) assessed the prognostic value of OUES in a large 
sample of CAD patients with a mean age of 61 years.  OUES was calculated in 
participants who underwent maximal exercise testing at baseline and again at follow-
up 7.4 ± 3.2 years later.  OUES was significantly related to all-cause (hazard ratio 0.57, 
p<0.001 and CV mortality (0.46, p<0.001) and remained significantly related to 
mortality after adjusting for other submaximal exercise parameters (Coeckelberghs et 
al., 2015).  Similarly, a 9 year follow up study in HF patients found that OUES, 
calculated from maximal treadmill exercise testing was the only significant 
independent predictor of mortality in multivariate analysis that included both V̇O2 
peak and VAT (Davies et al., 2006).  Arena et al., (2007) found that OUES calculated 
from 50% (OUES50) and 100% of the exercise data (OUES100) collected during a ramp 
exercise treadmill test at baseline and 3 years later was a significant predictor of 
mortality in heart failure patients (Arena et al., 2007). 
OUES in children 
The utility of the OUES was initially examined in a cohort of healthy children 
and children with congenital heart disease (Baba et al., 1996) and has since been 
investigated in both healthy normal weight and overweight/obese children and 
adolescents (Breithaupt et al., 2012, Drinkard et al., 2007, Marnivov et al,. 2007, 
Marnivov et al., 2003,  Akkerman et al., 2010).   
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To determine if the OUES is independent of effort, a number of studies have 
compared maximal and submaximal values in children and adolescents. Cross 
sectional studies involving healthy normal weight children between the age of 7 and 
18 years found no difference in submaximal OUES calculated using exercise data up 
to VAT, and maximal OUES calculated using 100% of the data from the graded 
exercise test (Akkerman et al., 2010, Marniov et al., 2007).  In contrast, Drinkard et 
al., (2007) reported a significant increase in OUES with increasing exercise intensity in 
both normal weight and severely overweight 12-17 year old adolescence showing a 
dependence of OUES on exercise intensity (Drinkard et al., 2007). 
Studies in children and adolescents have also shown that the OUES is highly 
correlated with V̇O2peak (Akkerman et al., 2010, Marniov et al., 2007). Akkerman et 
al., (2010) reported that submaximal OUES, calculated using exercise data up to the 
VAT was highly correlated with V̇O2peak (r=0.88, p<0.01) in 46 healthy children and 
adolescents aged between 7-17 years.  The strength of the association however, 
declined after submaximal OUES was normalized for BSA (r=0.67, p<0.01), body mass 
(r=0.62, p<0.01) and FFM (r=0.49, p<0.01) (Akkerman et al., 2010).  This is not 
surprising considering that the OUES is significantly related to age and 
anthropometric variables including height, BSA, weight, FFM and BMI (Akkerman et 
al., 2010, Marniov et al., 2007). In a similar aged cohort, Marinov et al., (2007) also 
reported a strong correlation between OUES and V̇O2peak (r=0.92) in 58 and 56 
healthy boys and girls respectively (Marinov et al., 2007).  Others studies examining 
the OUES in overweight and obese children and adolescents have also reported a 
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strong correlation between OUES and V̇O2peak (Drinkard et al., 2007, Breithaupt et 
al., 2012). 
OUES in overweight/ obese children  
A number of studies have compared the OUES in overweight/obese children 
and adolescents and healthy normal weight age matched controls (Marniov et al., 
2003, Breithaupt et al., 2012, Drinkard et al., 2007).  Using a maximal cycle ergometer 
test, Drinkard et al, (2007) compared the OUES at the intensity corresponding to the 
lactate threshold (OUES LT), 150% LT (OUES 150) and V̇O2peak (OUES peak) in 
severely overweight 12 to 17 year old adolescents and aged matched non-overweight 
controls.  There was no significant difference between absolute values of V̇O2peak, 
OUES peak, OUES LT and OUES 150 between the overweight and normal weight 
adolescents.  V̇O2peak, OUES peak and OUES LT were significantly higher in the 
overweight than normal weight controls but when expressed relative to lean body 
mass, V̇O2peak, OUES peak, OUES 150 and OUES LT were significantly lower in the 
overweight than the control group (Drinkard et al., 2007).  Similarly, Breithaupt et al., 
(2012) found that both maximal OUES (L.min-1) and submaximal OUES (L.min-1) values 
were significantly higher in obese 7-18 year children than healthy normal weight 
children but were significantly lower in obese children when adjusted for body mass, 
body surface area (BSA) and FFM (Breithaupt et al., 2012).   
In contrast, Marinov et al., (2003) found no significant difference between 
OUES values in obese 11-year-old children and normal-weight, age, sex and height 
matched controls during an incremental maximal treadmill test (Marinov et al., 
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2003).  Obese children had greater V̇O2peak values (L.min
-1) than the controls, but 
when normalized for body weight, V̇O2peak, was significantly lower in the obese 
group than the control group (Marinov et al., 2003). Findings from these studies 
would indicate that absolute V̇O2peak values and OUES values are higher in obese 
children than normal weight children but are lower when expressed relative to 
anthropometric variables including body mass, BSA and FFM. 
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Table 2.9: Studies that examined the OUES in healthy and overweight/obese children and adolescents  
Author Cohort Age 
Exercise parameters 
measured 
Measurement of 
CRF 
Findings 
Akkerman et al.,  
(2010) 
Healthy 
N=46 (m/f)=27/19 
 
7-17 Submaximal OUES 
(data up to VAT), 
Maximal OUES (100% 
data from test) VO2 
peak, VE peak, VAT 
Maximal CE test  No difference in submaximal OUES, and 
maximal OUES 
OUES sig correlated with V̇O2peak, VE peak 
and VT - correlations declined after OUES 
was normalized for BSA, body mass and 
FFM 
OUES was significantly correlated with age 
height, BSA, weight, FFM and BMI  
Marinov et al,  
(2007) 
Healthy  
N=114 
(m/f)= 58/56  
7-18 Submaximal OUES 
(data up to VT), 
Maximal OUES (100% 
data from test) 
V̇O2peak, V̇O2max, 
RER 
Maximal TM test  No sig difference in submaximal OUES, and 
maximal OUES 
OUES was significantly correlated with 
V̇O2peak 
OUES was significantly correlated with age 
height , BSA, weight, FFM and BMI 
 
Drinkard et al., 
(2007) 
Overweight vs. 
Healthy  
N=107 OW 
m/f=55/52 
N=43 healthy 
m/f=17/26 
 
Age: 8-15 
12-17 OUES LT, OUES 150, 
V̇O2peak (OUES peak)  
Maximal CE test No sig difference in absolute V̇O2peak 
/OUES peak, OUES LT and OUES 150 
between groups. V̇O2peak/OUES peak and 
OUES LT significantly higher in the 
overweight than normal weight but when 
expressed relative to lean body mass, 
V̇O2peak /OUES peak, OUES 150 and OUES 
LT were significantly lower in the 
overweight than the non-overweight 
group. OUES at all exercise intensities for 
both groups were significantly related to 
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V̇O2peak. Significant increase in OUES with 
increasing exercise intensity in both groups 
 
Breithaupt  et 
al., (2012) 
Obese  
N=56  (m/f)=25/31  
 
7-18 Submaximal OUES 
(data up to VT), 
Maximal OUES (100% 
data from test) 
V̇O2peak, VE,  VT 
Maximal TTM test Maximal and submaximal OUES were 
significantly correlated with each other 
and to V̇O2peak, VE peak and VT. Following 
adjustment for BSA and body mass, the 
relation between both maximal and 
submaximal OUES and V̇O2peak, , VE and 
VT was attenuated 
but remained significant. After adjustment 
for FFM, this relation was no longer 
significant. 
 
Marinov et al.,  
(2003) 
Obese vs. healthy  
n=obese 
30(m/f)=15/15 
n=healthy 30(m/f) 
15/15  
11 ±  1.1 Submaximal OUES 
(data up to VT), 
Maximal OUES (100% 
data from test) 
V̇O2peak 
Maximal TM test No sig. difference in OUES values between 
obese and normal-weight controls. Obese 
children had greater absolute V̇O2peak 
than controls but when normalized for 
body weight, V̇O2peak, was significantly 
lower in the obese group than the control 
group. OUES was strongly correlated with 
V̇O2peak and height, BSA, FFM, age, 
weight and BMI Submaximal OUES and 
maximal OUES were strongly correlated 
with each other, with submaximal OUES 
differing by 1.1% from maximal OUES.  
OUES, oxygen uptake efficiency slope; VT, Ventilatory threshold; V̇O2peak, peak oxygen uptake; VE peak, peak minute ventilation; BSA, body surface area; 
CE, cycle ergometer; TM, treadmill; sig, significant; BMI, body mass index; LT, lactate threshold; VE, minute ventilation, OUES LT, oxygen uptake efficiency 
slope calculated up to lactate threshold, OUES peak, oxygen uptake efficiency slope at peak exercise, OUES 100, oxygen uptake efficiency slope calculated 
using 100% of exercise data; V̇O2max, maximal oxygen uptake
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OUES and Vascular Function  
To date, only one published study has investigated the relation between OUES 
and vascular function (Arena et al., 2009).  This study examined the relation between 
OUES, V̇O2max and large artery compliance in healthy middle-age men and women.  
Aortic wave velocity (AWV) was assessed using magnetic resonance imaging.  OUES 
was calculated using data up to 50% (OUES50) and 100% (OUES100) VO2max 
determined during an incremental treadmill exercise test.  V̇O2max, OUES50, and 
OUES100 were significantly related to AWV.  However, only V̇O2max was retained in a 
linear regression analysis developed to predict aortic wave velocity (Arena et al., 
2009).   
Physical Activity  
Physical activity (PA) is defined as any bodily movement produced by skeletal 
muscle that results in the expenditure of energy (Caspersen et al., 1985) and can be 
classified as light intensity PA (LIPA), moderate to vigorous intensity PA (MVPA), and 
vigorous intensity PA (VPA).  LIPA, MVPA and VPA are defined as energy expenditure 
between 1.6-2.9 METs, 3.0-6.0 METs and >6 METs, respectively (Fisher et al., 2015). 
Once considered a sedentary behaviour, standing is now also recognized as a PA 
behaviour due to its positive association with cardiometabolic health, in particular its 
association with changes in skeletal muscle enzyme lipoprotein lipase (LPL) (Owen, 
2010). 
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Physical Activity Recommendations  
 The health benefits associated with increased MVPA are well documented 
(Paffenbarger et al., 1986, Blair et al., 1989, Lee et al., 2012).  Current PA guidelines 
for children and adolescents recommend a minimum of 60 min of accumulated 
MVPA each day (CDC, 2015).  Currently, only 19% of Irish primary school children and 
12% of post primary students meet these recommendations (Woods et al., 2010).  It 
has been suggested that recommendations for LIPA be included in PA guidelines as 
this behaviour accounts for the majority of daily energy expenditure rather than 
MVPA, and may therefore be more attainable (Levine et al., 2006, Owen et al., 2010). 
Measurement of Physical Activity 
PA can be measured subjectively using self-reported techniques including 
questionnaires, diaries and proxy reports.  It can also be objectively measured using 
motion sensors including pedometers and accelerometers (Trost, 2007).  Self-report 
is the most utilized measurement of PA because of low cost and low participation 
burden (Trost, 2007).  The validity of self-reported PA measurements in children and 
adolescents varies significantly across validation methodology and measurement 
protocol (Trost, 2007, Sallis & Saelens, 2000).  The major limitations of self-report 
measures of PA include recall bias and their unsuitability for use in children under-10 
years of age (Trost, 2007). 
Accelerometry is currently the most commonly used objective method for 
measuring PA (Trost, 2007, Reilly et al., 2008).  It measures the acceleration of an 
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object relative to free fall and the output generated produces accelerometer/activity 
counts.  These accelerometer counts provide an objective measure of movement 
intensity (Trost, 2007).  The advantages associated with the use of accelerometry 
measured PA include their small size, robust design, modest cost and their ability to 
measure intensity, frequency and duration of PA (Trost, 2007).  Limitations include 
positioning of the monitor, compliance, output analysis and the inability to measure 
PA during inclined activities such as stair-walking and during water based activities, 
upper body exercises and cycling (Trost, 2007).  In children and adolescents, 
moderate to high correlations have been found between activity counts generated by 
accelerometry and energy expenditure using indirect calorimetry (Trost et al., 2005, 
Freedson et al., 2005). 
Physical Activity and CVD risk factors in Children and Adolescents 
A number of studies have examined the independent association between 
objectively measured PA and the clustering of CMD risk factors in healthy children 
and adolescents (Table 2.10) (Ekelund et al., 2006, Rizzio et al., 2007).  As part of the 
European Youth Heart Study, Andersen et al., (2006) examined the association 
between objectively measured PA and clustering of CMD risk factors in 9 to 15 year 
old boys and girls (Andersen et al., 2006).  The risk factors included in the clustered 
CVD risk score were SBP, TG, TC: HDL-C, insulin resistance, sum of four skinfolds and 
CRF.  There was a graded inverse relation between PA quintiles and clustered CVD 
risk after adjusting for age and gender.  The highest CVD risk was found in the lowest 
three PA quintiles.  The odds ratio for the presence of clustered CVD risk for 
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ascending quintile of PA was 3.29, 3.13, 2.51 and 2.03 compared to the most active 
quintile. 
After adjusting for confounders including adiposity and CRF, Ekelund et al., 
(2006) found a significant association between total minutes spent in PA and 
clustered CVD risk score in 9 to 10 and 15 to 16 year old boys and girls (Ekelund et al., 
2006).  In similar aged cohorts, Ekelund et al., (2007) also found that total time in PA, 
and the time in LIPA, MPA, and VPA was significantly associated with CVD risk score 
in both boys and girls.  The association between total time in PA and clustered CMD 
risk score remained unchanged after adjusting for waist circumference and CRF 
adiposity.  The same study found no independent association between CRF and CVD 
risk score suggesting that PA is more strongly related to CVD risk in children and 
adolescents.  In contrast, after adjustment for CRF and body fat, Rizzo et al., (2007) 
did not find an independent association between total and VPA and either clustered 
CVD risk score in 9 and 15 year olds boys and girls (Rizzo et al., 2007).  In contrast to 
Ekelund et al., (2007) this study found that CRF was more strongly related to 
clustered CVD risk than PA.  
Others have also found no associated between time spent in LIPA, MVPA and 
VPA and total time in PA and clustered CMD risk in healthy 9 year old (Brage et al., 
2004) and 10-14 year old children, respectively (Bailey et al., 2012) after controlling 
for confounders including age, sex, ethnicity, socioeconomic status (Bailey et al., 
2012), sexual maturation and adiposity (Brage et al., 2004).  
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Table 2.10: Cross sectional studies that examined the relation between objectively measured PA and clustered metabolic risk factors in children 
and adolescents  
Author Cohort Measurement of PA 
Measure of Clustered 
Metabolic risk  
Confounders 
adjusted for  
Findings  
Andersen et al., (2006) n (m/f)=817/915 
Age: 9 and 15 yr 
 
Uni-axial 
Accelerometer > 3 
days Total PA  
SBP, TG, TC-HLC-C, HOMA, 
sum of 4 skinfolds, CRF 
zMS 
Age, sex, country OR for having clustered 
risk for ascending quartiles 
of total PA were 3.29, 
3.13, 2.51 and 2.03 
respectively compared 
with the most active 
quintile  
  
Ekelund et al, 2007 n (m/f)= 838/908 
Age: 9 yr and 15 yr 
Uni-axial 
accelerometer ≥ 
3days, TPA, LIPA, 
MPA and VPA 
(min/day)  
WC, BP, glucose, insulin  
HDL-C, TG zMS, non-Ob 
zMS 
Sex, age, study 
location, birth 
weight, pubertal 
status, smoking, 
maternal BMI, 
parental SES, CRF 
and adiposity (when 
non-Ob zMS is the 
outcome) 
Significant associations 
between zMS and total 
physical activity, LIPA, and 
VPA.Significant 
associations for non-Ob 
zMS and total PA, LIPA, 
MPA and VPA   
Rizzo et al., (2007) n (m/f)= 264/265  
Age: 9 yr. and 15  
yr. 
Uni-axial 
accelerometer ≥ 
3days, TPA, MPA, 
VPA and MVPA 
(min/day) 
Insulin, glucose, TG, TC, 
HDL-C, BP, sum of 
skinfolds zMS, non-OB 
zMS 
Pubertal status, 
body height, SES and 
parental smoking, 
age, gender and CRF 
Total PA inversely 
associated with zMS and 
non-zMS in 15-year-old 
girls. No significant 
association between total 
PA and zMS or no-Ob zMS 
for all other age and sex 
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groups. MPA, VPA and 
MVPA all associated with 
with non-OB zMS in 15-
year-old adolescents only 
(results for zMS not 
reported. When CRF was 
adjusted for, total PA was 
not associated with zMS 
or non-Ob zMS in any 
group. MPA, VPA and 
MVPA not associated with 
non-Ob zMS (results for 
zMS not reported)  
Ekelund et al., (2006) n (m/f)=911/1010  
Age: 9 and 15 yr  
Uni-axial 
Accelerometer > 3 
days Total PA 
BMI, sum of skinfolds, BP 
glucose, HDL-C, TG, insulin 
zMS, non-Ob zMS 
Sex, age, study 
location, birth 
weight, maturity, 
smoking, parental 
SES, CRF (and 
adiposity when 
outcome non-Ob 
zMS)  
Inverse association total 
PA and zMS and non-ob 
zMS 
 
Brage et al., (2004) n=(m/f) 279/310  
Age: 9 and 15 yr 
Uni-axial 
Accelerometer > 3 
days Total PA 
BP, sum of 4 skinfolds, 
insulin, glucose, TG and 
HDL-C zMS, non-ob zMS  
Age, sex sexual 
maturation, 
ethnicity, parental 
smoking, SES (and 
adiposity when 
outcome non-Ob 
zMS) 
Total PA inversely related 
to zMS and non-Ob zMS 
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Bailey et al., (2012) n=(m/f) 41/59 
Age: 10-14 
Tri-axial 
Accelerometer > 
3days  
LIPA, MVPA and VPA 
WC, BP, TC: HDL-C ratio, 
TG, glucose  
Age, sex, ethnicity, 
and socioeconomic 
status 
No association between 
spent in LIPA, MVPA and 
VPA and clustered CMD 
risk  
PA, physical activity; m/f, male/female; LIPA, light intensity physical activity; MVPA, moderate intensity physical activity; VPA, vigorous intensity 
physical activity ;CMD, cardiometabolic disease; zMS, standardized metabolic risk score; non-Ob zMS, standardized metabolic risk score 
excluding adiposity; OR, odds ratio; SES, socioeconomic status; CRF, cardiorespiratory fitness; WC, waist circumference; TC: HDL-C, total 
cholesterol HDL-C ratio, HOMA; homeostasis model assessment; TG, triglycerides; TC, total cholesterol; BP, blood pressure 
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Physical Activity in Adolescence and CVD risk factors in Adulthood 
In contrast to studies that found a significant inverse association between CRF 
during adolescence and CVD risk factors in adulthood (Twisk et al., 2000, Ferreira et 
al., 2002, Hasselstrom et al., 2002, Andersen et al., 2004,  Eisenmann et al., 2005), a 
number of prospective studies have found no association between PA during 
childhood and adolescence and CVD risk factors in adulthood (Boreham et al., 2002,  
Hasselstrom et al.,  2002, Lefevre et al., 2002).  The relation between PA at 12 and 15 
years of age and CVD risk factor profile in young adulthood (mean age 22.5 years) 
was examined as part of the Northern Ireland Young Hearts Project.  No significant 
relation was found between self-reported PA during adolescence and TC, HDL-C, TC: 
HDL-C, SBP, DBP and the sum of four skinfolds in young adulthood (Boreham et al., 
2002).  Similarly, Hasselstrom et al., (2002) found no associated between PA levels 
measured during adolescence and CVD risk score in adulthood.  However, PA in males 
during adolescence was significantly related to waist girth and TG levels in adulthood.  
A significant relation was found between the changes in PA and CVD risk factors.  No 
association was found between PA levels at 13-18 years of age and CVD risk factors at 
40 years in the Leuven Longitudinal Study on Lifestyle, Fitness and Health (Lefevre et 
al., 2002). PA levels measured during childhood and adolescence are not associated 
with CVD risk factors in adulthood. CRF level obtained during adolescence is more 
predictive of CVD health profile in adulthood.  
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Tracking of Physical Activity 
  In terms of physical activity, tracking refers to the tendency of individuals to 
maintain their relative PA level rank over time (Malina, 1996).  The majority of studies 
that have tracked PA from childhood to adolescence have used self-reported 
measures and have reported consistently low to moderate tracking of PA (Janz et al., 
2000, Mc Murray et al., 2003, Pate et al., 1999).  Studies that have tracked PA 
between the ages of 11-42 years, 8-34 years and 9-30 years using self-reported 
measures have reported correlations of ranging from 0.03 to 0.35  (Parson et al, 
2006) (Telema et al., 2005).  In one of the relatively few studies to track objectively 
measures PA using, Kristensen et al., (2008) found that the tracking of PA was very 
low, but increased when the coefficients were adjusted for random error due to day 
to day variation and within instrumental measurement error (Kristensen et al., 2008).   
Sedentary Behaviour  
Sedentary behaviour describes activities that do not substantially increase 
energy expenditure above the resting level of approximately 1.0 MET (Pate et al., 
2008).  Such activities include sleeping, sitting and lying (Sedentary Behaviour 
Research Network, 2012).  Sedentary behaviour is distinct to physical inactivity which 
refers to the lack of engagement in leisure time PA or failure to meet daily PA 
recommendations (Pate et al., 2008).  Epidemiological evidence has demonstrated 
that engagement in prolonged periods of sedentary behaviours can have negative 
effects on metabolic health, even in adults who meet the daily PA recommendations 
(Owen et al., 2010). Such observations have led to the emergence of sedentary 
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behaviour as a distinct risk factor for CVD and all-cause mortality independent of PA 
levels.  
Measurement of Sedentary Behaviour  
Similar to PA, sedentary behaviour can be assessed using a variety of self- 
report measures or objective measures such as accelerometers.  While the Actigraph 
GT1M and GT3X are valid measures of PA, their measurement of sedentary behaviour 
is based on thresholds (Dowd et al., 2012). A threshold of 100 counts per min is most 
commonly used to discriminate between sedentary behaviour and LIPA (Pate et al., 
2008). The use of such thresholds may not accurately calculate sedentary time as it 
has been suggested that their analysis may include other activities such as standing 
(Owen et al., 2010). This limitation in their use has led to the development of  
Inclinometer based activity monitors that can distinguish between sitting and 
standing and are therefore a more accurate measure of  sedentary behaviour in 
children and adolescents (Dowd et al., 2012, Aminian & Hinckson, 2012). The Activpal 
Professional Physical Activity Monitor (PAL Technologies Ltd., Glasgow, UK) is a tri-
axial accelerometer with an inbuilt inclinometer that can distinguish between 
changes in posture in addition to the examination of ambulation (Dowd et al., 2012). 
As a result, its use in the examination of total sedentary time in addition to more 
detailed variables of sedentary behaviours including breaks in sedentary time and 
sedentary bout duration has been recommended (Bassett Jr et al., 2010).  
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Sedentary Behaviour and Cardiometabolic Health  
Sedentary behaviour has emerged as a distinct risk factor for CVD and 
premature mortality, independent of PA (Owen et al., 2010).  For example, self-
reported television viewing time is positively associated with an increased risk of 
cardiovascular and all-cause mortality (Dunstan et al., 2010, Grøntved & Hu, 2011, 
Katzmarzyk et al., 2009).   
Using a rodent model, Bey and Hamilton (2003) compared the effect of 
acute, (12 h) and chronic, (10 h.d-1 for 11 days) hind limb unloading on heparin-
releasable LPL activity to ambulating controls (Bey & Hamilton, 2003).  LPL activity 
was significantly reduced after 4 h of unloading.  A recovery period of 4 h of normal 
cage activity and low-intensity treadmill walking following acute unloading resulted in 
a reversal of LPL activity reduction.  Reductions in skeletal muscle LPL activity were 
localized to the immobilized skeletal muscle and were paralleled with significant 
reductions in [3H]TG-derived fatty acid uptake locally in hind limb muscles and a 
significant decrease in HDL-C after both acute and chronic unloading.  Changes in LPL 
protein content and activity were not accompanied by changes in LPA mRNA 
concentration.  
In contrast, both LPL mRNA expression and LPL activity were significantly 
increased following 14-20 d of run training in rodents (Hamilton et al., 1998).  There 
was a ≥ 2.5 fold increase in LPL activity compared to a 10-fold decrease in activity 
following 10 h of inactivity (Hamilton et al., 1998).  The findings of these studies in 
rodents highlight the difference in the magnitude of LPL activity response to exercise 
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and inactivity.  Inactivity induced reductions in LPL activity occurred more readily 
than increases in LPL activity in response to exercise training.  Furthermore, 
decreases in LPL activity occur in the absence of change in LPL mRNA concentration 
despite decreases in LPL protein content. 
Sedentary Behaviour and Insulin Action  
Sedentary time is positively associated with insulin resistance and the risk of 
T2DM (Stephens et al., 2011).  Reductions in insulin mediated glucose uptake have 
been found following prolonged periods of muscular unloading using hind limb 
suspension in rodents, and bed rest in humans (Mikines et al., 1991, Seider, et al., 
1982).  Stephens et al., (2011) measured insulin action in 14 healthy men and women 
during a continuous infusion of [6,6-2H]-glucose the morning after each of the 
following 24 h conditions; a) active, non-sitting with a high energy expenditure and 
matched energy intake (NO SIT), b) sitting with low energy expenditure and no 
reduction in energy intake (SIT) and c) sitting with low energy expenditure and a 
reduction in energy intake to match expenditure (SIT BAL) (Stephens et al., 2011).  
Insulin action, defined as whole-body rate of glucose disappearance normalized to 
mean plasma insulin, was decreased by 39% in SIT group and 18% SIT group 
compared to NO SIT group.  Insulin action was significantly lower in the SIT group 
than the SIT-BAL group.  One day of sitting substantially reduced insulin action and 
this effect was attenuated, but not prevented, when energy intake was decreased to 
match expenditure.  
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Interrupting sedentary time has a beneficial effect on insulin action (Dunstan 
et al., 2012).  Interrupting 5 h of uninterrupted sitting with 2 min bouts of light (3.2 
km.h-1) or moderate-intensity (5.8-6.4 km.h-1) treadmill walking every 20 min 
significantly reduces the glucose incremental area under the curve (iAUC) and insulin 
iAUC in middle-age overweight men and women.  Similar reductions in glucose and 
insulin were observed following interruption with either light or moderate-intensity 
exercise (Dunstan et al., 2012). 
As demonstrated in the above studies, sedentary behavior has deleterious 
effects on cardiometabolic health and is associated with increased TG, decreased 
HDL-C and decreased insulin sensitivity  (Tremblay et al., 2010).  These effects are 
partially mediated by changes in LPL activity, an enzyme that is synthesized primarily 
by muscle cells and adipocytes, is present on the luminal surface of endothelial cells 
and facilitates the uptake of free fatty acids into skeletal muscle and adipose tissue 
(Hamilton et al., 2004).  LPL binds to circulating ApoB containing lipoproteins and 
mediates triglyceride lipolysis.  The regulation of LPL in skeletal muscles is highly 
dependent on physical activity/inactivity levels.  Loss of local contractile stimulation 
induced by acute and chronic sedentary behaviour results in the suppression of 
skeletal muscle LPL activity and reduced tissue specific uptake of free fatty acids.  This 
results in an increase in circulating levels of TG and associated CVD risk (Hamilton et 
al., 2004).  
 114 
Sedentary Behaviour and Vascular Function   
It has been postulated that low shear stress in the vasculature in response to 
sedentary behaviour may have a deleterious effect on vascular function  (Thosar et 
al., 2012).  Low shear stress results in a direct reduction of nitric bioavailability by 
decreasing eNOS phosphorylation or indirectly by producing endothelial 
microparticles and subsequent oxidative stress (Thosar et al., 2012).  Inactivity 
increases NAPDH oxidase activity in mice resulting in increased oxidative stress (Laufs 
et al., 2005).  
Limited studies have investigated the effect of sedentary behaviour on 
vascular function in adults with the majority of studies involving bed rest or periods 
of microgravity. Consequently, these studies do not accurately represent sedentary 
behaviour as there is no postural activity associated with such activities.  Hamburg et 
al., (2007) examined the effect of 5 days of bed rest on insulin sensitivity and vascular 
function in 20 healthy adults with a mean age of 31 years (Hamburg et al., 2007).  The 
study participants were permitted to get out of bed for up to 30 min within a 24 h 
period.  Brachial artery FMD and reactive hyperemic responses was assessed using 
ultrasound at baseline and on day 3 and day 5.  Venous occlusion plethysmography 
was used to measure lower limb blood flow at baseline and on day 3 and day 5.  After 
bed-rest, reactive hyperemia was reduced by 20% and 30% in lower and upper limbs, 
respectively indicating impaired microvascular function.  Insulin resistance increased 
by 67% following bed rest.  There was also a significant increase in BP and brachial 
artery diameter suggesting increases in basal arterial tone.   
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Protocols that simulate microgravity have also been used to examine the 
effect of sedentary behavior on vascular function (Demiot et al., 2007).  Findings of 
the WISE study found that 56 days of head down bed rest resulted in a decrease in 
EDD and increased endothelial cell damage in healthy women (Demiot et al., 2007).  
Sedentary Behaviour in Children and Adolescents  
Common sedentary behaviours among children and adolescents include 
television viewing, computer gaming, surfing the Internet and motorized transport.  A 
recent study found that European children between the ages of 12-18 years spend on 
average 9 h per day or 71% of their waking hours in sedentary behaviour (Ruiz et al., 
2011).  Sedentary behaviour increases from childhood to adolescence (Trang et al., 
2013, Brodersen, et al., 2007) with 11-14 and 15-19 year olds spending approximately 
1.3 h and 2.0 h respectively, more per week than children under the age of 11 years 
(Colley et al., 2011).  The American Academy of Pediatrics recommends that screen-
time should be limited to 2 h.d-1 day in children and adolescents (American Academy 
of Pediatrics 2001).  One third of European teenagers exceed these recommendation 
on a weekday and 60% at the weekend (Ruiz et al., 2011). 
Sedentary Behaviour and CVD Risk Factors in Children and Adolescents  
 While self-reported screen time has been consistently associated with 
increased adiposity and CMD risk factors in children and adolescents independent of 
PA (Tremblay et al., 2011 , Chaput et al., 2013,  Martinez-Gomez et al., 2012) results 
from studies examining the relation between objectively measured sedentary time 
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and CMD risk factors (Table 2.11) have been equivocal (Carson & Janssen, 2011, 
Colley et al., 2013, Ekelund et al., 2012, Mitchell et al., 2009,  Steele et al., 2009, Hsu 
et al., 2011, Atkin et al., 2013, Henderson et al., 2012). 
A number of cross-sectional studies have found no independent association 
between sedentary time and CMD risk factors in healthy children and adolescents.  
After adjusting for age, sex, race, socioeconomic status, smoking, total fat, saturated 
fat, cholesterol and sodium and MVPA, Carson and Janssen (2011) found no relation 
between sedentary time measured using accelerometry and clustered CMD risk  in a 
large cohort of 6 to 19 year old children and adolescents (Carson & Janssen, 2011).  In 
a similar cohort of 1608 children, no association was found between sedentary time 
measured using accelerometry and BMI, waist circumference, non HDL-C, SBP and 
DBP after adjusting for age, wear time and MVPA (Colley et al., 2013).  Similarly, after 
adjustment for sex, age, BMI, MVPA and pubertal status, sedentary time measured 
using an Actigraph accelerometer was not associated with CRP, adiponectin or other 
adipokines in adolescents between the ages of 13-17 years (Martinez-Gomez et al., 
2012). 
In contrast to self-reported studies that found a strong association between 
adiposity and sedentary behaviour (Ekelund et al., 2006, Goldfield et al., 2013 ), two 
recent studies that used accelerometers to objectively measure sedentary behaviour 
did not find a significant relation between sedentary time and fat mass in 8-15 year 
olds after adjusting for height and MVPA (Kwon et al., 2013) or between sedentary 
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time and percentage body fat and waist-to-hip ratio with or without adjustment for 
confounding factors including MVPA in children aged 8-10 years (Chaput et al., 2012).  
Some recent studies have found a significant relation between sedentary time 
and CMD risk factors independent of PA but not adiposity (Atkin et al., 2013, 
Henderson et al., 2012).  In a recent study involving 9 and 15 year old children and 
youth, Atkin et al., (2013) found that sedentary time, calculated using 4 different 
threshold cut-off points was associated with an increased clustered CMD risk 
independent of age group, sex, study location, sexual maturity, day of week, season, 
wear time, adiposity and total PA.  The relation however was however, no longer 
significant after adjusting for adiposity (Atkin et al., 2013).  Similarly, a cross-sectional 
study involving 8 to 11 year old children with a family history of obesity found that 
sedentary time was positively associated with insulin resistance after adjustment for 
sex, age, pubertal stage, fitness and MVPA but not after additional adjustment for 
adiposity (Henderson et al., 2012). 
A large study examining sedentary behavior and CMD risk factors in 20,870 
children from 10 different countries ranging in age from 4 to 18 years found that 
after adjustment for age, sex, adiposity and diet, sedentary time was associated with 
fasting insulin but not with waist circumference, SBP, TG or HDL-C.  The relation 
between sedentary time and fasting insulin was no longer significant after additional 
adjustment for MVPA (Ekelund et al., 2012).  Similarly, Mitchell et al., (2009) found 
no relation between sedentary time and increased risk of obesity in 5,434 youth with 
a mean age of 12 years after adjustment for MVPA (Mitchell et al., 2009)  In a 
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younger cohort of healthy 9-10 year old children, objectively measured sedentary 
time was positively associated with waist circumference and fat mass.  Sedentary 
time remained associated with fat mass after adjusting for age, sex, socioeconomic 
status, and birth weight, sleep duration and maternal BMI.  However, this association 
was not significant after adjusting for MVPA (Steele et al., 2009).  Hsu et al., (2011) 
also found that sedentary time was no longer positively associated with waist 
circumference and SBP after adjustment for MVPA in 8-19 year old healthy children 
(Hsu et al., 2011).  The relation between sedentary behaviour and cardiometabolic 
disease factors independent of MVPA and adiposity in children and adolescents 
remains unclear with studies presenting equivocal findings. While sedentary 
behaviour has been proposed as an independent risk factor for CVD in adults, further 
investigation on sedentary behaviour as a risk factor for CVD independent of MVPA in 
children and adolescents is warranted.  
 119 
Table 2.11: Cross sectional studies that examined the relation between objectively measured sedentary behaviour and cardiometabolic disease risk 
factors in children and adolescents  
Author Cohort Measurement of 
sedentary 
behaviour  
Measure of Clustered 
Metabolic risk  
Confounders 
adjusted for  
Findings  
Carson and Janssen 
(2011) 
n (m/f)=1284/1243 
Age: 6-19 yr 
 
Actigraph 
accelerometer  
< 100 cpm  
Total sedentary time  
WC, SBP, non HDL-C, 
hsCRP  
Age, sex, race, SES, 
smoking, total fat, 
saturated fat, 
cholesterol, sodium, 
MVPA 
No association between 
sedentary time and 
clustered metabolic risk 
after adjustment for 
confounders and 
additional adjustment for 
MVPA 
 
  
Colley et al, (2013) n (m/f)= 809/799  
Age: 6-19 yr 
Actical 
accelerometer  
< 100 cpm  
Total sedentary time 
BMI, WC, SBP, DBP, non 
HDL-C 
Age, wear time and 
MVPA 
Sedentary time was not 
associated with BMI, WC, 
non HDL-C, SBP and DBP 
independent of age, wear 
time and MVPA 
Kwon et al., (2013) n (m/f)= 277/277 
  
Age: 8-15 yr 
Actigraph 
accelerometer  
< 100 cpm  
Total sedentary time  
Fat mass Height, physical 
maturity, MVPA  
No association between 
sedentary time and fat 
mass after adjustment for 
height and MVPA  
Chaput et al., (2012) n (m/f)=299/251  Actigraph % body fat and waist-to- Age, sex, sleep No association between 
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Age: 8-11 yr with a 
family hX of obesity  
accelerometer  
< 100 cpm  
Total sedentary time 
height ratio  duration, energy 
intake, sexual 
maturation, parental 
SES and BMI or 
MVPA  
sedentary time and % 
body fat or waist height 
ratio with or without 
adjustment for 
confounders 
Ekelund et al., (2012) n=(m/f) 
10,097/10,773 
Age: 4-18 yr 
Actigraph 
accelerometer  
< 100 cpm  
Total sedentary time 
WC, SBP, TG, HDL-C and 
insulin  
Age, sex, monitor 
wear time, WC, 
MVPA, height 
Sedentary time was 
related to fasting insulin 
but not to WC, SBP, TG, 
HDL-C when adjusted for 
age, sex, monitor wear 
time and height. After 
additional adjustment for 
MVPA, there was no 
relation between 
sedentary time and any of 
the measured CMD risk 
factors  
Mitchell et al., (2009) n=(m/f) 2950/2844 
Age: 12 yr 
Actigraph 
accelerometer  
≤ 199 cpm  
Total sedentary time 
Fat mass, BMI Gender, SES, 
pubertal status and 
early life sleep and 
TV habits 
Sedentary time was 
significantly associated 
with increased risk of 
obesity independent of 
potential confounders. 
This association was no 
longer significant after 
adjustment for MVPA 
Steele et al., (2009) n=(m/f) 
820/1042  
Actigraph 
accelerometer  
BMI, WC and fat mass 
index 
Age, sex, SES, birth 
weight, sleep 
duration, maternal 
Sedentary time was 
significantly related to WC 
and fat mass index but not 
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Age: 9-10 < 100 cpm  
Total sedentary time 
BMI BMI and this relation 
remained significant after 
adjustment for 
confounders. This relation 
was no significant after 
additional adjustment for 
MVPA. 
Hsu et al., (2011)  n=(m/f) 
26/79 
Age: 8-19 yr 
Actigraph 
accelerometer  
< 100 cpm  
Total sedentary time 
WC, fat and lean tissue 
mass, SBP, DBP, TG, 
fasting glucose 
Age, sex, ethnicity, 
fat and lean tissue 
mass, and pubertal 
tanner stage 
Sedentary time was 
positively associated with 
WC and SBP but not TG, 
fasting glucose or DBP 
after adjustment of 
confounders. After 
adjustment for MVPA, 
Sedentary time was not 
associated with any 
outcome 
Henderson et al., 
(2012) 
n=(m/f) 
222/202 
Age: 8-11 yr 
Actigraph 
accelerometer  
< 100 cpm  
Total sedentary time 
HOMA, oral glucose 
tolerance test  
Age, sex pubertal 
status, CRF, MVPA, 
percent fat mass 
Sedentary time was 
positively associated with 
with insulin resistance 
after adjustment for age, 
sex, puberty, CRF and 
MVPA but not after 
additional adjustment for 
percent fat mass  
Atkin et al., (2013) 
 
n=(m/f) 
1059/1268 
Actigraph 
accelerometer  
<100, <500, <800 
BP, insulin resistance, sum 
of skinfolds, HDL-C 
Age, group age, sex, 
study location, day 
of week, season, 
Sedentary time was 
associated with clustered 
metabolic risk but not 
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Age: 9 and 15 yr and <110 cpm 
Total sedentary time 
wear time adiposity 
and total PA 
with adiposity 
independent of 
confounders. The 
strongest relations 
between sedentary time 
and clustered CMD risk 
were observed at high 
accelerometry thresholds 
 
PA, physical activity; m/f, male/female; cpm, counts per minute; LIPA, light intensity physical activity; MVPA, moderate intensity physical activity; VPA, 
vigorous intensity physical activity ;CMD, cardiometabolic disease; SES, socioeconomic status; CRF, cardiorespiratory fitness; WC, waist circumference; 
TC: HDL-C, total cholesterol HDL-C ratio, HOMA; homeostasis model assessment; TG, triglycerides; BP, blood pressure, SBP, systolic blood pressure; DBP, 
diastolic blood pressure;  HDL-C,  high density lipoprotein cholesterol; BMI, body mass index; hsCRP, high sensitivity C-Reactive protein 
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Chapter III 
STUDY 1 
MAXIMAL AEROBIC CAPACITY, SELECTED CVD RISK FACTORS AND VASCULAR 
HEALTH IN MALE ADOLESCENTS 
Rationale 
 CVD is the leading cause of morbidity and premature mortality in Ireland 
accounting for 32% of all deaths (Irish Heart Foundation 2015).  Atherosclerosis, a 
chronic inflammatory disease, is the most common cause of CVD and begins early in 
life.  Clinical manifestations of the disease usually occur in middle and late adulthood.  
In 2009, CVD accounted for approximately 6% of total Irish health care expenditure 
(McGee, 2010), most of which was spent on surgical interventions and treatment of 
risk factors. 
 The vascular endothelium is an active paracrine organ that plays an important 
role in maintaining vascular homeostasis and is intimately involved in the initiation 
and progression of atherosclerosis.  Damage to the vascular endothelium represents 
one of the earliest events in the pathogenesis of atherosclerosis and precedes 
structural changes in the vascular wall such as IMT (Deanfield et al., 2007).  
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 The severity of atherosclerosis is not only associated with the presence and 
extent of CVD risk factors but also to the persistence of risk factors over time 
(Berenson et al., 1998).  Childhood risk factors track into adulthood (Juhola et al., 
2011, Nicklas et al., 2002) and contribute to the development of sub-clinical 
atherosclerosis in young adulthood (Davis et al., 2001, Li et al., 2003, Raitakari et al., 
2003).  Considering the long latent phase of atherosclerotic progression prior to 
clinical manifestation, the ability to non-invasively measure structural and functional 
markers of sub-clinical atherosclerosis during childhood is a critical aspect of early 
detection and risk classification (Berenson, 2002).  Studies have reported increased 
cIMT and impaired endothelial function in young children with established ACVD risk 
factors such as overweight (Woo et al., 2004), obesity (Meyer et al., 2006,  Zhu et al., 
2005),  and T1DM (Järvisalo et al., 2004). 
 Low CRF is an independent risk factor for CVD and all-cause mortality (Blair, et 
al., 1989, Blair et al., 1995).  In contrast, a high level of CRF is cardioprotective and 
largely negates the adverse effects of traditional risk factors on subsequent CVD and 
mortality (Blair et al., 1996 , Church et al., 2004, Lyerly et al., 2008, Lyerly et al., 
2010).  Studies in asymptomatic children and adolescents have found that high levels 
of CRF are positively associated with a more favorable cardiometabolic health profile 
compared to their unfit counterparts (Ruiz et al., 2007, Ekelund et al., 2007, 
Anderssen et al., 2007).  High levels of CRF during adolescence are predictive of a 
healthier CVD risk factor profile in adulthood (Twisk et al.,  2002).  Despite the wealth 
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of evidence linking high levels of CRF to a reduced risk of CVD mortality, its 
measurement is often neglected in CVD risk assessment.  
Improvements in CRF, that accompany regular exercise training have been 
found to improve endothelial function and CVD risk factor profile and decrease cIMT 
in obese adolescents (Watts et al., 2004, Meyer et al., 2006). Exercise induced 
increases in shear stress enhances EDD by increasing the up-regulation of eNOS and 
subsequent bioavailability of NO (Hambrecht, 2003).  To date, no published study has 
examined the relation between objectively measured CRF, CVD risk factors and 
vascular structure and function in healthy adolescents.   
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Study Purpose 
 The purpose of this study was to compare selected CVD risk factors and 
vascular health in LF, MF and HF healthy male adolescents, and to examine the 
relation between CRF, CVD risk factors and vascular health. 
Specific Aims 
1. To compare serum blood lipids, fasting glucose, insulin, HOMA-IR, pro-
inflammatory cytokines, vascular adhesion molecules, BP, body 
composition, EDD and cIMT in LF, MF and HF healthy male adolescents.  
2. To examine the bivariate relation between CRF and EDD in healthy 
male adolescents. 
3. To examine the bivariate relation between CRF and cIMT in healthy 
male adolescents. 
Hypothesis 
1. HDL-C and EDD will be significantly lower and TC, LDL-C, TG, fasting 
glucose, insulin, HOMA-IR, BP, pro-inflammatory cytokines, sICAM-1, 
sVCAM-1, sum of skinfolds, waist-to-hip ratio, body weight, BMI and 
cIMT will be significantly higher in LF than MF and HF male 
adolescents.  
2. There will be a significant positive linear relation between V̇O2max and 
EDD in healthy male adolescents.  
127 
 
 
3. There will be a significant inverse relation between V̇O2max and cIMT 
in healthy male adolescents.  
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STUDY 1 
Methodology 
Study Overview  
A total of 350 post-primary school students in the Greater Dublin region 
undertook a multistage shuttle run test (20-MST) to estimate their aerobic fitness 
level as part of a screening process.  The test was undertaken during a scheduled 
physical education class.  Based on the number of shuttle runs completed, 
participants were classified as low fit (LF) (0-40th percentile), MF (MF) (40-70th 
percentile), and (HF) (70th-100th percentile) in accordance with European age and 
gender specific percentiles for aerobic fitness (Ortega et al., 2011).  A random sample 
was selected from each of the 3 fitness groups to participate in the study.   
The selected participants wore an accelerometer for 7 d and made a single 
visit to the Vascular Research Unit in Dublin City University (DCU) during which a 
fasting blood sample was drawn and body composition, pubertal status, BP, 
endothelial function, cIMT, and V̇O2max were measured. 
Participants  
 A total of 82 healthy male adolescents (LF n=26 LF, MF n=30, HF=26) aged 13-
17 years participated in the study.  Participants and their parents were fully informed 
of the experimental procedures and were provided with a plain language statement 
before written assent and informed consent were obtained in accordance with the 
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Research Ethics Committee at DCU (Appendix A).  A physical activity readiness 
questionnaire (PAR-Q) was also completed by each participant prior to commencing 
the study (Appendix B).  Participants were excluded if they were current smokers, 
had a condition that precluded them from exercising, uncontrolled hypertension (SBP 
>180 mmHg, diastolic BP >100 mmHg), failed to reach a heart rate ≥ 90% of their age 
predicted maximal value during the 20-MST or did not obtain informed consent from 
a parent or guardian. 
20-MST  
The test involved running back and forth between two lines 20 m apart, while 
keeping time to a series of audio signals.  The initial velocity was 8.0 km.hr-1 and 
increased by 0.14 m.s-1. each min.  The test was terminated if the participant 
voluntarily dropped out, or was unable to maintain the set pace by failing to reach 
either end-line before or on two consecutive bleeps.  The total number of shuttle 
runs completed and the total distance achieved were recorded.  Participants wore a 
heart rate monitor (Polar team 2 Pro, Polar Electro Inc., NY, USA) during the test.  The 
purpose of the 20-MST was to screen participants for aerobic fitness and subsequent 
study recruitment. 
Study Visit 
 Participants abstained from strenuous PA for 24 h, and abstained from food, 
alcohol and caffeine for at least 12 h before the visit.  During the visit, a fasting blood 
sample was drawn, pubertal status was self-reported and body composition, blood 
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pressure, endothelial function, cIMT and maximal aerobic capacity (V̇O2max) were 
measured.  The order of testing is outlined in Figure 3.1. 
 
Figure 3.1:  Order of tests undertaken by participants during the study visit 
Body Mass Index   
Height and body mass were measured using a wall stadiometer and electronic 
balance (Seca 797, USA), respectively.  Footwear was removed prior to the 
measurement.  Height was measured to the nearest 0.1 cm and body mass was 
measured to the nearest 0.1 kg.  Body mass index (BMI) was calculated by dividing 
body weight in kilograms by height in meters squared (kg.m-2).  Age and gender 
specific BMI percentiles were calculated and Centers for Disease Control and 
Prevention (CDC) standards were used to classify participants as normal weight (BMI 
< 85th percentile), overweight (BMI ≥ 85th and < 95th percentile) and obese (BMI ≥ 95th 
percentile)(Kuczmarski et al., 2002). 
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Waist-to-hip ratio  
 Waist and hip circumferences were measured in duplicate using a non-elastic 
flexible standard measuring tape (RollFix, Hoechstmass, Germany).  Measurements 
were recorded to the nearest 0.1 cm.  Waist circumference was measured at the 
minimum circumference between the iliac crest and the rib cage (Taylor et al., 2000). 
Hip circumference was recorded at the maximum circumference over the buttocks 
(Taylor et al., 2000).  Waist-to-hip ratio was calculated by dividing the mean waist 
measurements by the mean hip measurements. 
Body Fat  
 Double thickness subcutaneous adipose tissue was measured on the right side 
of the body using skinfold calipers (Harpenden, Cambridge Scientific Industries, MD).  
Chest, abdomen and thigh skinfold measurements were recorded to the nearest 0.1 
cm.  A minimum of two measurements was taken at each site and a third was taken if 
the initial two measurements varied by > 1.0 cm.  The sum of the chest, abdomen 
and thigh skinfold thickness was used as an overall measure of subcutaneous body 
fat.  
Maturation  
 Participants self-reported their genital and pubic hair development using 
standardized Tanner drawings representing different stages of sexual maturity 
(Tanner et al., 1962) (Appendix C).  Participants were classified as pre-pubertal (PP, 
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Tanner Stage 1), mid-pubertal (MP, Tanner Stages 2-4) or late-pubertal (LP, Tanner 
Stage 5) (Marlatt et al., 2013). 
Blood Pressure   
Prior to blood pressure measurements, participants rested in an upright-
seated position for 5 min in a quiet, temperature controlled room.  Blood pressure 
was measured using a mercury sphygmomanometer (Dekamet Model Accoson 
Sphygmomanometers, Harlo Essex) and stethoscope (Classic II 3M Littmann, St. Paul, 
MN).  SBP and DBP readings were categorized based on gender, age and height 
specific percentiles for BP evaluation in children and adolescents; normal (<90th 
percentile); prehypertension (SBP and/or DBP between the 90th and 95th 
percentiles); hypertension (SBP and/or DBP ≥ 95th percentile) (NIH, 2005). 
Blood Sampling  
Participants rested in a seated position for 5 min with legs uncrossed in order 
to minimize plasma volume shifts.  Blood samples were drawn from the antecubital 
vein.  Serum vacutainers were allowed to stand for 20 min before centrifugation at 
3000 rpm (1600 g) for 15 min at 4C.  
Biochemical Analysis  
 Serum TG, TC, HDL-C, LDL-C levels were determined using spectrophotometric 
assays, performed on an automated bench-top clinical chemistry system (Randox RX 
Daytona, Randox Laboratories, UK) using the appropriate reagents, calibrators and 
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controls.  Haematocrit, haemoglobin concentrations and circulating leukocytes were 
determined from an EDTA whole blood sample using an automated haematology 
analyzer (AcTdiff2, Beckman Coulter, USA).   
Insulin Sensitivity  
Fasting glucose was analyzed using a YSI 2300 STAT Plus™ Glucose and Lactate 
Analyzer.  Fasting Insulin was analyzed using an ultrasensitive insulin assay, which is a 
simultaneous one step immunoenzymatic “Sandwich “ assay (UniCek Dxl 8000, access 
immunoassay system, S/N 602530, Version 5.1)  HOMA-IR was calculated using the 
following equation; HOMA-IR= Glucose (mmol/L) x Insulin (mIU/ml)/22.5 (Wallace, 
Levy, & Matthews, 2004).  A HOMA-IR value ≥ 3.16 was used to diagnose the 
presence of insulin resistance (Keskin et al., 2005).  
Proinflammatory cytokines 
Pro-inflammatory cytokines IL-1β, IL-6, INF-γ and TNF-α were measured 
using the V-Plex Human Proinflammatory Panel 1 (4-plex) immunoassay 
(Mesoscale Discovery, Maryland, USA) using the appropriate reagents, calibrators 
and controls.  The results were analyzed using a Mesocale Discovery sector imager 
2400 (Mesoscale Discovery, Maryland, USA).  
Markers of Vascular Injury  
sICAM-1, sVCAM-1 and hsCRP and SAA were analyzed using the V-Plex Plus 
Vascular Injury Panel 2 (human) Kit immunoassay (Mesocale Discovery, Maryland 
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USA) using the appropriate reagents, calibrators and controls.  The results were 
analyzed using a Mesocale Discovery sector imager 2400  (Mesoscale Discovery, 
Maryland, USA).  
Overview of Endothelial Function Assessment   
Brachial artery FMD was determined using high-resolution ultrasonography.  
Measurements were performed by the same investigator using a SonoSite, 
MicroMaxx® (Sonosite Inc., Bothell, Washington, US) ultrasound system with a linear 
array transducer, operating at a frequency of 12.0 MHz (Figure 3.2).   
 
 
 
 
 
 
 
Figure 3.2: Sonosite MicroMaxx® ultrasound system and 12.0 MHz linear array 
transducer  
Brachial artery images were acquired with the participants in a supine 
position in a quiet, temperature-controlled room, with their right arm rested on an 
examination table perpendicular to the bed and extended and externally rotated to 
permit imaging of the right brachial artery.  An automated pneumatic cuff was placed 
on the right forearm, distal to the brachial artery (Figure 3.3) and electrodes for a 3-
lead ECG were placed on their chest.  The ECG tracing was activated on the 
135 
 
 
ultrasound system and settings adjusted to ensure clear identification of the R wave, 
which corresponds to the end of diastole in the cardiac cycle.  
Figure 3.3: Arm position and cuff placement  
Participant Preparation 
 Participants were tested between 9 and 11 am, by the same experienced 
investigator, in a quiet, temperature-controlled room (Vascular Research Unit).  
Participants arrived to the Vascular Research Unit, DCU after a 9 h overnight fast.  
Only water consumption was permitted prior to the test.  Participants were not 
permitted to exercise, or ingest substances that might affect FMD such as caffeine 
and vitamin C or use tobacco for at least 6 h before the study.   
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Ultrasound Technique and Image Acquisition  
Anatomic landmarks such as veins and fascial planes were noted and used to 
ensure that all M-mode images and Doppler measurements were recorded at the 
same site.  A longitudinal image of the brachial artery was obtained using B mode 
ultrasound.  The brachial artery was insonated 3-7 cm above the antecubital crease.  
Great care was taken to ensure that the anterior and posterior intimal interfaces 
between the lumen and the arterial wall were clearly visible.  Depth and gain settings 
were optimized to delineate the lumen-arterial interface optimally on both the near 
(anterior) and far (posterior) wall.  The boundaries were clearly visualized with the 
angle of insonation perpendicular to the vessel.  It is recommended that the imaging 
plane should bisect the vessel in the longitudinal direction to ensure that diameter 
measurements obtained from the images reflect the true diameter of the vessel 
(Corretti et al., 2002).  Images were magnified using a “zoom” function.  
M Mode Imaging  
The brachial artery was imaged using M mode function to facilitate arterial 
diameter measurements at appropriate time points (Figure 3.4).  Brachial artery 
diameter was assessed in real time using the in-built ultrasound calipers (SonoSite 
MicroMaxx®).  Each image acquired incorporated a minimum of 2 and a maximum of 
3 consecutive ECG R waves.  The brachial artery diameter measurements were 
obtained at cross sections corresponding to the R waves. 
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Figure 3.4: M mode ultrasound image of the brachial artery 
Doppler Imaging 
Doppler imaging was used to measure blood flow velocity (cm.s-1) in the 
brachial artery.  The Doppler scale was adjusted to accommodate the spectral signal 
and the expected increase in blood flow following cuff release.  The scale was 
maintained at the minimum range to decrease measurement error.  The Doppler gate 
was set to minimum (1.5 mm) and was positioned in the centre of the artery lumen.  
The Doppler gate was aligned with the direction of flow and the transducer was 
adjusted to achieve an angle of insonation of 70 (Harris, Nishiyama, Wray, & 
Richardson, 2010).  The insonation angle between the pulsed-wave Doppler beam 
and the vessel walls was adjusted by manipulation of the transducer, to allow the 
beam to be steered and the angle corrected in alignment with the vessel 
orientation/parallel, and blood flow axis at a discrete segment of 70 (Harris et al., 
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2010). The Doppler function traced the spectral wave-form (Figure 3.5).  The image 
was frozen and peak systolic velocity was manually measured using the in-built 
ultrasound calipers (SonoSite MicroMaxx®). 
 
 
 
 
 
 
 
 
 
Figure 3.5 Frozen screen shot of a Doppler image 
Endothelial -Dependent Dilation (EDD) 
 Figure 3.6 illustrates the endothelial-dependent dilation assessment 
protocol.  Following a 10 min rest period a pneumatic cuff was inflated to 250 mmHg 
for 5 min (Corretti et al., 2002). Following 5 min of occlusion, the cuff was rapidly 
released resulting in reactive hyperemia and a subsequent increase in brachial artery 
blood flow.  Post-deflation peak systolic velocity was measured using Doppler within 
15 sec of cuff release (Corretti et al., 2002). M-mode images of the brachial artery 
were recorded every 30 sec post-deflation for 5 min for the off-line analysis of 
brachial artery diameter from which the peak diameter was obtained. The percent 
change in vessel diameter (%FMD) was calculated using the following equation; % 
FMD= Peak diameter (cm) - Baseline diameter (cm)/Baseline diameter (cm)*100 
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(Harris et al., 2010).  Peak shear rate (SRpeak), an estimate of shear stress without 
blood viscosity was assessed prospectively and was calculated using the formula; 4 x 
maximal velocity/vessel diameter at the time of peak velocity (Parker et al., 1985).  
This measure of shear rate is significantly correlated with % change in FMD and highly 
correlatwed with SRAUC (Gibbs et al., 2011), which is most commonly used method to 
normalize FMD respinses for shear rate.   
 
Figure 3.6:  Overview of the protocol used to assess endothelial-dependent dilation 
Endothelial-Independent Dilation  
Figure 3.7: illustrates the endothelial-independent dilation assessment 
procedure.  Participants rested for 15 min to eliminate endothelium-dependent 
effects on the brachial artery diameter.  Following this period, a new baseline 
brachial artery image was recorded.  Gylceryl trinitrate (GTN; 400 g) was then 
administered sublingually.  M-mode images were named and recorded every 30 s for 
5 min following GTN administration for the off-line analysis of brachial artery 
diameter from which the peak diameter was obtained. 
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Figure 3.7:  Overview of the protocol used to assess endothelial-independent 
dilation 
Off-line Arterial Measurement Software  
Brachial artery diameter was determined by the off-line analysis of ultrasound 
images using custom-designed, semi-automated ultrasound arterial measurement 
software. Measurements were performed in a blinded fashion.  Images were selected 
for analysis using a standard dialog box (Figure 3.8).  For each image, the artery was 
located and the area between the anterior and posterior arterial walls was manually 
selected.  The software used this point to segment the arterial boundary using a 
constrained region-growing algorithm, and the result was depicted visually in that the 
segmented arterial lumen was highlighted using grey shading.  The segmentation of 
the artery was updated in real-time.  The automated values could be overridden by 
selecting a new seed point or by using a slider to adjust the threshold intensity values 
of the segmentation until a satisfactory diameter estimate was obtained.  Gated 
measurements of the brachial artery diameter were recorded using a minimum of 2 
and maximum of 3 consecutive R waves on the ECG tracing.  The mean of the 2-3 
measurements was taken as the brachial artery diameter.  
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    Figure 3.8:  Standard Dialog box 
Carotid Intima Media Thickness  
Carotid intima media thickness (cIMT) was assessed using a 12.0 MHz linear-
array transducer (SonoSite, MicroMaxx).  Images were obtained with the participant 
resting in a supine position, with the head turned slightly to the contralateral side.  
(Figure 3.9) 
 
 
 
 
 
Figure 3.9:  Participant position for cIMT measurement  
The CCA, including the carotid bulb, was visualized, and longitudinal B-mode 
images of the left and the right CCA were recorded and electronically stored.  
Measurement of cIMT were taken 0.5 cm, 1.0 cm and 2.0 cm proximal to the carotid 
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bulb in the near and far wall of the right and left CCA (Figure 3.10).  Near and far wall 
measurements at each of the 3 sections of CCA were combined to calculate mean 
near and far wall CIMT.  Advanced Vascular aging was defined as having a mean far 
wall IMT of the right CCA and left CCA ≥ 25th percentile for race and sex matched 
healthy 45 year old (Howard et al., 1993). 
 
 
 
Figure 3.10:  Measurement of cIMT 
Maximal Aerobic Capacity (V̇O2max) 
 Maximal aerobic capacity (V̇O2max) was assessed on a treadmill (Marquette 
2000, General Electric, USA) using 1 of 3 incremental protocols (Appendix D), 
depending on the individual’s level of fitness.  Participants in the LF, MF and HF group 
undertook a 2 min warm up on a 0% grade, which consisted of 2 min at 6.0, 7.0 and 
9.0 km.hr-1 respectively, After the warm-up the treadmill velocity was increased to 
7.0, 8.0 and 11.0 km.hr-1 in the respective groups for 1 min and then was increased to 
8.0, 10.0 and 12.0 or 13 km.hr-1 in the LF, MF and HF respectively after which the 
speed remained constant and the grade was increased by 0.5% every 30 sec until 
volitional exhaustion.  The protocol was designed to ensure that participants reached 
volitional exhaustion between 8 to 12 min.  Participants were verbally encouraged to 
give their maximal effort.  
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 Respiratory metabolic measures were monitored continuously throughout the 
test and V̇O2max was determined by averaging the three highest consecutive 20-sec 
values.  Rating of perceived exertion (RPE) was recorded during the last 15 sec of 
each min using the Borg 16 point category rating scale.  Heart rate was continuously 
recorded throughout the test using heart rate telemetry (Polar team 2 Pro, Polar 
Electro Inc., NY, USA).  The test was deemed maximal if at least two of the following 
four criteria were satisfied: (i) a plateau in oxygen consumption (defined as a ≤ 2.0 
ml.kg.min-1 change in VO2 during the last minute of exercise) (ii) heart rate >200 bpm, 
(iii) RER >1.0 or (iv) volitional fatigue (Breithaupt et al., 2012). 
Cardiorespiratory and Metabolic Measures  
 Respiratory metabolic responses were determined using standard open-
circuit spirometry techniques (Sensormedics Vmax 229, Sensormedics Corp., CA).  
Prior to testing, the gas analysers were calibrated with standard gases of known 
concentration.  A mass flow sensor (Sensormedics, Loma Linda, CA, USA) was used to 
collect breath-by-breath measurement of ventilation.  A 3 L volume syringe 
(Sensormedics, Loma Linda, CA, USA) was used to calibrate the mass flow sensor 
prior to each test.   
Mass Flow Sensor Heated Wire Anemometer- Mode of Operation  
 The mass flow sensor is a low resistance tube with a tapered internal 
diameter extending from both ends of a laminar flow throat.  A cold and hot stainless 
steel wire electrically heated to -180°C and -240°C respectively, are centered in the 
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flow stream.  These wires are elements in a servo-controller bridge circuit that 
maintain the resistance ratio of the two wires at a constant value.  If only the 
temperature of the inspired gases changes then both wires lose heat at the same 
rate and no current change is required to keep the bridge balanced.  As air flows 
across the wires, the hot air loses heat more rapidly than the cold air and current 
must be added to keep the bridges balanced at a 3:4 ratio. The amount of current 
required is proportional to the mass flow of the gas.  This method ensures that the 
sensor measures only the heat loss from the molecular convection of the moving gas 
stream, and not the artifact due to cooling of the gas as it passes through a breathing 
assembly.  The mass flow meter responds to instantaneous flow rates between 0-16 
L.sec-1 and integrated flow between 0-350 L.min-1 with flow resistance <1.5 cmH2O.L
-
1.sec-1.  The mass flow sensor was outputted to the analyser module of the Vmax 229 
and was sampled at a rate of 125 Hz.  
Mass Flow Sensor Calibration  
 A 3.0 L volume syringe (Sensormedics, Loma Linda, CA, USA) was connected to 
the mass flow sensor, and stroked four times in order to measure inspired and 
expired volumes.  The volumes were calculated by expressing 3 L as a fraction of each 
measured inspired and expired volume achieved during calibration.  An average 
correction factor was calculated for inspired and expired volumes, and used to fine-
tune the volume measurement.   
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 A verification procedure was performed. This involved stroking the 3 L volume 
syringe four times.  Inspired and expired volumes were measured using the newly 
calculated correction factors.  In order to pass the calibration procedure, one of the 
four strokes had to have an average flow rate < 0.5 L.sec-1, and at least one of the 
four strokes had to have an average flow > 3.0 L.sec-1.  
Gas Analysers   
 The Vmax 229 utilizes a rapid response infrared measurement technique.  An 
O2 and CO2 analyser is integrated with the Vmax 229.  A small sample of inspired air 
is drawn through a sample cell, and exposed to an infrared light through an optical 
that is passed through a band pass filter and the sample cell.  An infrared detector 
responds to the amount of infrared light that passes through the sample cell.  The 
amount of light that passes through the sample cell varies according to the 
concentration of CO2 in the sample cell.  Based on measured levels of infrared light 
intensity, the analyser computes the PCO2 in the gas sample.  The CO2 analyser is 
linearly scaled across the 0-100% range with a resolution of 0.01% CO2, and a 
response time of < 130 ms (10-90%) at 500 ml.min-1 flow.  The O2 analyser is based 
on the high paramagnetic susceptibility of O2.  A diamagnetic glass dumbbell 
suspended in a magnetic field rotates in proportion to the PO2.  The analyser is 
linearly scaled across the 0-100% range with a resolution of 0.01% O2 and a response 
time of < 130 ms (10-90%) at 500 ml.min-1 flow.  
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Calibration of CO2 and O2 Analysers   
 The gas analysers were calibrated with standard gases of known 
concentration (BOC gases, Dublin, Ireland).  The first calibration gas contained 26.00 
± 0.02% oxygen and the balance nitrogen (N2).  The second calibration gas contained 
4.00 ± 0.02% carbon dioxide, 16.00 ± 0.02% O2, and the balance N2.  A small bore 
drying tube connected to the CO2 and O2 analysers sampled the calibration gases.  
The absorption and evaporative properties of the drying tube ensured that the 
relative humidity of the calibration gas was equilibrated to ambient conditions prior 
to sampling by the O2 and CO2 analysers.  The calibration gas was sampled at a rate 
of 125 Hz. The response time was similar between O2 and CO2 analyser.  
Statistical Analysis  
Prior to statistical analysis the data was checked for normality using the 
Kolmogorov- Smirnov (K-S) test.  A one-way ANOVA (parametric) and a Kruskal-Wallis 
test (non-parametric) were used to compare selected CMD risk factors, endothelial 
function, cIMT and physiological and perceptual responses during maximal exercise 
between LF, MF and HF groups.  Significant main effects were probed using a 
Bonferroni post hoc test (parametric, equal variances assumed) or Games-Howell poc 
hoc test (parametric, equal variances not assumed) and Mann-Whitney U test (non-
parametric).  Statistical significance was accepted at the p <0.05 level of confidence.  
Univariate analysis was undertaken using the Pearson product-moment correlation.  
Statistical significance was accepted at the p<0.05 level of confidence. Partial 
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correlations were undertaken using Pearson product-moment correlation.  SPSS for 
Windows statistical software (V21.0, SPSS Inc, IL) was used to perform the statistical 
analysis 
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RESULTS 
Participant characteristics 
Participant physical characteristics and resting BP are summarized in table 3.1.  
Weight, BMI, waist circumference, hip circumference, sum of skinfolds, SBP and DBP 
were significantly lower in HF and MF than LF.   48% and 16% of LF were obese or 
overweight respectively. Within MF, 3% and 17% were classified as obese or 
overweight respectively.  No HF participants were obese. 12% of HF were overweight. 
Waist-to-hip ratio was significantly higher in HF than both MF and LF.  Tanner stage 
was significantly higher in HF and MF than LF.  With the exception of waist-to-hip 
ratio and SBP, there were no significant differences in any of the measured 
parameters between HF and MF.   
Table 3.1 Physical characteristics and resting blood pressure  
 Group 
 HF MF LF 
Age (y) 15.81 ± 0.49 15.70 ± 0.53 15.32 ± 0.85 
Height (cm) 172.71 ± 6.10 175.49± 6.36 175.95 ± 6.73 
Weight (kg) 63.29 ± 7.65‡ 66.51 ± 10.72‡ 82.87 ± 18.62 
BMI (kg.m-2) 21.19 ± 2.11‡ 21.54 ± 2.90‡ 26.88 ± 6.31 
Waist circumference (cm) 71.06 ± 4.12* 68.04 ± 14.22* 80.32 ± 19.76 
Hip circumference (cm) 75.73 ± 5.68* 75.12 ± 15.80* 88.93 ± 21.06 
Waist-to-hip ratio 0.94 ± 0.04*c 0.91 ± 0.04 0.91 ± 0.08 
Sum of skinfolds 29.26 ± 10.25‡ 40.33 ± 19.95‡ 83.72 ± 38.93 
Tanner Stage 4.10 ± 0.45* 4.17 ± 0.53* 3.70 ± 0.68 
SBP (mmHg) 113.81 ± 6.25‡a 122.23 ± 6.04‡ 131.32 ± 7.70 
DBP (mmHg) 75.00 ± 4.66‡ 76.63 ± 4.66‡ 81.68 ± 4.34 
Values are means  SD; ‡p < 0.001 vs. LF, *p <0.05 vs. LF; ap< 0.001 vs. MF; cp <0.05 vs. MF 
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Physiological and Perceptual Responses at Maximal Exercise 
The mean physiological and perceptual responses during the maximal graded 
exercise test are presented in table 3.2.  Relative V̇O2max (ml
.kg-1.min-1) was 
significantly higher in HF than MF and LF and in MF than LF.  Absolute V̇O2max (L
.min-
1) was significantly higher in HF than MF and LF.  Minute ventilation at maximal 
exercise was significantly higher in HF and MF than LF.  There were no significant 
differences in maximum heart rate and maximal RPE between the three groups.  
Table 3.2 Physiological and perceptual responses at maximal exercise  
 Group 
 HF MF LF 
V̇O2max (ml
.kg-1.min-1) 
V̇O2max (L.min-1) 
HR max (beats.min-1) 
VE max (L.min-1) 
63.58 ± 3.67‡a 
4.03 ± 0.50‡a 
199.65 ± 5.30 
104.83± 13.56‡ 
53.17 ± 3.99‡ 
3.47 ± 0.50 
199.90 ± 7.70 
95.63 ± 14.07* 
39.99 ± 5.11 
3.25 ± 0.61 
197.54 ± 11.36 
82.19 ± 16.19 
RER  1.13 ± 0.03 1.11 ± 0.08 1.13 ± 0.14 
RPE  19.00 ± 1.20 18.87 ± 1.46 19.05 ± 1.33 
Values are means  SD; ‡p < 0.001 vs. LF, *p <0.05 vs. LF; ap< 0.001 vs. MF  
Blood Lipids 
 Fasting serum levels of blood lipids are presented in Table 3.3.  Fasting TG 
were significantly lower in HF and MF than LF.  With the exception of 1 participant in 
MF, TG values were within the acceptable normal range of < 90 mg.dL-1 for 
participants in both MF and HF.  In contrast, 41% of LF had borderline to high TG 
values classified as > 90 mg.dL-1 (American Academy of Pediatrics, 2011).  Circulating 
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HDL-C was significantly higher in HF and MF than LF.  There were no significant 
differences in non HDL-C and TC between the groups. 
Table 3.3 Fasting serum levels of circulating blood lipids  
 Group 
 HF MF LF 
Total cholesterol (mg.dL-1) 137.62 ± 25.09 134.38 ± 24.32 141.04 ± 28.53 
HDL-cholesterol (mg.dL-1)  43.03 ± 11.26* 42.67 ± 8.52* 35.45 ± 10.06 
LDL-cholesterol (mg.dL-1) 76.90 ± 16.98 72.50 ± 20.20* 89.82 ± 24.96 
Non-HDL-cholesterol (mg.dL-1)  94.60 ± 17.67 91.71 ± 19.93  105.59 ± 23.56 
Triglycerides (mg.dL-1) 51.46 ± 13.24‡ 55.95 ± 16.44† 78.18 ± 24.50 
Values are means  SD; ‡p < 0.001 vs. LF, † p<0.01 vs. LF, *p <0.05 vs. LF;  
Insulin sensitivity  
 Fasting glucose, insulin and HOMA-IR are presented in table 3.4.  Glucose and 
insulin levels were significantly lower in HF and MF than LF.  HOMA-IR was 
significantly lower in HF and MF than LF and in HF than MF.  No participant in MF or 
HF was classified as insulin resistant based on a HOMA-IR value > 3.16.  In contrast, 
37% of LF participants were classified as insulin resistant.  
Table 3.4 Fasting serum levels of glucose, insulin and HOMA-IR  
 Group 
 HF MF LF 
Glucose (mg.dL-1) 78.32 ± 7.18† 79.12 ± 5.92† 85.04 ± 7.70 
Insulin (mlU L-1) 4.27 ± 1.31‡ 5.83 ± 1.67‡ 11.04 ± 5.16 
HOMA-IR 0.85 ± 0.29‡c 1.15 ± 0.35‡ 2.34 ± 1.17 
Values are means  SD; ‡p < 0.001 vs. LF; †p< 0.01 vs. LF; cp <0.05 vs. MF 
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Cytokines and Vascular Adhesion Molecules 
Circulating levels of pro-inflammatory cytokines and vascular adhesion 
molecules are presented in table 3.5.  There was no significant difference in any of 
the measured pro-inflammatory cytokines and vascular adhesion molecules between 
the groups. 
Table 3.5 Pro-inflammatory cytokines and vascular adhesion molecules  
 Group 
 HF MF LF 
IL-1 (ng.mL-1) 0.10 ± 0.14 0.10 ± 0.13 0.09 ± 0.12 
IL-6 (ng.mL-1) 0.34 ± 0.25 0.44 ± 0.47 0.38 ± 0.21 
TNF- α (ng.mL-1) 1.41± 0.69 1.68 ± 0.80 1.80 ± 0.59 
INF- (ng.mL-1) 6.10 ± 4.58 5.57 ± 4.46 5.75 ± 3.79 
SAA (ng.mL-1) 3644.32 ± 4046.23 5097.33 ± 7022.89 3134.99 ± 1774.05 
hsCRP (mg.L-1) 0.83 ± 0.72 0.91 ± 1.06 1.28 ± 1.43 
sICAM-1 (ng.mL-1) 691.59 ± 87.74  706.69 ± 120.49 838.90 ± 255.84 
sVCAM-1 (ng.mL-1) 823.54 ± 173.51 850.8 ± 226.87 925.63 ± 185.27 
Values are means  SD 
Endothelial Function 
 Resting brachial artery diameter was significantly higher in HF than LF (Table 
3.6).  The percentage change in EDD and EID is illustrated in figures 3.11.  The percent 
change in EDD was significantly higher in HF (12.4%) and MF (9.7%) than LF (7.1%) 
and in HF than MF (figure 3.11A).  There was no significant difference in percent 
change in EID between the three groups (figure 3.11B).  
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The absolute change in EDD and EID is presented in table 3.6.  The absolute 
change in EDD was significantly higher in HF and MF than LF and in HF than MF.  The 
absolute change in EID was significantly higher in HF than LF.  There was no 
significant difference in absolute change in EID between either the HF and MF and 
the MF and LF groups.  There was no significant difference in peak blood flow (BF) 
velocity following reactive hyperemia between the three groups (Table 3.6).  There 
was also no difference in peak shear rate (SRpeak) between the three groups. 
 
   
  
Figure 3.11 Percent change in EDD (A) and EID (B) in HF, MF and LF.  Values 
are means  SD.  ‡p < 0.001 vs. LF; *p <0.05 vs LF; ap< 0.001 vs. MF 
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Table 3.6   Brachial artery diameter, absolute change in EDD and EID and peak blood 
flow velocity 
 Group 
 HF MF LF 
Brachial artery diameter (cm) 0.40 ± 0.05* 0.37 ± 0.04 0.36 ± 0.04 
EDD (cm) 
EID (cm) 
Peak BF velocity (cm.s-1) 
Peak Shear Rate 
0.40 ± 0.05* 
0.05 ± 0.01‡a 
0.08 ± 0.02* 
174.93 ± 25.96 
0.37 ± 0.04 
0.04 ± 0.01‡ 
0.07 ± 0.02 
170.09 ± 28.80 
0.36 ± 0.04 
0.03 ± 0.01 
0.07 ± 0.02 
180.97 ± 20.39 
Values are means  SD; ‡p < 0.001 vs. LF, *p <0.05 vs. LF; ap< 0.001 vs. MF 
Carotid Intima media thickness  
Near and far wall IMT measurements of the right and left CCA are presented 
in table 3.7.  Right CCA near wall IMT, left CCA near wall IMT, right CCA far wall IMT 
and left CCA far wall IMT were significantly lower in HF and MF than LF and in HF than 
MF. 
 
Table 3.7 Near and far wall cIMT measurements of right and left CCA 
 Group 
 HF MF LF 
Right near wall cIMT (mm) 
Left near wall cIMT (mm) 
Right far wall cIMT (mm) 
Left far wall cIMT (mm) 
0.39 ± 0.04‡c 
0.38 ± 0.03‡c 
0.39 ± 0.05‡a 
0.39 ± 0.04‡a 
0.44 ± 0.08‡ 
0.44 ± 0.08‡ 
0.49 ± 0.07‡ 
0.49 ± 0.07* 
0.52 ± 0.07 
0.53 ± 0.08 
0.57 ± 0.05 
0.55 ± 0.07 
Values are means  SD; ‡p < 0.001 vs. LF, *p <0.05 vs. LF; ap< 0.001 vs. MF, cp <0.05 
vs. MF 
Univariate Correlations - EDD 
There was a significant positive relation between Tanner stage and percent 
change in EDD (r=0.25, p=0.013) and Tanner stage and absolute change in EDD 
(r=0.238, p=0.019).  There was a significant positive relation between V̇O2max (ml.kg-
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1.min-1) and the percent change in EDD (r=0.70, p<0.001) (Figure 3.2).  After 
adjustment for baseline brachial artery diameter, pubertal stage, SBP, sum of 
skinfolds, insulin, HOMA-IR and TG, the strength of the association between V̇O2max 
(ml.kg-1.min-1) and percent change in EDD decreased (r=0.56, p=0.000) but remained 
significant.  
 
 
Figure 3.12 Relation between V̇O2max and percent change in EDD 
There was a significant positive relation between V̇O2max (ml.kg-1.min-1) and 
HDL-C (r=0.32, p=0.003).  There was a significant inverse association between 
V̇O2max (ml.kg-1.min-1) and weight (r=-0.61, p=0<001), BMI (r=-0.61,p<0.001), SBP 
(r=-0.79, p<0.001), DBP (r=-0.49, p<0.001), waist circumference (r=-0.40, p<0.001), 
hip circumference (r=-0.46, p<0.001), sum of skinfolds (r=-0.69, p<0.001), glucose (r=-
0.39, p<0.001), insulin (r=-0.72, p<0.001), HOMA-IR (r=-0.71, p<0.001), LDL-C (r=-0.29, 
p<0.001 
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p=0.007), non HDL-C (r=-0.26, p=0.014), TG (r=-0.57, p<0.001) sICAM-1 (r=-0.38, 
p=0.001) and sVCAM-1 (r=-0.23, p=0.044).   
Table 3.8 summarizes the significant univariate relation between EDD and 
selected CVD risk factors.  The strongest correlation coefficients were found for the 
association between EDD and SBP (r=-0.60), sum of skinfolds (r=-0.57), BMI (r=-
0.47), insulin (r=-0.44), HOMA-IR (r=-0.41) and TG (r=-0.46).  There was a significant 
positive relation between HDL-C and the percent change in EDD (r=0.24, p=0.022).   
Table 3.8: Univariate relation between EDD and selected CVD risk factors  
 Correlation 
Coefficient 
P value 
Weight (kg) r=-0.45 p=0.000 
BMI (kg.m2) r=-0.47 p=0.000 
SBP (mmHg) r=-0.60 p=0.000 
DBP (mmHg) r=-0.36 p=0.000 
Waist circumference (cm) r=-0.23 p=0.047 
Hip circumference (cm) r=-0.27 p=0.016 
Sum of skinfolds r=-0.57 p=0.000 
Glucose (mmol.L-1) r=0.31 p=0.007 
Insulin (mlU.L-1) r=-0.44 p=0.001 
HOMA-IR r=-0.41 p=0.002 
LDL-cholesterol (mg.dL-1) r=-0.28 p=0.010 
HDL-cholesterol (mg.dL-1)  r=0.24 p=0.022 
Non HDL-cholesterol (mg.dL-1)  r=-0.22 p=0.039 
Triglycerides (mg.dL-1)  r=-0.46 p=0.000 
Univariate Correlations – cIMT  
 There was a significant inverse relation between Tanner stage and right CCA 
far wall cIMT (r=-0.24, p=0.018) and Tanner stage and left CCA far wall cIMT (r=-0.25, 
p=0.01).  There was a significant inverse relation between V̇O2max (ml.kg-1.min-1) 
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and right near wall cIMT (r=-0.69, p<0.001), left near wall cIMT (r=-0.67, p<0.001) 
right far wall cIMT (r=-0.76, p<0.001) and left far wall cIMT (p<0.001, r=-0.67) of the 
CCA.  
 Table 3.9 summarizes the univariate analysis between selected CVD risk 
factors and near and far wall cIMT of the right and left CCA.  The strongest 
associations were found between right far wall cIMT of the CCA and SBP (r=0.75, 
p=0.000), sum of skinfolds (r=0.60, p=0.000), insulin (r=0.56, p=0.000) and HOMA-IR 
(r=0.54, p=0.000).  
 After adjustment for pubertal stage, SBP, sum of skinfolds, TG, insulin and 
HOMA-IR, the strength of the relation between V̇O2max (ml.kg-1.min-1) and right 
CCA far wall IMT (r=-0.47, p=0.001) and left far wall cIMT of the CCA (r=-0.44, 
p=0.001) was reduced, but remained significant.  
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Table 3.9 Univariate analysis between selected CVD risk factors and cIMT 
 cIMT 
 RT near wall LT near wall RT far wall LT far wall 
V̇O2max (ml
.kg-1.min-1)    r=-0.69, p=0.000               r=-0.67, p=0.000  r=-0.76, p=0.000 r=-0.72, p=0.000 
V̇O2max (L
.min-1)  r=-0.26, p=0.022 r=-0.31, p=0.006  r=-0.34, p=0.002 r=-0.27, p=0.017 
Weight (kg) r=0.50, p=0.000 r=0.45, p=0.000 r=0.53, p=0.000 r=0.53, p=0.000 
BMI (kg.m-2) r=0.51, p=0.000 r=0.43, p=0.000   r=0.51, p=0.000      r=0.53, p=0.000 
SBP (mmHg) r=0.67, p=0.000 r=0.62, p=0.000 r=0.75, p=0.000 r=0.67, p=0.000 
DBP (mmHg) 
Waist circumference (cm) 
r=0.40, p=0.000 
r=0.45, p=0.000 
r=0.36, p=0.001 
r=0.36, p=0.001 
r=0.40, p=0.000 
r=0.39, p=0.000 
r=0.39, p=0.000 
r=0.46, p=0.000 
Hip circumference (cm) r=0.47, p=0.000                 r=0.42, p=0.000 r=0.43, p=0.000 r=0.48, p=0.000 
Sum of skinfolds  r=0.54, p=0.000 r=0.49, p=0.000 r=0.60, p=0.000 r=0.56, p=0.000 
Glucose (mg.dL-1)    r=0.27, p=0.019                 r=0.27, p=0.021   r=0.34, p=0.003      r=0.34, p=0.002 
Insulin (mlU.L-1) 
HOMA-IR 
LDL-cholesterol (mg.dL-1) 
HDL-cholesterol (mg.dL-1) 
Non HDL-cholesterol (mg.dL-1) 
Triglycerides (mg.dL-1) 
IL-6 (ng.mL-1) 
TNF-α (ng.mL-1) 
ICAM-1 (ng.mL-1) 
VCAM-1 (ng.mL-1) 
hsCRP (mg.L-1) 
r=0.53, p=0.000 
r=0.49, p=0.000 
ns 
r=-0.26, p=0.014 
ns 
r=0.43, p=0.000 
r=0.27, p=0.025 
ns 
r=0.23, p=0.047 
ns 
r=0.21, p=0.041 
r=0.54, p=0.000 
r=0.51, p=0.021 
ns 
r=-0.32, p=0.003 
ns 
r=0.32, p=0.004 
r=0.35, p=0.003 
r=0.30, p=0.022 
ns 
ns 
ns 
 
r=0.56, p=0.000 
r=0.54, p=0.000 
r=0.27, p=0.011 
r=-0.25, p=0.019 
  r=0.26, p=0.014 
 r=0.47, p=0.000 
ns 
ns 
r=0.23, p=0.045 
  r=0.30, p=0.011 
ns 
 
r=0.53, p=0.000 
r=0.53, p=0.000 
r=0.19, p=0.058 
r=-0.24, p=0.023 
     r=0.19, p=0.059 
r=0.50, p=0.000 
r=0.28, p=0.0017 
ns 
ns 
ns 
r=0.25, p=0.019 
 158 
Summary of Results  
EDD was significantly higher and cIMT was significantly lower in HF and MF 
than LF.  CVD risk factors including obesity, hypertension, and insulin resistance and 
elevated circulating TG were present in a large majority of LF participants.  A large 
proportion of LF had advanced VA of both left and right CCA and impaired EDD.   
In univariate analysis, CVD risk factors including SBP, HOMA-IR, insulin and TG 
were significantly related to EDD and cIMT.  However, the strongest association was 
between V̇O2max (ml
.kg-1.min-1) and both EDD and CIMT. V̇O2max was independently 
related to EDD and cIMT after adjustment for potential confounding variables.  
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Chapter IV 
STUDY 2 
OXYGEN UPTAKE EFFICIENCY SLOPE AND VASCULAR HEALTH IN MALE 
ADOLESCENTS  
Rationale 
Cardiopulmonary exercise testing (CPET) is commonly used in clinical settings 
to assess the response to exercise in both healthy and diseased populations 
(Akkerman et al., 2010).  Maximal oxygen uptake (V̇O2max) obtained during a 
progressive exercise test is recognized as the gold standard measurement of CRF.  
However, due to its effort dependency, a true plateau in V̇O2 during maximal exercise 
testing is seldom attained, particularly in overweight and obese pediatric populations 
(Marinov et al., 2003).  The application of V̇O2max testing may therefore be limited to 
healthy, trained and motivated individuals.  
Maximal exhaustive exercise testing does not mimic the daily activities of 
children.  Exercise performance at submaximal intensities may be better tolerated 
and more reflective of the intensity of activities undertaken by adolescents 
(Akkerman et al., 2010).  The OUES derived from the linear relation between oxygen 
uptake and the logarithm of minute ventilation during incremental exercise has been 
proposed as an objective and effort independent submaximal measure of CRF (Baba 
et al., 1996).  It is calculated using the equation; V̇O2=a logV̇E + b; where V̇O2 
represents oxygen uptake (ml.min-1), the constant ‘a’ represents the rate of increase 
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in V̇O2 in response to an increasing V̇E (OUES), log V̇E is the common logarithm of V̇E 
and the constant ‘b’ represents the intercept (figure 2.1) (Bongers, 2013).  The 
logarithm transformation of V̇E results in the linearization of the relation of V̇O2 
versus V̇E during incremental exercise making the OUES theoretically effort 
independent (Mezzani et al., 2009).  OUES reflects the integrative capacity of the 
respiratory, cardiovascular and musculoskeletal systems during aerobic exercise, but 
unlike V̇O2max, is independent of subject effort, and can be obtained during 
submaximal exercise (Arena et al., 2009).  Children with higher V̇O2peak values 
exhibit greater OUES values, reflecting greater oxygen uptake during exercise, than 
children with lower V̇O2peak values (Akkerman et al., 2010). 
Given its prognostic value in CAD and HF patients (Coeckelberghs et al., 2015, 
Davies et al., 2006) and its strong positive correlation with V̇O2max in healthy 
children (Marinov et al., 2007, Akkerman et al., 2010) overweight/obese children 
(Breithaupt et al., 2012) and in children with chronic conditions such as cystic fibrosis 
and congenital heart disease (Bongers et al., 2012, Baba et al., 1996), OUES may be of 
clinical utility and may be used as a surrogate for V̇O2max in the assessment of CRF.  
Cross-sectional studies in healthy children and adolescents have found a positive 
relation between V̇O2max and cardiovascular health profile (Anderssen et al., 2007, 
Ekelund et al., 2007,  Ruiz et al., 2007) and vascular health (Hopkins et al., 2009, Silva 
et al., 2014).  In the only published study to examine OUES and vascular health, a 
significant inverse relation was found between OUES and arterial stiffness in healthy 
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middle-aged adults (Arena et al., 2009).  To date, no published studies have examined 
the relation between OUES and vascular health in children and adolescents.  
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Study Purpose 
 The purpose of this study was to examine the relation between OUES and 
vascular health and to compare OUES in LF, MF and HF healthy male adolescents and 
to.  
Specific Aims 
1. To determine the relation between maximal OUES/submaximal OUES and 
V̇O2max in healthy male adolescents and whether the OUES can be used as an 
alternative to V̇O2max in the assessment of CRF in adolescents. 
2. To examine the relation between both maximal OUES and submaximal OUES 
and EDD in healthy male adolescents. 
3. To examine the relation between both maximal OUES and submaximal OUES 
and cIMT in healthy male adolescents.  
4. To determine the predictors of EDD in a multivariate analyses. 
5. To compare maximal OUES and submaximal OUES in LF, MF and HF 
adolescents. 
Hypothesis 
1. Both maximal OUES and submaximal OUES will be significantly related to 
V̇O2max in healthy male adolescents and are suitable alternative measures to 
V̇O2max in the assessment of CRF in adolescents. 
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2. There will be a significant positive linear relation between both maximal OUES 
and submaximal OUES and EDD in healthy male adolescents. 
3. There will be a significant inverse relation between both maximal OUES and 
submaximal OUES and cIMT in healthy male adolescents.  
4. V̇O2max will be the primary predictor of EDD in a multiple linear regression 
analysis that includes V̇O2max and OUES. 
5. Maximal OUES and submaximal OUES will be significantly lower in LF than MF 
and HF healthy male adolescents.  
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Methodology 
Overview of Study Design 
As previously described in methods section of Chapter III  
Participants 
Nineteen LF (n=19), twenty-two MF (n=22) and twenty-two HF (n=22) healthy 
male adolescents aged 13-17 years participated in the study.  These participants were 
a subset of Study 1. 
Participant Recruitment  
As previously described in methods section of Chapter III  
Body Mass Index   
As previously described in methods section of Chapter III  
Body Surface Area  
Body surface area (BSA) was calculated using the following equation of 
Haycock et al., (1978); BSA (m2) = 0.024265 · Ht (cm) 0.3964  · Wt (kg) 0.5378 (Haycock et 
al., 1978). 
Maturation  
As previously described in methods section of Chapter III  
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Endothelial Dependent Dilation and Endothelial Independent Dilation Assessment  
As previously described in methods section of Chapter III  
Carotid Intima Media Thickness  
As previously described in methods section of Chapter III  
Maximal Aerobic Capacity  (V̇O2max) 
As previously described in methods section of Chapter III 
Oxygen Uptake Efficiency Slope (OUES)   
 Breath-by-breath gas data collected during the maximal exercise test was 
averaged at 20 sec intervals and stored in a database for off-line calculation of the 
OUES.  The OUES was calculated by spreadsheet software (Microsoft Excel 2015) 
using the equation of Baba et al., (1996); V̇O2 = a logVE + b where the constant “a” 
represents the OUES, “logVE” represents the logarithm of V̇E and the constant ‘b’ 
represents the intercept (Appendix E).  Specifically, V̇O2 and V̇E data used to calculate 
the OUES were expressed in liters/minute. V̇E was logarithmically transformed and 
the slope V̇O2 (y-axis) and V̇E (x-axis) was determined (Appendix E). 
 All data excluding the first min of exercise was used to calculate maximal 
OUES.  The first min of exercise was excluded from the analysis to eliminate the 
confounding influence of hyperventilation that is common at the onset of exercise.  
Only exercise data up to the ventilatory anaerobic threshold (VAT) was included in 
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the analysis for determination of submaximal OUES.  Relative values for V̇O2max, 
OUES and V̇E were calculated by dividing the absolute values by body mass and BSA. 
Ventilatory Anaerobic Threshold  
 The ventilatory breakpoint method was used to determine the VAT.  This 
involved plotting V̇O2 (x-axis) against V̇E (y-axis).  The V̇O2 at which V̇E increased 
nonlinearly was used to determine the point of the VAT.  
 
 Figure 4.1:  Example of how the VAT was determined 
Cardiorespiratory and Metabolic Measures  
As previously described in methods section of Chapter III  
Mass Flow Sensor Heated Wire Anemometer- Mode of Operation  
As previously described in methods section of Chapter III  
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Mass Flow Sensor Calibration  
As previously described in methods section of Chapter III  
Gas Analysers  
As previously described in methods section of Chapter III  
Calibration of CO2 and O2 Analysers  
As previously described in methods section of Chapter III  
Statistical Analysis  
Prior to statistical analysis, the data was checked for normality using the 
Kolmogorov- Smirnov (K-S) test.  A one-way ANOVA (parametric) and a Kruskal-Wallis 
test (non-parametric) were used to compare mean group differences. Significant 
main effects were probed using a Bonferroni post hoc test (parametric, equal 
variances assumed) or Games-Howell poc hoc test (parametric, equal variances not 
assumed) and Mann-Whitney U test (non-parametric).  A paired sample t-test was 
used to compare differences between maximal and submaximal OUES.  Univariate 
regression analysis was undertaken using the Pearson product-moment correlation.  
A multiple linear regression analysis that included V̇O2 max, maximal OUES and 
submaximal OUES was used to predict EDD using the stepwise method. Statistical 
significance was accepted at the p<0.05 level of confidence.  SPSS for Windows 
statistical software (V21.0, SPSS Inc, IL) was used to perform the statistical analysis. 
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RESULTS 
Participant characteristics 
Participant physical characteristics are summarized in table 4.1.  Weight, BMI 
and BSA were significantly lower in HF and MF than LF.  Tanner stage was higher 
(p<0.05) in MF than LF.  There was no significant difference in age and height 
between the three groups.  
Table 4.1: Physical characteristics in participants 
 Group 
 HF MF LF 
Age (y) 15.77 ± 0.53 15.68 ± 0.57 15.32 ± 0.89 
Height (cm) 173.47 ± 5.64 175.48 ± 7.09 176.40 ± 6.48 
Weight (kg) 64.79 ± 6.61‡ 64.63 ± 9.95‡ 83.87 ± 18.05 
BMI (kg.m-2) 21.53 ± 2.05†  20.93 ± 2.56† 27.13 ± 6.42 
BSA (m-2) 1.76 ± 0.11‡ 1.77 ± 0.16‡ 2.03 ± 0.24 
Tanner stage (I-V) 4.09 ± 0.48 4.25 ± 0.51* 3.74 ± 0.69 
Values are means  SD; ‡p < 0.001 vs. LF, †p< 0.01 vs. LF, *p <0.05 vs. LF 
 
OUES and V̇O2max 
 Table 4.2 summarizes the significant relations between maximal and 
submaximal OUES parameters and V̇O2max. Maximal OUES/kg (r=0.72, p<0.001) and 
submaximal OUES (r=0.78, p<0.001) were both positively related to V̇O2max (ml
.kg-
1.min-1), with a stronger association observed between submaximal OUES and 
V̇O2max (ml
.kg-1.min-1). (Table 4.2). Maximal OUES/kg and submaximal OUES/kg were 
significantly related to each other (r=0.95, p=0.001). There were also significant 
associations between V̇O2VT and submaximal OUES/kg (r=0.77, p<0.000) and 
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submaximal OUES/BSA (r=0.67, p<0.001).  There was no relation between any 
maximal OUES variable and %V̇O2VT.  In contrast, there was a significant relation 
between %V̇O2VT and both submaximal OUES/kg (r=0.32, p=0.016) and submaximal 
OUES/BSA (r=0.25, p=0.044).  VE max was significantly related to maximal OUES 
(r=0.31, p=0.008), submaximal OUES (r=0.39, p=0.003), maximal OUES/BSA (r=0.24, 
p=0.030) and submaximal OUES/BSA (r=0.31, p=0.016). 
 
Table 4.2 Univariate analysis between maximal and submaximal OUES 
parameters and absolute V̇O2max and V̇O2max relative to body weight and BSA 
 V̇O2max  
(L.min-1) 
V̇O2max  
(ml.kg-1.min-1) 
V̇O2max/BSA  
(ml.min-1.m-2) 
Maximal OUES  r=0.67, p=0.000 r=0.23, p=0.038 r=0.46, p=0.000 
Maximal OUES/kg r=0.35, p=0.023 r=0.72, p=0.000 r=0.66, p=0.000 
Maximal OUES/BSA r=0.53, p=0.000 r=0.57, p=0.000 r=0.64, p=0.000 
Submaximal OUES r=0.73, p=0.000 r=0.39, p=0.004 r=0.60, p=0.000 
Submaximal OUES/kg r=0.42, p=0.002 r=0.78, p=0.000 r=0.73, p=0.000  
Submaximal OUES/BSA r=0.58, p=0.000 r=0.69, p=0.000 r=0.74, p=0.000  
OUES and EDD 
There was a significant positive relation between maximal OUES/kg and both 
percent change in EDD (r=0.51, p<0.001) (figure 4.2) and absolute change (r=0.52, 
P<0.001) in EDD. After adjustment for pubertal stage, weight, BMI and BSA, the 
strength of the association between maximal OUES/kg and percent change in EDD 
(r=0.38, p=0.001) and maximal OUES/kg and absolute change in EDD (r=0.43, 
p=0.001) decreased, but remained significant. 
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Figure 4.2 Relation between maximal OUES/kg and percent change in EDD 
 A stronger positive association was found between submaximal OUES/kg and 
both the percent change in EDD (r=0.52, p<0.001) (figure 4.3) and the absolute 
change in EDD (r=0.56, P<0.001) than maximal OUES/kg.  After adjustment for 
pubertal stage, weight, BMI and BSA, the association between submaximal OUES and 
both the percentage change in EDD (r=0.41, p=0.003) and the absolute change in EDD 
(r=0.50, p=0.001) decreased, but remained significant.   
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Figure 4.3 Relation between submaximal OUES/kg and percent change in EDD 
 Table 4.3 summarizes the significant univariate relations between selected 
physiological parameters at maximal exercise and EDD.  The strongest relation was 
found between V̇O2max and (ml
.kg-1.min-1) and EDD.  After adjustment for pubertal 
stage, weight, BMI and BSA, the relation between V̇O2max (ml
.kg-1.min-1) and the 
percent change in EDD (r=0.60, p=0.001) decreased, but remained significant.  There 
was a significant positive relation between EDD and absolute V̇O2VT (ml
.kg1.min1) and 
%V̇O2VT.  The relation was much stronger for V̇O2VT (ml
.kg1.min1) than %V̇O2VT.  In a 
stepwise multiple linear regression analysis that included V̇O2max (ml
.kg-1.min-1), 
maximal OUES, maximal OUES/kg, submaximal OUES and submaximal OUES/kg, only 
V̇O2max (ml
.kg-1.min-1) was a significant predictor of EDD (p<0.001). 
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Table 4.3: Univariate relations between EDD and selected submaximal and  
maximal physiological parameters 
 Correlation 
Coefficient 
P value 
V̇O2max (ml
.kg-1.min-1)  r=0.72,  p<0.001 
V̇O2max (L
.min-1) 
V̇O2max/BSA 
r=0.37  
r=0.65  
 p=0.001 
 p<0.001 
Maximal OUES/kg r=0.51  p<0.001 
Maximal OUES/BSA r=0.39  p=0.001 
Submaximal OUES/kg r=0.52  p<0.001 
Submaximal OUES/BSA r=0.44 p=0.002 
VE max r=0.31 p=0.007 
VE max/BSA 
V̇O2VT (ml
.kg1.min1) 
% V̇O2VT 
r=0.53 
r=0.74 
r=0.44 
p<0.001 
p<0.001 
p=0.001 
P<0.05  
OUES and cIMT 
There was a significant inverse relation between both maximal OUES and 
submaximal OUES expressed relative to body weight and BSA and all measures of 
cIMT (Table 4.4). Of the OUES variables measured, the strongest association was 
observed between submaximal OUES expressed relative to body weight and cIMT. 
Table 4.4 summarizes the significant relations between other selected physiological 
characteristics during maximal exercise including OUES variables and near and far 
wall cIMT of the right and left CCA.  The strongest associations were found to be 
between V̇O2max (ml
.kg-1.min-1) and right (r=-0.67, p<0.001) and left far wall cIMT (r=-
0.75, p<0.001).  
  
 173 
Table 4.4 Univariate analysis between physiological characteristics during exercise and cIMT 
 cIMT   
 RT near wall     LT near wall RT far wall LT far wall  
V̇O2max (ml.kg
-1.min-1) r=-0.67, p=0.000              r=-0.67, p=0.000 r=-0.77, p=0.000 r=-0.75, p=0.000  
V̇O2max (L.min
-1) r=-0.26, p=0.026 r=-0.32, p=0.007 r=-0.41, p=0.000 r=-0.32, p=0.006  
V̇O2max (L.min
-1)/BSA r=-0.57, p=0.000 r=-0.61, p=0.000 r=-0.72, p=0.000 r=-0.67, p=0.000  
Maximal OUES ns  ns ns ns  
Maximal OUES/kg r=-0.40, p=0.001 r=-0.46, p=0.000 r=-0.53, p=0.000   r=-0.48, p=0.000  
Maximal OUES/BSA 
Submaximal OUES 
Submaximal OUES/kg 
r=-0.26, p=0.026 
ns 
r=-0.43, p=0.002 
r= -0.37, p=0.002 
ns 
r=-0.46, p=0.001 
r=-0.41, p=0.000 
r=-0.28, p=0.031 
r=-0.59, p=0.000 
  r=-0.34, p=0.004 
ns 
    r=-0.57, p=0.000 
 
Submaximal OUES/BSA r=-0.35, p=0.002 r=-0.39, p=0.004 r=-0.51, p=0.000      r=-0.47, p=0.001  
V̇e max  r=-0.33, p=0.006                r=-0.32, p=0.006 r=-0.39 ,p=0.001         r=-0.37, p=0.002  
  V̇e max/BSA r=-0.57, p=0.000                       r=-0.55, p=0.000                   r=-0.62, p=0.000            r=-0.62, p=0.000 
  V̇O2VT (ml.kg
-1.min-1)           r=0.62, p= 0.000                       r=-0.66, p=0.000                   r=-0.78, p=0.000            r=-0.77, p=0.000 
   % V̇O2VT                         r=-0.26, p=0.045                        r=-0.37, p=0.006                   r=-0.39, p=0.004            r=-0.31, p=0.018 
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Maximal and Submaximal OUES values 
Absolute and relative maximal and submaximal OUES values are presented in 
Table 4.5.  Maximal OUES was significantly higher in HF than MF.  Maximal OUES/kg 
was significantly higher in HF and MF than LF, and in HF than MF.  Maximal OUES/BSA 
was significantly higher in HF than both MF and LF.  Submaximal OUES, OUES/kg and 
OUES/BSA were significantly higher in HF than both MF and LF.   
In HF, there was a significant difference between maximal OUES and 
submaximal OUES (p=0.001) and no difference between maximal and submaximal 
OUES relative to body weight or BSA.  In MF and LF there was no significant 
difference between maximal OUES and submaximal OUES or between maximal and 
submaximal OUES relative to body weight or BSA. 
Table 4.5 Maximal and submaximal OUES in participants 
 Group 
 HF MF LF 
Maximal OUES  4693.76 ± 771.39a 3778.65 ± 732.29 4146.86 ± 943.41 
Maximal OUES/kg    72.56 ± 10.59‡a 59.16 ± 12.43* 49.99 ± 8.30 
Maximal OUES/BSA 2657.46 ± 383.33‡a 2142.02 ± 405.12 2032.98 ± 342.03 
Submaximal OUES 4686.18 ± 837.60†a 3589.45 ± 808.31 3799.18 ± 783.93 
Submaximal OUES/kg 73.40 ± 11.23‡a 56.31 ± 14.18 46.51 ± 9.43 
Submaximal OUES/BSA 2693.41 ± 415.11‡a 2043.50 ± 466.52 1873.89 ± 300.97 
Values are means  SD; ‡p < 0.001 vs. LF, *p <0.05 vs. LF; ap< 0.001 vs. MF  
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The mean physiological and perceptual responses during the maximal graded 
exercise test are presented in table 4.6.  Absolute V̇O2max and V̇O2max relative to 
both body weight and BSA was significantly higher in HF than MF and LF.  V̇O2max 
relative to body weight and BSA were significantly higher in MF than LF.  Absolute V̇E 
max and V̇E max relative to both body weight and BSA was significantly higher in HF 
than LF and V̇E max relative to BSA was significantly higher in MF than LF.  The relative 
oxygen uptake at VT (V̇O2VT) was higher (p<0.001) in both HF and MF than LF and 
%V̇O2VT was higher (p<0.05) in HF than LF.  RER was higher (p<0.05) in HF and LF.  
There was no significant difference in maximum heart rate and RPE between the 
three groups.  In total, 32% of the cohort did not achieve a plateau in oxygen 
consumption.  Interestingly, a higher percentage of LF achieved a plateau in oxygen 
consumption (73.4%) than MF (68.2%) and HF (54.5).  In addition, to a plateau in 
oxygen consumption, a number of secondary criterion including a respiratory 
exchange ratio (RER) > 1.0, heart rate (HR) >200 bpm and volitional fatigue (RPE 18-
20) were used to verify attainment of attainment of V̇O2max.  Attainment of at least 
two of the four criteria was required for the test to be considered maximal.  Based on 
these criteria, a maximal test was achieved by all HF, MF and LF participants.   
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Table 4.6: Exercise parameters during the graded exercise test  
 Group 
 HF MF LF 
V̇O2max (ml.kg
-1.min-1) 63.52 ± 3.79‡
a  52.78 ± 4.02‡ 40.17 ± 4.9 
V̇O2max (L.min
-1) 4.12 ± 0.44‡
a 3.39 ± 0.47 3.31 ± 0.55 
V̇O2max/BSA (ml.kg
-1.m2) 2332.85 ± 152.74‡
a
 1914.61 ± 138.00‡ 1626.89 ± 153.83 
HR max (beats.min-1)  199.59 ± 4.94 198.43 ± 5.53 197.39 ± 11.82 
VE max (L.min
-1) 104.39 ± 14.19‡ 94.49 ± 14.20 83.27 ± 17.33 
VE max/kg (L.min
-1) 1.62 ± 0.22‡ 1.47 ± 0.20 1.01 ± 0.16 
VE max/BSA (L.min
-1.m2) 59.27 ± 7.52 53.41 ± 6.22 40.90 ± 6.14 
RER 1.13 ± 0.03* 1.11 ± 0.05 1.10 ± 0.07 
RPE 18.91 ± 1.27 18.73 ± 1.64 19.06 ± 1.39 
V̇O2VT (ml.kg
-1.min-1)  54.58 ± 4.62‡ 45.26 ± 3.81‡ 32.12 ± 5.58 
% V̇O2VT 86.05 ± 6.02* 85.76 ± 3.58 80.73 ± 6.14 
Values are means  SD; ‡p < 0.001 vs. LF, *p <0.05 vs. LF; ap< 0.001 vs. MF 
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Maximal OUES and submaximal OUES were significantly related to each other 
(r=0.93, p=0.001).  There was also a significant positive relation between maximal 
OUES/kg and submaximal OUES/kg (r=0.95, p=0.001) and maximal OUES/BSA and 
submaximal OUES/BSA (r=0.94, p=0.001).  Among HF, there was a significant positive 
association between maximal OUES and submaximal OUES (r=0.99, p=0.001), 
maximal OUES/kg and submaximal OUES/kg (p=0.96, p=0.001) and maximal 
OUES/BSA and submaximal OUES/BSA (r=0.99,p=0.001).  Among MF, there was a 
significant positive relation between OUES and submaximal OUES (r=0.998, p=0.001), 
maximal OUES/kg and submaximal OUES/kg (p=0.94, p-0.001) and OUES/BSA and 
submaximal OUES/BSA (r=0.93, p=0.001).  Among LF, there was a significant positive 
correlation between maximal OUES and submaximal OUES (r=0.759, p=0.001) and 
between maximal OUES/kg and submaximal OUES/kg (0.589, p-0.034).  There was no 
association between maximal OUES/BSA and submaximal OUES/BSA. 
 Table 4.7 summarizes the univariate correlations between maximal and 
submaximal OUES and anthropometric parameters.  There was a significant 
association between maximal OUES, maximal OUES/kg and submaximal OUES and 
weight, BMI and BSA.  Submaximal OUES and submaximal OUES/BSA were 
significantly correlated with Tanner stage and weight, respectively.  
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Table 4.7 Univariate analysis between OUES and anthropometric parameters  
 Age 
(yr) 
Height  
(cm) 
Weight  
(kg) 
BMI  
(kg.m-2) 
BSA  
(m-2) 
Tanner Stage 
(I-V) 
Maximal OUES  Ns Ns r=0.37, p=0.001 r=0.36, p=0.002 r=0.37, p=0.001 Ns 
Maximal OUES/kg Ns Ns r=-0.47, p=0.000 r=-0.41, p=0.000 r=-0.47, p=0.000 Ns 
Maximal OUES/BSA Ns Ns Ns ns     Ns Ns 
Submaximal OUES Ns Ns Ns ns Ns r=-0.30, p=0.020 
Submaximal OUES/kg Ns Ns r=-0.50,p=0.000  r=-0.47, p0.000 r=-0.49, p=0.000 Ns 
Submaximal OUES/BSA Ns Ns  r=-0.24, p=0.050 ns Ns Ns 
P<0.05, ns= not significant  
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Summary of Results  
 OUES, a submaximal measure of CRF and has been suggested as potential 
surrogate for V̇O2max in the assessment of CRF in children and adolescents. Both 
maximal and submaximal OUES were significantly correlated with V̇O2max and were 
independently related to both EDD and cIMT in healthy male adolescents. Similar 
associations were found between maximal and submaximal OUES and EDD suggesting 
that the OUES calculated during submaximal exercise can be used to examine the 
relation between health CRF and vascular health. This is advantageous as maximal 
exercise testing in children and adolescents is not always feasible.  
While a significant independent positive relation was found between both 
maximal OUES/kg and submaximal OUES/kg and EDD, a stronger association was 
observed between V̇O2max and EDD. Furthermore, only V̇O2max was retained in a 
linear regression analysis used to predict EDD that included maximal OUES/kg and 
submaximal OUES/kg.   
 Maximal OUES/kg was significantly higher in HF and MF than LF and in MF than 
LF.  Maximal OUES/BSA, submaximal OUES/kg and submaximal OUES/BSA were 
significantly higher in HF than both MF and LF.  Submaximal OUES values were slightly 
but significantly lower than maximal OUES. However, when these values were 
expressed relative to body weight and BSA, there was no significant difference in 
maximal and submaximal OUES showing that the OUES is effort independent. 
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Chapter V 
STUDY 3 
PHYSICAL ACTIVITY, SEDENTARY BEHAVIOUR, SELECTED CVD RISK FACTORS AND 
VASCULAR HEALTH IN MALE ADOLESCENTS 
Rationale 
 Epidemiological studies in adults have demonstrated an inverse relation 
between PA and both CVD and all-cause mortality (Morris et al., 1953, Paffenbarger et 
al., 1986).  In children and adolescents, objectively measured PA is independently 
associated with CMD risk (Ekelund et al., 2007, Ekelund et al., 2006). Regular PA 
enhances endothelial function through shear stress induced upregulation of eNOS, 
which subsequently increases the bioavailability of NO (Moyna & Thompson, 2004). 
Relatively few studies have examined the relation between objectively measured PA 
and vascular function in children and adolescents (Abbott et al., 2002, Pahkala et al., 
2008, Hopkins et al., 2009).  A cross sectional study examining the relation between 
objectively measured PA and brachial artery FMD in pre-pubertal children found that 
time spent in moderate and high intensity PA was significantly related to brachial 
artery FMD (Hopkins et al., 2009).  To date no published studies have examined the 
relation between objectively measured PA and both vascular function and structure in 
healthy adolescents.   
Current PA guidelines recommend that Irish children and adolescents aged 2-
17 years undertake at least 60 min of daily MVPA (Get Ireland Active). Alarmingly, 
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results from a large observational study examining PA levels in Irish children and 
adolescents found that 81% of primary and 88% of post primary pupils do not meet 
the current PA recommendations (Woods et al., 2010).  The effect of low levels of PA 
on vascular health in adolescents is not known.  
 Sedentary behavior has recently emerged as a distinct risk factor for CVD and 
all-cause mortality independent of traditional CVD risk factors and PA (Dunstan et al., 
2010, Healy et al., 2007, Owen et al., 2010).  While the mechanisms responsible for 
the adverse cardiometabolic effects associated with sedentary behaviour are not fully 
understood, it appears that the deleterious effect may be partially mediated by a 
reduction in LPL activity (Tremblay et al., 2010).  Low levels of LPL are associated with 
increased circulating triglycerides and decreased HDL-C (Hamilton et al., 2007). Other 
potential mechanisms include a reduction in insulin action (Stephens et al., 2011) and 
glucose uptake (Hamilton et al., 2004, Stephens et al., 2011). 
 It is estimated that European children aged 12-18 years spend on average  
currently spend on average 9 h per day or 71% of their waking hours in sedentary 
behaviours (Ruiz et al., 2011). Findings from cross sectional studies examining the 
relation between objectively measured sedentary behaviour and CVD risk factors in 
children and adolescents have been equivocal (Tremblay et al., 2014).  Some studies 
report no relation between sedentary behaviour and CVD risk after adjustment for 
MVPA (Hsu et al., 2011, Steele et al., 2009, Mitchell et al., 2010) while others found a 
significant relation between sedentary time and CVD risk factors, independent of PA 
(Atkin et al., 2013, Henderson et al., 2012).  
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 In addition to metabolic health, limited evidence in adults suggests that 
sedentary behavior may also have deleterious effects on vascular function (Hamburg 
et al., 2008, Demiot et al., 2007). Sedentary behavior induces hemodynamic 
alterations within the vasculature, in particular low shear stress which results in a 
direct reduction in NO bioavailability (Thosar et al., 2012) and increased oxidative 
stress (Laufs et al., 2005).  In children aged 9-10 years, Hopkins et al., (2012) found no 
relation between brachial artery FMD and objectively measured total sedentary time 
and between seasonal change in sedentary behaviour and change in FMD (Hopkins et 
al., 2012).  With the majority of studies having examined the relation between 
sedentary time and CVD risk factors solely and limited studies examining the relation 
of sedentary behaviour and vascular health, the proposed study will be unique in that 
it will be the first study to examine sedentary behaviours and both CVD risk factors 
and vascular health in healthy adolescents in addition to PA behaviours.  This study 
will also examine the relation between sedentary behaviour and vascular health 
independent of MVPA, as findings in this area have been equivocal.    
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Study Purpose 
 The purpose of this study was to compare PA levels, sedentary behaviour, 
selected CVD risk factors and vascular health in LF, MF and HF apparently healthy male 
adolescents and to examine the relation between both PA and sedentary behaviours 
and CVD risk factors and vascular health in healthy male adolescents.  
Specific Aims 
1. To compare serum blood lipids, fasting glucose, insulin, HOMA-IR, pro-
inflammatory cytokines, vascular adhesion molecules, BP, body composition, 
EDD, cIMT, time spent sitting/lying, number and time spent in sedentary bouts 
<20 min, >20min, >30 min and >60 min, time standing, LIPA, LIPA including 
standing and MVPA, in LF, MF and HF healthy male adolescents.  
2. To examine the relation between time spent in LIPA and MVPA and EDD and 
time spent in LIPA and MVPA and cIMT in healthy male adolescents.  
3. To examine the relation between sedentary behaviour and EDD and sedentary 
behaviour and cIMT in healthy male adolescents independent of MVPA. 
Hypothesis 
1. Number of sedentary bouts <20 min and time spent in sedentary bouts <20 
min, time spent in LIPA and MVPA, HDL-C and EDD will be significantly lower 
and time spent sitting/lying and in sedentary bouts >20 min, >30 min and >60 
min, TC, LDL-C, TG, fasting glucose, insulin, HOMA-IR, pro-inflammatory 
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cytokines, sICAM-1, sVCAM-1, BP, sum of skinfolds, waist-to-hip ratio, BMI, 
cIMT will be significantly higher in LF than MF and HF healthy male 
adolescents.  
2. There will be a significant positive relation between time spent in LIPA and 
MVPA and EDD and a significant inverse relation between time spent in LIPA 
and MVPA and cIMT in healthy male adolescents.  
3.  Sedentary behavior will be significantly related to EDD and cIMT independent 
of MVPA. 
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Methodology 
Study Overview  
As previously described in methods section of Chapter III  
Participants 
Eighteen LF (n=18), eighteen MF (n=18) and eighteen HF (n=18) healthy male 
adolescents aged 13-17 years participated in the study.  These participants were a 
subset of Study 1. 
Participant recruitment  
As previously described in methods section of Chapter III  
Body Mass Index   
As previously described in methods section of Chapter III  
Waist-to-Hip Ratio  
As previously described in methods section of Chapter III  
Body fat  
As previously described in methods section of Chapter III  
Maturation  
As previously described in methods section of Chapter III  
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Blood Pressure  
As previously described in methods section of Chapter III 
Blood Sampling  
As previously described in methods section of Chapter III  
Biochemical Analysis  
As previously described in methods section of Chapter III  
Insulin Sensitivity  
As previously described in methods section of Chapter III  
Pro-inflammatory cytokines assays 
As previously described in methods section of Chapter III  
Vascular Adhesion molecules assays 
As previously described in methods section of Chapter III  
Endothelial Dependent Dilation and Endothelial Independent Dilation Assessment  
As previously described in methods section of Chapter III  
Carotid Intima Media Thickness  
As previously described in methods section of Chapter III  
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Physical Activity and Sedentary Behaviour Measurement  
The ActivPAL3™ triaxial physical activity logger (PAL Technologies Ltd., Glasgow, 
UK) (figure 5.1) is a single unit triaxial accelerometer measuring (53 x 35 x 7 mm) and 
weighs approximately 15 g.  The device samples at 10 Hz and measures bodily 
accelerations using a triaxial accelerometer.  The ActivPAL3™ provides information on 
steps and activity counts which can be used to determine PA levels and inclinometer 
information used to determine posture. The data was allocated into 15 s epochs of 
sitting/lying, standing, and stepping using the on-board microprocessor.  Proprietary 
algorithms provided outputs including time spent sitting/lying, standing, in LIPA, LIPA 
including standing, MVPA and step counts.  
 
 
 
 
Figure 5.1 : ActivPAL3™ triaxial physical activity logger 
Each participant was provided with an ActivPAL3™ and given a verbal 
description and written demonstration of its use.  Participants were instructed to wear 
the device continuously for 7 d, except during water activity periods.  The ActivPal3™ 
was worn on the midpoint of the anterior aspect of the right thigh and attached using 
a Tegaderm™ film adhesive frame dressing (Figure 5.2) (3M Health Care, Neuss, 
Germany).  If required, an elastic tube bandage was worn over the device for further 
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stability.  After 7 d, the ActivPAL3™ was retrieved and the data was downloaded to a 
PC via a USB interface.  
 
 
 
Figure 5.2: ActivPAL3™ placement 
Data Processing 
For data to be included in the analysis, participants were required to provide 
≥4 valid days, including one weekend day, where a valid day was defined as ≥ 600 min 
of recording during daytime hours, i.e., 7 am to 11 pm (Trost, McIver, & Pate, 2005). 
Non-wear time was defined as ≥60 min of continuous unbroken zero counts from the 
output data file (Harrington et al., 2011).  Recorded data was accessed using the 
ActivPAL™ proprietary software (ActivPAL™ Professional VX) and exported to a 
Microsoft Excel format file (Microsoft Excel 2010, Microsoft Corporation, WA, USA). 
Data was displayed as the number of seconds that the participants engaged in 
sitting/lying, standing, and stepping for each 15 s epoch.  Values were summed over a 
24 h period to provide the total time spent sitting/lying, standing and stepping and the 
average time spent in these behaviour categories during the recording period were 
calculated.   
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Sedentary Behaviour  
Sedentary behaviour characteristics were further examined by processing the 
ActivPAL™ data output files using a customized MATLAB® (version 7.0.1, Mathworks 
Inc, Natick, MA, USA) computer software programme (Harrington et al., 2011).   The 
customized MATLAB® programme examined the ActivPAL™ output file epoch-by-
epoch and binary coded each epoch.  A sedentary epoch was categorized as an epoch 
spent entirely sitting/lying, i.e., a full 15 s, (code = 1) and a non-sedentary epoch was 
categorized as an epoch containing >0 s of standing or stepping or <15 s of sitting/lying 
(code = 0) (Dowd et al., 2012).  A sedentary epoch identified the start of a sedentary 
bout and the last consecutive sedentary epoch marked the end of the sedentary bout.  
Daily sedentary bout duration and the number of sedentary bouts were calculated.  
Sedentary bouts were categorized by specific durations, namely <20 min, >20 min, 
>30min, >60 min to determine shorter and more prolonged sedentary behaviours.  
The number and total duration spent in sedentary bouts in each category were 
calculated.   
Percentage non bed time in sedentary activities of specific duration, were 
identified by calculating bed hours and waking hours.  A start time of 7.00 am was 
used to identify the start time for each 24 h measurement day and the first registered 
non-sedentary epoch of the day identified as rise time (Dowd et al., 2012).  Bed time 
was identified as the last unregistered epoch of the day which was followed by a long, 
uninterrupted sedentary period (> 2 h) (Dowd et al., 2012).  Bed hours were calculated 
as the sum of the time between 7.00 am and the first non-sedentary epoch and the 
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time between the last non-sedentary-epoch and the next 7.00 am time point.  Waking 
hours were then calculated by subtracting bed hours from 24 h (Dowd et al., 2012).   
Statistical Analysis  
Prior to statistical analysis the data was checked for normality using the 
Kolmogorov- Smirnov (K-S) test.  A one-way ANOVA (parametric) and a Kruskal-Wallis 
test (non-parametric) were used to compare selected CMD risk factors, endothelial 
function, cIMT, PA and sedentary behaviours physiological and perceptual responses 
during maximal exercise between LF, MF and HF groups.  Significant main effects were 
probed using a Bonferroni post-hoc test (parametric, equal variances assumed) or 
Games-Howell post-hoc test (parametric, equal variances not assumed) and Mann-
Whitney U test (non-parametric).  Statistical significance was accepted at the p<0.05 
level of confidence.  Univariate analysis was undertaken using the Pearson product-
moment correlation. Partial correlations were undertaken using the Pearson product 
moment correlation. SPSS for Windows statistical software (V21.0, SPSS Inc, IL) was 
used to perform the statistical analysis. 
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RESULTS 
Participant characteristics 
Participant physical characteristics, blood pressure and maximal aerobic 
capacity are summarized in Table 5.1.  Weight, BMI, waist circumference, hip 
circumference, sum of skinfolds, SBP, DBP and V̇O2max (ml.kg
-1.min-1) were 
significantly lower in HF and MF than LF.  Weight, sum of skinfolds, SBP and V̇O2max 
(ml.kg-1.min-1) was significantly lower in HF than MF.  Absolute V̇O2max was 
significantly higher in HF than LF.  Tanner stage was significantly higher in MF than LF.   
Table 5.1  Physical characteristics, blood pressure and maximal aerobic capacity  
 Group 
 HF MF LF 
Age (y) 15.67 ± 0.49 15.67 ± 0.59 15.44 ± 0.78 
Height (cm) 171.57 ± 6.69 175.43 ± 7.16 176.67 ± 4.98 
Weight (kg) 60.34 ± 6.31‡c 68.18 ± 10.50* 81.37 ± 20.29 
BMI (kg.m-2) 20.48 ± 1.76† 22.07 ± 2.55* 26.08 ± 6.43 
Waist circumference (cm)  69.41 ± 2.60* 65.16 ± 16.63* 80.49 ± 19.08 
Hip circumference (cm) 74.12 ± 4.72* 71.65 ± 18.40* 87.96 ± 19.99 
Waist-to-hip ratio 0.94 ± 0.04 0.91 ± 0.04 0.92 ± 0.08 
Sum of skinfolds 28.40 ± 10.25‡c 44.59 ± 19.13* 81.91 ± 39.09 
Tanner Stage 4.08 ± 0.43 4.19 ± 0.55* 3.64 ± 0.74 
SBP (mmHg) 
DBP (mmHg)  
113.00 ± 7.08‡a 
74.06 ± 5.05‡ 
123.61 ± 5.01† 
77.28 ± 5.29† 
131.28 ± 8.54 
81.78 ± 4.37 
V̇O2max (ml.kg
-1.min-1) 63.31 ± 3.89‡
a 52.95 ± 4.07‡ 40.76 ± 4.36 
V̇O2max (L.min
-1) 3.82 ± 0.40† 3.52 ± 0.51 3.26 ± 0.65 
Values are means  SD; ‡p < 0.001 vs. LF, †p< 0.01 vs. LF, *p <0.05 vs. LF; ap< 0.001 vs. 
MF, cp <0.05 vs. MF 
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Blood Lipids  
Fasting serum lipid levels are presented in Table 5.2.  Fasting TG were 
significantly lower in HF and MF than LF.  There were no significant differences in TC, 
HDL-C, LDL-C and non HDL-C between the three groups. 
Table 5.2 Fasting serum levels of circulating blood lipids in participants  
 Group 
 HF MF LF 
Total cholesterol (mg.dL-1) 137.12 ± 24.53 134.38 ± 24.32  143.39 ± 26.97 
HDL-cholesterol (mg.dL-1) 42.36 ± 11.35 42.67 ± 8.52 35.96 ± 10.01 
LDL-cholesterol (mg.dL-1) 76.80 ± 16.54 72.50 ± 20.20 91.63 ± 24.05 
Non HDL-cholesterol (mg.dL-1)  94.76 ± 17.67 91.71 ± 19.93 107.43 ± 22.46 
Triglycerides (mg.dL-1) 56.15± 24.67* 55.95 ± 16.44
c 77.73 ± 25.01 
Values are means  SD; *p <0.05 vs. LF, c p <0.05 vs. MF 
Insulin Sensitivity  
Fasting glucose, insulin and HOMA-IR in participants are presented in Table 5.3.  
Glucose and insulin were significantly lower in HF and MF than LF.  HOMA-IR was 
significantly lower in HF than MF and LF.  
Table 5.3 Fasting serum levels of glucose, insulin and HOMA-IR  
 Group 
 HF MF LF 
Glucose (mg.dL-1) 78.53 ± 7.67* 80.76 ± 5.99* 84.65 ± 7.92 
Insulin (mlU.L-1) 4.17 ± 1.41‡ 6.20 ± 1.88* 10.06 ± 5.17 
HOMA-IR 0.82 ± 0.33‡c 1.24 ± 0.38* 2.12 ± 1.16 
Values are means  SD; ‡p < 0.001 vs. LF, *p< 0.05 vs. LF, cp <0.05 vs. MF 
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Inflammatory Markers and Adhesion Molecules 
Circulating levels of pro-inflammatory cytokines and vascular adhesion 
molecules are summarized in Table 5.4.  There was no significant difference in any of 
the inflammatory cytokines and vascular adhesion molecules between the groups. 
Table 5.4 Pro-inflammatory cytokines and vascular adhesion molecules  
 Group 
 HF MF LF 
IL-1 (ng.mL-1) 0.98 ± 0.14 0.11 ± 0.14 0.11 ± 0.13 
IL-6 (ng.mL-1) 0.39 ± 0.26 0.53 ± 0.59 0.38 ± 0.22  
TNF- α (ng.mL-1) 1.37 ± 0.70 1.54 ± 0.77 1.79 ± 0.52 
INF-  (ng.mL-1) 5.77 ± 4.06 6.70 ± 5.02 5.91 ± 4.31 
SAA (ng.mL-1) 2508.10 ± 786.13 5162.57 ± 5277.41 2592.07 ± 687.38 
hsCRP (mg.L-1) 0.83 ± 0.72 0.91 ± 1.06  1.28 ± 1.43 
sICAM-1 (ng.mL-1) 682.74 ± 81.70 745.75 ± 110.61 781.74 ± 193.29 
sVCAM-1 (ng.mL-1) 834.44 ± 199.59 913.94 ± 227.47 896.58 ± 158.02 
Values are means  SD 
Physical Activity and Sedentary Behaviour  
Total Time in Physical Activity and Sedentary Behaviour  
The mean total daily time over a 24 h period spent in PA behaviours, 
sitting/lying and steps per day are summarized in Table 5.5.  The total time spent 
standing, in LIPA and in LIPA including standing was significantly higher in HF than LF.  
Total time spent in MVPA and steps per day were significantly higher in HF than both 
MF and LF.  Total time spent sitting/lying was significantly lower in HF than MF and LF.  
There were no significant differences in any of the PA behaviours and total 
sitting/lying time between MF and LF.  
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Table 5.5 Total time spent in sitting/lying, standing, LIPA and MVPA and the number 
of steps per day 
 Group 
 HF MF LF 
Steps per day  13871.10 ± 2778.75‡b 10600.70 ± 2563.49 9649.48 ± 3475.34 
Sitting/lying (h) 
Standing (h) 
17.59 ± 1.07‡c 
3.59 ± 0.86* 
18.58 ± 0.94 
3.32 ± 0.72 
19.37 ± 1.34 
2.74 ± 1.00 
LIPA (h) 
LIPA Inc. standing (h)  
0.86 ± 0.25‡ 
4.45 ± 1.02† 
 0.70 ± 0.22 
4.02 ± 0.86 
0.59 ± 0.21 
3.33 ± 1.16 
MVPA (h)  1.94 ± 0.49†c  1.40 ± 0.55  1.30 ± 0.59  
Values are means  SD; ‡p < 0.001 vs. LF, †p< 0.01 vs. LF, *p <0.05 vs.LF; bp < 0.01 vs. 
MF, cp <0.05 vs. MF 
Waking/Sleeping hours  
 The total number of sleeping hours (8.95 ± 0.68), MF (8.87 ± 0.56) and LF (8.87 
± 0.56) and waking hours (15.05 ± 0.68), MF (15.13 ± 0.56) and LF (14.66 ± 0.84) was 
similar in the three groups. 
Percentage of Waking Hours Spent Sitting/Lying and in PA Behaviours 
The percentage of mean daily waking hours spent sitting/lying and in PA 
behaviours are presented in table 5.6.  The percentage of time spent sitting/lying 
during waking hours was significantly lower in HF than both MF and LF.  The 
percentage of waking hours spent standing, in LIPA and in LIPA including standing was 
significantly higher in HF than LF.  The percentage of time spent in MVPA during 
waking hours was significantly higher in HF than both MF and LF.  There were no 
significant differences in the percentage of time spent sitting/lying and percentage of 
time in any of the PA behaviours between MF and LF.  
  
 195 
Table 5.6   Percentage of waking hours spent in sitting/lying, standing, LIPA and MVPA 
per day 
 Group 
 HF MF LF 
Sitting/lying (%) 
Standing (%) 
LIPA (%) 
57.45 ± 7.82‡c 
23.85 ± 5.70 * 
5.71 ± 1.83† 
63.98 ± 6.04 
22.13 ± 4.81 
4.68 ± 1.48 
68.46 ± 9.14 
18.64 ± 6.81 
4.07 ± 1.45 
LIPA inc. standing (%) 
MVPA (%) 
29.56 ± 6.95* 
12.90 ± 3.63†c 
26.80 ± 5.64 
  9.25 ± 3.56 
22.72 ± 7.96 
8.85 ± 3.93 
Values are means  SD; ‡p < 0.001 vs. LF, †p< 0.01 vs. LF, *p <0.05 vs. LF; c p <0.05 vs. 
MF. 
Number of sedentary bouts  
The number of bouts spent in short and longer uninterrupted sedentary 
behaviour categories is presented in table 5.7.  The total number of sedentary bouts 
was significantly higher in HF and MF than LF.  The number of sedentary bouts < 20 
min was significantly higher in HF and MF than LF.  The number of sedentary bouts > 
20 min and > 30 min was significantly lower in HF than MF and LF.  The number of 
sedentary bouts > 60 min was significantly lower in HF than LF.  With the exception of 
total number of sedentary bouts and the number of sedentary bouts < 20 min, there 
was no difference in the number of sedentary bouts between MF and LF.  
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Table 5.7 Number of daily bouts spent in sedentary categories  
 Group 
 HF MF LF 
Total number of sedentary bouts  56.93 ± 8.6† 55.78 ± 9.9* 47.11 ± 9.6 
No. of sedentary bouts <20 min 49.49 ± 9.63† 46.75 ± 11.32* 38.14 ± 9.62 
No. of sedentary bouts >20min  7.43 ± 1.69†c 9.02 ± 1.93 8.98 ± 2.10 
No. of sedentary bouts >30 min  4.16 ± 1.51†c 5.54± 1.74 5.9 ± 1.65 
No. of sedentary bouts >60 min   0.98 ± 0.63‡ 1.40 ± 0.76 1.93 ± 0.85 
Values are means  SD; ‡p < 0.001 vs. LF, †p< 0.01 vs. LF*p <0.05 vs. LF, cp <0.05 vs. MF  
Sedentary bout duration   
The duration of sedentary bouts spent in sedentary categories is summarized 
in table 5.8.  There was no significant difference in time spent in sedentary bouts < 20 
min between the three groups.  The total time spent in sedentary bouts and time 
spent in sedentary bouts >20 min and > 30 min was significantly lower in HF than LF.  
Time spent in sedentary bouts > 60 min was significantly lower in HF and MF than LF.  
With the exception of time spent in sedentary bouts > 60 min, there was no difference 
in time spent in sedentary behaviour between MF and LF.  
Table 5.8 Duration of daily sedentary bouts spent in sedentary categories  
 Group 
 HF MF LF 
Total sedentary time (min) 507.62 ± 95.33‡ 577.41 ± 71.47 621.05 ± 109.39 
Sedentary bouts <20 min  202.98 ± 31.05  208.16 ± 48.52 180.42 ± 39.09 
Sedentary bouts >20 min  304.64 ± 97.16‡ 369.25 ± 105.21 440.63 ± 124.62 
Sedentary bouts >30 min  224.09 ± 97.16† 284.17 ± 100.57 365.43 ± 123.25 
Sedentary bouts >60 min   92.93 ± 63.92†  120.14 ± 68.26† 207.49 ± 121.33 
Values are means  SD; ‡p < 0.001 vs. LF, †p< 0.01 vs. LF, cp <0.05 vs. MF  
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PA behaviours and V̇O2max  
The relation between V̇O2max and selected PA behaviours is presented in table 
5.9.  With the exception of absolute V̇O2max and total time standing, and absolute 
V̇O2max and % of waking day spent in LIPA, there was a significant positive relation 
between either relative V̇O2max or absolute V̇O2max and all measured PA behaviours.  
Table 5.9 Summary of the relation between PA behaviours and V̇O2max  
 V̇O2max (ml
.kg-1.min-1) V̇O2max (L
.min-1) 
Total standing (h)    r=0.45, p=0.000 ns 
Total LIPA (h) 
Total MVPA (h) 
r=0.45 p=0.000 
 r=0.41, p=0.001 
r=0.41, p=0.001 
r=0.37, p=0.003 
Total LIPA inc. standing (h)  r=0.48, p=0.000 r=0.27, p=0.026 
Total steps   r=0.49, p=0.000 r=0.42, p=0.001 
Standing waking hours (%) r=0.42, p=0.001 r=0.43, p=0.000 
LIPA waking hours (%) r=0.41, p=0.001 ns 
LIPA inc. standing waking hours (%) r=0.45, p=0.000 r=0.26, p=0.028 
MVPA waking hours (%)  r=0.39, p=0.002   r=0.36, p=0.004 
P<0.05,  ns= not significant  
Sedentary behaviours and V̇O2max  
 The relation between sedentary behaviours and V̇O2max are presented in table 
5.10.  With the exception of the number of sedentary bouts < 20 min and time spent in 
sedentary bouts < 20 min, there was a significant inverse relation between all 
measured sedentary behaviours and V̇O2max.  There was a significant positive relation 
between both relative V̇O2max and absolute V̇O2max and time spent in sedentary 
bouts and the number of sedentary bouts < 20 min.   
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Table 5.10: Relation between sedentary behaviours and V̇O2max 
 V̇O2max (ml
.kg-1.min-1) V̇O2max (L
.min-1) 
Total sitting/lying (h) 
Sitting/lying waking hours (h)   
r=-0.59, p=0.000 
r=-0.46, p=0.000 
r=-0.39, p=0.002 
r=-0.41, p=0.001 
Sitting/lying waking hours (%) 
No. of sedentary bouts < 20 min 
r=-0.55, p=0.000 
r=0.49, p=0.000 
r=-0.38, p=0.002 
r=0.44, p=0.000 
Time in sedentary bouts < 20 min (min) r=0.29, p=0.017 r=0.40, p=0.001 
No of sedentary bouts > 20 min 
Time in sedentary bouts > 20 min 
No. of sedentary bouts > 30 min 
Time in sedentary bouts > 30 min (min) 
No. of sedentary bouts > 60 min 
r=-0.45, p=0.000 
r=-0.59, p=0.000 
r=-0.54, p=0.000 
r=-0.61, p=0.000 
r=-0.51, p=0.000 
r=-0.36, p=0.004 
r=-0.45, p=0.000 
r=-0.49, p=0.000 
r=-0.48, p=0.000 
r=-0.57, p=0.000 
Time in sedentary bouts > 60 min (min) r=-0.53, p=0.000 r=-0.42, p=0.001 
Total number of sedentary bouts 
Total time in sedentary bouts (min) 
r=-0.45, p=0.000 
r=-0.58, p=0.000 
r=-0.41, p=0.001 
r=-0.37, p=0.003 
Relation between PA behaviours and CVD risk factors  
 Table 5.11 summarizes the relation between PA behaviours and selected CVD 
risk factors.  The percentage of time spent in MVPA during waking hours was 
significantly and inversely related to SBP, DBP, TG and sICAM-1.  The percentage of 
time spent in LIPA during waking hours was significantly related to sum of skinfolds, 
SBP, DBP, glucose, TG and sICAM-1.  The percentage of time spent in LIPA including 
standing during waking hours was inversely related to weight, BMI, WC, hip 
circumference, sum of skinfolds, SBP, DBP, TG, insulin, HOMA-IR, INF-y and sICAM-1. 
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Table 5.11: Correlation coefficients between PA behaviours during waking hours and CVD risk factors  
 Physical Activity Behaviours 
 LIPA LIPA inc. standing MVPA 
Body Composition    
Weight (kg) 
BMI (kg.m-2) 
ns 
ns 
r=-0.25, p=0.032 
r=-0.31, p=0.010 
ns 
ns 
Sum of skinfolds r=-0.23, p=0.051 r=-0.29, p=0.016 ns 
Waist circumference (cm) ns r=-0.36, p=0.004 ns 
Hip circumference (cm) ns r=-0.38, p=0.002 ns 
Blood Pressure    
SBP (mmHg) r=-0.37, p=0.003 r=-0.39, p=0.002 r=-0.33, p=0.007 
DBP (mmHg) r=-0.29, p=0.016 r=-0.27, p=0.023 r=-0.28, p=0.022 
Metabolic Risk Factors    
Triglycerides (mg.dL-1)   r=-0.38, p=0.005 r=-0.34,p=0.010 r=-0.36,p=0.007 
Glucose  r=-0.26, p=0.032              ns ns 
Insulin 
HOMA-IR 
ns 
     ns 
r=-0.28, p=0.043 
r=-0.29, p=0.039 
ns 
ns 
Inflammatory Markers    
INF-y (ng.mL-1) ns r=-0.35, p=0.031 ns 
ICAM-1 (ng.mL-1) r=-0.42, p=0.001 r=-0.40, p=0.002 r=-0.27, p=0.028 
P<0.05, ns= not significant  
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Sedentary time and CVD risk factors   
The percentage of time spent sitting and lying during waking hours was 
positively correlated with weight (r=0.24,p=0.038), SBP (r=0.48,p=0.000), DBP 
(r=0.35, p=0.005), BMI r=0.31,p=0.011, sum of skinfolds (r=0.33,p=0.008), glucose, 
(r=0.25,p=0.037 ), insulin (r=0.27,p=0.050) HOMA-IR (r=0.29,p=0.042) and sICAM-1 
(r=0.46, p=0.001).  
Endothelial Function  
EDD and EID – Group Comparisons 
 Resting brachial artery diameter and the percentage change and absolute 
change in EDD and EID are presented in table 5.5.  Resting brachial artery diameter 
was similar in the three groups.  The percentage change in EDD was significantly 
higher in HF than LF.  There was no significant difference in percent change in EDD 
between MF and LF.  The percentage change in EID was similar in the three groups.  
The absolute change in EDD was significantly higher in HF and MF than LF and in HF 
than MF.  There was no difference in the absolute change in EID between the three 
groups.  There was no significant difference in peak blood flow velocities following 
reactive hyperemia between the three groups. There was also no difference in peak 
shear rate (SRpeak) between the three groups. 
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Table 5.12 Resting brachial artery diameter and absolute and percentage change 
in EDD and EID  
 Group 
 HF MF LF 
Brachial artery diameter (cm) 
EDD (%) 
EDD (cm) 
EID (%) 
EID (cm) 
0.40 ± 0.06 
12.11 ± 2.39‡ 
0.05 ± 0.01‡c 
20.12 ± 5.29 
0.08 ± 0.02 
0.37 ± 0.04 
10.04 ± 2.40 
0.04 ± 0.01* 
21.08 ± 4.79 
0.08 ± 0.02 
0.36 ± 0.04 
7.62 ± 2.04 
0.03 ± 0.01 
19.35 ± 6.12 
0.07 ± 0.02 
Values are means  SD; ‡p < 0.001 vs. LF, *p <0.05 vs. LF. cp <0.05 vs. MF 
Physical Activity and Endothelial Function 
 The relation between PA behaviours and both the percentage and absolute 
change in EDD are presented in table 5.13.  There was a significant moderate positive 
relation between the total time spent over a 24 h period in standing, LIPA, LIPA 
including standing, and MVPA and both the percentage and absolute change in EDD.  
There was a significant moderate positive relation between total daily steps 
accumulated and both the percentage and absolute change in EDD.  There was a 
significant moderate positive relation between the percentage of time spent in LIPA, 
LIPA including standing, and MVPA during waking hours and both the percentage and 
absolute and in EDD. 
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Table 5.13 Correlation coefficients between PA behaviours and EDD 
 Percent change in 
EDD  
Absolute change in 
EDD 
Total (h)   
Standing   r=0.37, p=0.004 r=0.32, p=0.011 
LIPA 
LIPA including standing (h 
MVPA  
r=0.48, p=0.000 
r=0.42, p=0.001 
r=0.37, p=0.004 
r=0.49, p=0.000 
r=0.38, p=0.003 
r=0.50, p=0.000 
Total steps  r=0.46, p=0.000 r=0.56, p=0.000 
Percentage of Waking Hours   
Standing  r=0.34, p=0.008  r=0.31, p=0.015 
LIPA  r=0.44, p=0.001      r=0.46, p=0.000 
LIPA including standing  r=0.39, p=0.003      r=0.36, p=0.000 
MVPA  r=0.33, p=0.010 r=0.47, p=0.000 
LIPA = light intensity physical activity, MVPA = moderate to vigorous intensity physical 
activity, EDD = endothelial dependent dilation  
After adjusting for pubertal stage, SBP, sum of skinfolds and V̇O2max (ml
.kg-
1.min-1), percent of time spent in MVPA and percent of time spent sitting and lying, 
the relation between total time spent in LIPA and both the percentage change 
(r=0.27, p=0.035) and absolute change EDD remained statistically significant, the 
relation between the percentage of time spent in LIPA during waking hours and the 
absolute change EDD (r=0.25, p=0.052) remained significant, whereas the percentage 
change in EDD (r=0.23, r=0.068) was no longer significant.  After adjusting for the 
same potential confounding variables, no significant relation was found between the 
total time spent in LIPA (including standing) and the percentage of time spent in this 
behaviour during waking hours and both the percent change and absolute change in 
EDD 
After adjusting for pubertal stage, SBP, sum of skinfolds, relative V̇O2max and 
percentage of time spent sitting/lying, the relation between both the total MVPA 
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hours and the percentage of time spent in MVPA during waking hours and the 
percent change in EDD were no longer significant.  The relation between the absolute 
change in EDD and total MVPA hours (r=0.31, p=0.022) and the percentage of time 
spent in MVPA during waking hours (r=0.26, p=0.045) remained statistically 
significant.  
V̇O2max and Endothelial Function 
There was a significant positive relation between V̇O2max (ml
.kg-1.min-1) and 
both the percentage change (r=0.68, p<0.001) and absolute change (r=0.74, p<0.001) 
in EDD.  After statistically adjusting for pubertal stage, sum of skinfolds, SBP, percent 
of time spent in MVPA and percent of time sitting/lying during waking hours the 
association between V̇O2max and the percentage change (r=0.28, p=0.032) and 
absolute change (r=0.32, p=0.017) in EDD remained statistically significant. 
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Sedentary Behaviour and Endothelial Function 
The relation between sedentary behaviours and both percentage and 
absolute change in EDD are presented in table 5.14.  There was a significant 
moderate inverse relation between the total time spent sitting/lying in a 24 h period, 
and during waking hours and both the percentage change and absolute change in 
EDD.  There was a significant moderate inverse relation between the percentage of 
time spent sitting/lying during waking hours and the percentage and absolute change 
in EDD.  
There was a significant low to moderate positive relation between the total number 
of sedentary bouts and the number of sedentary bouts < 20 min and both the 
percentage and absolute change in EDD.  There was a significant low to moderate 
inverse relation between the number and duration of sedentary bouts > 20 min, >30 
min and >60 min and both the percentage change and absolute change in EDD.  
There was a significant low to moderate positive relation between both the 
percentage and absolute change in EDD and the total accumulated minutes of 
sedentary bouts and the duration of sedentary bouts < 20 min.   
 After statistically adjusting for the percentage of waking hours spent in MVPA, 
the association between the total sedentary time over a 24 hour period (r=-0.43, 
p<0.05), total sedentary time during waking hours (r=-0.24, p=0.051)  and the 
percentage of time spent sedentary during waking hours (r=-0.36, p<0.05)and 
percentage change in EDD  remained significant.  
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 After statistically adjusting for pubertal stage, sum of skinfolds, SBP, 
percentage of waking hours in MVPA and relative V̇O2max, the association between 
the total time and the percentage of time spent sitting and lying during waking hours, 
and the percentage and absolute change in EDD no longer remained statistically 
significant.    
Table 5.14 Correlation coefficients between sedentary behaviours and EDD 
 Percent change 
in EDD  
Absolute change 
in EDD 
Total sitting/lying in a 24 h period (h)   r=-0.52, p=0.000 r=-0.54, p=0.000 
Total sitting/lying waking hours (h) r=-0.37, p=0.004 r=-0.43, p=0.001 
Sitting/lying waking hours (%) r=-0.47, p=0.000 r=-0.51, p=0.000 
No of sedentary bouts (n)   
< 20 min r=0.33, p=0.010 r=0.34, p=0.008 
> 20 min r=-0.39, p=0.002 r=-0.37, p=0.004 
> 30 min r=-0.47, p=0.000 r=-0.45, p=0.001 
> 60 min r=-0.28, p=0.026 r=-0.34, p=0.007 
Total  r=0.28, p=0.026 r=0.30, p=0.019 
Duration of sedentary bouts (min)   
< 20 min  r=0.25, p=0.039 r=0.25, p=0.038 
> 20 min r=-0.46, p=0.000 r=-0.45, p=0.001 
> 30 min r=-0.47, p=0.000 r=-0.47, p=0.000 
> 60 min r=-0.36, p=0.006 r=-0.38, p=0.003 
Total min r=-0.44, p=0.001 r=-0.42, p=0.001 
P<0.05,  ns= not significant  
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Carotid Intima Media Thickness 
cIMT - Group Comparisons  
Near and far wall cIMT measurements of the right and left CCA are presented 
in table 5.15.  Right and left CCA near and far wall IMT were significantly lower in HF 
and MF than LF and in HF than MF. 
Table 5.15 Near and far wall cIMT measurements of right and left CCA 
 Group 
 HF MF LF 
Right near wall cIMT (mm) 
Left near wall cIMT (mm) 
Right far wall cIMT (mm) 
Left far wall cIMT (mm) 
0.39 ± 0.04‡c 
0.38 ± 0.03‡c 
0.40 ± 0.05‡a 
0.40 ± 0.05‡a 
0.45 ± 0.05* 
0.45 ± 0.08* 
0.51 ± 0.06* 
0.49 ± 0.06* 
0.52 ± 0.07 
0.52 ± 0.08 
0.57 ± 0.06 
0.56 ± 0.08 
Values are means  SD; ‡p < 0.001 vs. LF, *p <0.05 vs. LF; ap< 0.001 vs. MF, cp <0.05 
vs. MF 
Physical Activity and cIMT  
The correlation between PA behaviours and cIMT are summarized in table 
5.16.  There was a significant inverse relation between all measures of cIMT and both 
the total time and the percentage of waking hours for standing, LIPA and LIPA 
including standing.  With the exception of the right far wall cIMT there was no 
significant association between MVPA and cIMT.  There was a significant inverse 
association between total daily steps and right near and fall and left far wall cIMT.  
After statistically adjusting for pubertal stage, sum of skinfolds, V̇O2max 
(ml.kg-1.min-1) SBP and percent of time spent sitting/lying during waking hours, the 
association between the percent of time spent in LIPA during waking hours and 
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right CCA far wall cIMT (r=-0.05, p=0.380) and the percent of time spent in LIPA 
during waking hours and left CCA far wall cIMT (r=-0.25, p=0.043) remained 
statistically significant. 
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Table 5.16 Correlation coefficients between PA behaviours and cIMT 
 Carotid Intima Media Thickness  
 RT near wall LT near wall RT far wall LT far wall 
Total (h)     
Standing  r=-0.48, p=0.001 r=-0.25,p=0.039 r=-0.34, p=0.007 r=-0.37, p=0.003 
LIPA r=-0.44, p=0.001 r=-0.34, p=0.007 r=-0.37, p=0.003 r=-0.44, p=0.001 
LIPA including standing r=-0.51, p=0.000 r=-0.29, p=0.021 r=-0.37, p=0.004 r=-0.41, p=0.001 
MVPA ns ns r=-0.27, p=0.026 ns 
Total steps  r=-0.37, p=0.004 ns r=-0.41, p=0.001 r=-0.38, p=0.003 
Percentage of Waking Hours     
Standing  r=-0.44, p=0.001 r=-0.23, p=0.054 r=-0.32, p=0.011 r=-0.35, p=0.005 
LIPA  
LIPA including standing  
r=-0.40, p=0.002 
r=-0.46, p=0.000 
r=-0.34, p=0.008 
r=-0.27, p=0.029 
r=-0.35, p=0.006 
r=-0.35, p=0.006 
r=-0.41, p=0.001 
r=-0.39, p=0.002 
MVPA  ns ns r=-0.26, p=0.30 ns 
P<0.05,  ns= not significant  
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V̇O2max and cIMT  
There was a significant inverse relation between V̇O2max (ml
.kg1.min1) and 
right near wall (r=-0.73, p< 0.001), right far wall (r=-0.75, p< 0.001) cIMT and left near 
wall (-0.65, p< 0.001) and left far wall cIMT (r=-0.70, p< 0.001).  Following adjustment 
for pubertal stage, sum of skinfolds, SBP, percent of time spent in MVPA during 
waking hours and percent of time spent sitting/lying, the association between 
V̇O2max (ml
.kg-1.min-1) and right CCA far wall cIMT was no longer significant.  In 
contrast, the inverse relation between V̇O2max (ml
.kg-1.min-1) and left CCA far wall 
cIMT weakened but remained significant (r=-0.41, p=0.002). 
Sedentary Behaviour and cIMT  
The relation between sedentary behaviours and cIMT are summarized in 
Table 5.17.  There was a significant relation between the total time spent sitting/lying 
in a 24 h period, and during waking hours and all measures of cIMT.  There was also a 
significant relation between the percentage of time spent sitting/lying during waking 
hours and all measures of cIMT.  With the exception of right far wall cIMT there was a 
significant relation between the number sedentary bouts > 20 min, >30 min and >60 
min and all measures of cIMT.  There was a significant relation between the total 
number of sedentary bouts and the number of sedentary bouts < 20 min and all 
measures of cIMT.   
With the exception of right far wall cIMT there was a significant relation 
between the duration of sedentary bouts > 20 min, >30 min and >60 min and all 
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measures of cIMT.  There was a significant relation between the total time of 
sedentary bouts and all measures of cIMT.  Left near wall was the only IMT 
measurement that was significantly related to sedentary bouts < 20 min (r=-0.32, 
p=0.01). 
 After statistically adjusting for the percentage of waking hours spent in MVPA, 
the association between the total sedentary time over a 24 hour period (r=0.40, 
p<0.05), total sedentary time during waking hours (r=0.30, p<0.05)  and the 
percentage of time spent sedentary during waking hours (r=0.26, p<0.03) and left far 
wall cIMT remained significant. The association between these measures of 
sedentary behaviour and right far wall cIMT were no longer significant after 
adjustment for percentage of time spent in MVPA.  
Following adjustment for pubertal stage, SBP sum of skinfolds and percent 
of time spent in MVPA during waking hours and relative V̇O2max, there was no 
significant association between the percent of time spent sitting/lying during 
waking hours and right and left far wall cIMT and total time spent sitting and lying 
during waking hours and right and left far wall cIMT.   
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Table 5.17 Relation between sedentary behaviours and cIMT 
 Carotid Intima Media Thickness  
 RT near wall LT near wall RT far wall LT far wall 
Total sitting/lying (h) r=0.50, p=0.000 r=0.25, p=0.039 r=0.43, p=0.001 r=0.43, p=0.001 
Sitting/lying waking hours (h) 
Sitting/lying hours (%) 
r=0.37,p=0.004 
r=0.44, p=0.001 
r=0.27, p=0.028 
r=0.24, p=0.046 
r=0.35, p=0.006 
r=0.41, p=0.001 
r=0.39, p=0.002 
p=0.41, p=0.001 
No of sedentary bouts     
< 20 min r=-0.38, p=0.003 r=-0.43, p=0.001 r=-0.31, p=0.013 r=-0.33, p=0.008 
> 20 min r=0.31, p=0.014 r=0.35, p=0.005 r=0.33, p=0.008 r=0.42, p=0.001 
> 30 min r=0.35, p=0.005 r=0.41, p=0.002 r=0.41, p=0.001 r=0.44, p=0.001 
> 60 min r=0.34, p=0.007 r=0.37, p=0.004 ns r=0.25, p=0.037 
Total  
Duration of sedentary bouts (min) 
r=-0.35, p=0.006 
 
r=-0.40, p=0.002 
 
r=-0.27, p=0.026 
 
r=-0.27, p=0.024 
 
< 20 min Ns r=-0.32, p=0.011 ns ns 
> 20 min r=0.42, p=0.001 r=0.42, p=0.001 r=0.33, p=0.008 r=0.38, p=0.003 
> 30 min r=0.42, p=0.001 r=0.42, p=0.001 r=0.35, p=0.006 r=0.37, p=0.004 
> 60 min r=0.40, p=0.002 r=0.37, p=0.004 ns r=0.24, p=0.042 
Total sedentary bouts (min) r=0.42, p=0.001 r=0.37, p=0.004 r=0.33, p=0.008 r=0.37, p=0.004 
P<0.05,  ns= not significant  
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Summary of Results  
Both total time over 24 h and the percentage of waking hours standing, in 
LIPA, and in LIPA including standing was significantly higher in HF than LF.  Total time 
and the percent of time spent in MVPA during waking hours were significantly higher 
in HF than both MF and LF. There were no significant differences in the total time and 
percentage of time spent in the measured PA behaviours between MF and LF.   
There was a significant positive relation between the total time, and the 
percent of time in LIPA and MVPA during waking hours and EDD. Following 
adjustment for potential confounders, these associations were no longer significant. 
There was a significant inverse relation between the percent of time spent in 
sitting/lying during waking hours and EDD.  The association between sedentary time 
and EDD remained significant after adjustment for MVPA.  V̇O2max was also 
independently related to EDD after statistically adjusting for confounders.  There was 
no significant association between all measures cIMT and the percentage of time 
spent in LIPA during waking hours after adjusting for potential confounders. 
Sedentary behaviours were positively associated with left far wall cIMT following 
adjustment for MVPA.  V̇O2max (ml
.kg-1.min-1) was also independently related to left 
far wall cIMT after adjustment for confounders.  
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Chapter VI 
DISCUSSION 
Overview 
Atherosclerosis, a chronic inflammatory disease, primarily of large and 
medium-sized conduit arteries, is the primary underlying cause of CVD (Libby et al., 
2010).  Although the clinical manifestations of CVD occur in middle and late 
adulthood, the atherosclerotic process begins in childhood in response to exposure to 
established and unknown risk factors.   
As clinical CV events are rare in children and adolescents, the ability to 
measure structural and functional markers of sub-clinical atherosclerosis non-
invasively is a critical aspect of early detection and risk classification (Berenson, 
2002).  Increased cIMT and impaired brachial artery FMD has been found in 
adolescents with ACVD risk factors including overweight (Woo et al., 2004), obesity 
(Meyer et al., 2006,  Zhu et al., 2005) and diabetes mellitus (Jarvisalo et al., 2004).  
Low levels of CRF (Blair et al., 1989)(Blair et al., 1996) and PA (Andersen et al., 2006) , 
Paffenbarger et al., 1986) and increased sedentary behaviour (Dunstan et al., 2010) 
are independent risk factors for CVD and all-cause mortality in adults.  Such 
behaviours induce hemodynamic alterations within the vasculature, in particular low 
shear stress that results in a direct reduction in NO bioavailability and increased 
oxidative stress. 
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A series of studies were undertaken to compare indices of CRF, PA and 
sedentary behaviour, CVD risk factors and vascular health in apparently healthy LF, 
MF and HF male adolescents and to examine the association between each of these 
behaviours (CRF, PA and sedentary behaviour) and vascular health. 
Study 1 
 Study 1 compared selected CVD risk factors, cIMT and endothelial function in 
apparently healthy LF, MF and HF male adolescents and examined the relation 
between V̇O2max and vascular health.  Established CVD risk factors cluster in 
adolescents with low levels of CRF with 48% being classified as obese, 75% 
hypertensive (NIH, 2005) and 41% having borderline to high fasting TG (American 
Academy of Pediatrics, 2011).  The important role of CRF in reducing CVD risk in 
children is illustrated by the fact that no participant in HF was classified as obese, 
hypertensive or hypertriglyceridemia, and with the exception of SBP and HOMA-IR 
there was no significant difference in CVD risk factors between HF and MF.  Data 
from NHANES in the US found significantly higher TG and SBP and significantly lower 
HDL-C in adolescent males with a low V̇O2max compared to those with a high V̇O2max 
(Carnethon et al., 2005).   
 The inverse association between CRF and clustered metabolic risk in children 
may be mediated by adiposity (Shaibi et al., 2005, Rizzo et al., 2007).  However, after 
adjusting for SBP, sum of skinfolds, TG, insulin and HOMA-IR, the relation between 
CRF and vascular health remained significant in study 1.  In a large sample of children 
between the age of 9 and 15 years, the odds ratio for the clustering of metabolic risk 
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factors was 15.8 for boys in the lowest CRF quartiles compared to those in the 
highest quartile (Anderssen et al., 2007).  The assessment of CRF is not mandatory in 
Irish post-primary schools.  This is surprising considering that the severity of 
atherosclerosis is associated with the presence and extent of CVD risk factors and 
that among Irish teenagers the greatest clustering of risk factors was found in the LF 
group.  These findings highlight the urgent need to develop of a comprehensive 
national strategy to increase CRF levels among school children. 
 Considerable evidence exists for the adverse effects of obesity on 
cardiovascular disease risk.  Using the statistical technique of principal components 
analysis, Goodman et al., (2005) reduced modifiable CVD risk factors that cluster in 
children and are significantly inter-correlated to a smaller number of summary 
factors that retain as much variance as possible as the original variables.  These 
summary risk factors were identified as adiposity, cholesterol, carbohydrate-
metabolic and blood pressure.  Obesity was identified as the most important 
correlate for being at risk for each the summary factors (Goodman et al., 2005).  
Almost 50% of the LF participants in study 1 were classified as obese.  The high 
prevalence of obesity in this study was perhaps not surprising, considering that global 
levels of overweight and obesity in children and adolescents mirrors trends in adults.  
It has been estimated that the worldwide prevalence of childhood obesity has 
increased by approximately 40% between 1980 and 2013 (Aver et al., 2015). 
 In a meta-analysis that included 49,220 school aged children between the 
age of 5 and 15 years, Friedemann et al., (2012) found that the presence of 
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overweight and obesity significantly worsens risk parameters for CVD.  Compared to 
normal weight children, resting SBP, DBP and TG levels were significantly higher and 
HDL-C significantly lower in overweight and obese than normal weight children.  
Glucose, insulin and insulin resistance were also significantly raised in obese children.  
The gradient effect of an increased BMI on CVD risk parameters was substantial.  For 
example, the mean difference in SBP between normal weight and obese children was 
40% higher than the difference between normal and overweight children.  Circulating 
levels of TC and LDL-C were 7.5 and 9 times higher respectively, in the obese versus 
normal weight comparison than in the overweight versus normal weight comparison.  
If this magnitude of difference persists into adulthood, then obese children may 
already be at a much higher risk than normal weight children for both fatal and non-
fatal cardiovascular events.  
Ultrasonographically determined cIMT is a non-invasive surrogate marker for 
ACVD.  Both near wall and far wall IMT of the right and left CCA was significantly 
higher in LF than MF and HF and in MF than HF.  Increased cIMT has previously been 
found in children and adolescents with ACVD risk factors and with low CRF (Meyer et 
al., 2006, Farpour-Lambert et al., 2009).  Currently, normative cIMT values for 
children and adolescents are limited (Le et al., 2010).  Advanced VA, defined as 
having a mean far wall IMT ≥ 25th percentile for age and race matched healthy 45 
year olds, may serve as a useful adjunct until normative cIMT data for children is 
established (Le et al., 2010).  Advanced VA was found in 54% of the study cohort, with 
the highest proportion in LF.  In addition, 32% of LF had a VA comparable to a healthy 
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normal 55-65 year old male.  In the only published study to examine VA in children 
and adolescents, Le et al., (2010) also found VA in a 12-16 year olds with ACVD risk 
factors that included hypertension, dyslipidemia and insulin resistance.   
 Among the CVD risk factors measured, V̇O2max had the strongest association 
with cIMT in a univariate analysis.  The association between V̇O2max and cIMT 
remained significant after controlling for adiposity, SBP, HOMA-IR, insulin, TG and 
pubertal stage.  The fact that V̇O2max was independently related to cIMT, suggests 
that a low V̇O2max may be considered an important marker for advanced VA and 
should be routinely measured in post-primary school students, particularly those with 
low CRF levels.  Indeed, assessment of CRF may be a cost-effective way to identify 
children with one of more modifiable CVD risk factors and at an increased risk for VA.  
 The vascular endothelium is an active paracrine organ that plays an 
important role in maintaining vascular homeostasis and is intimately involved in the 
initiation and progression of atherosclerosis.  Damage to the vascular endothelium 
represents one of the earliest events in the pathogenesis of atherosclerosis and 
precedes structural changes in the vascular wall (Deanfield et al., 2007).  Impaired 
endothelial function has previously been reported in children and adolescents with 
ACVD risk factors and low V̇O2max (Meyer et al., 2006, Farpour-Lambert 2009, 
Tounian et al., 2001, Aggoun et al., 2008).  In study 1, brachial artery FMD was 
impaired in the majority of LF participants.  EDD was significantly higher in HF and MF 
than LF and in HF compared to MF.  A brachial artery FMD <8% is defined as impaired 
EDD and was present in 54%, 28% and 0% of the LF, MF and HF, respectively.  Severe 
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impairment of EDD, defined as FMD <5.5% was found in 21% of LF.  The deleterious 
effect of CVD risk factors on reduced NO bioavailability and increased production of 
ROS may partly explain the impairment in EDD.    
The prevalence of impaired EDD was also very high among participants who 
were obese (41%) and hypertensive (63%).  Not surprisingly, in univariate analysis, 
obesity, SBP along with sum of skinfolds, insulin and HOMA-IR were independently 
associated with EDD.  After adjusting for each of these risk factors, V̇O2max remained 
strongly associated with EDD.  In the only previous published study to examine 
brachial artery FMD and objectively measured V̇O2peak in youth, Hopkins et al., 
(2009) found a significant relation between %FMD/SRAUC and V̇O2peak in pre-pubertal 
children.  Furthermore, V̇O2peak was significantly lower in children in the lowest 
tertile for FMD than those who were in the upper tertile for FMD (Hopkins et al., 
2009). 
 With the recognition that atherosclerosis is an inflammatory process (Libby et 
al., 2010) a number of blood biomarkers have been identified as putative indicators 
of subclinical CVD in disease in children.  Although TNF-α, hsCRP, sICAM-1and 
sVCAM-1 were higher in LF than MF and HF, the difference did not reach statistical 
significance.  Similarly, Kapiotis et al., (2006) found no difference in sICAM-1 and 
sVCAM-1 between obese children with impaired EDD and increased cIMT, and 
healthy normal weight children (Kapiotis et al., 2006).  In contrast, others have 
reported increased circulating levels of hsCRP, E-selectin, thrombomodulin and 
fibrinogen in obese children and adolescents with impaired EDD, increased cIMT and 
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low CRF (Farpour-Lambert et al., 2009, Meyer et al., 2006).  The variability in body 
weight in LF may help to explain the lack of significance.  Approximately one-third of 
LF were classified as normal weight or underweight.  It may be that excess weight is a 
prerequisite for the stimulation and release of markers such as TNF-, IL-6 and 
hsCRP, since adipocytes partially mediate the inflammatory response.  
High concentrations of pro-inflammatory cytokines are associated with 
impaired endothelial function through their direct effect on NO production or 
indirectly by increasing ROS generation.  Interestingly, in study 1, none of the pro-
inflammatory markers were associated with EDD.  In a previous study, hsCRP was 
found to be a significant and independent predictor for brachial artery FMD and cIMT 
in healthy 11 year old children (Jarvisalo et al., 2002).  Compared to children with 
hsCRP levels under the detection limit, children with higher hsCRP had significantly 
lower brachial artery FMD and significantly higher cIMT (Jarvisalo et al., 2002).  
Similarly, LF participants had significantly lower brachial artery FMD and significantly 
higher cIMT than MF and HF and based on their hsCRP levels were classified as being 
at a moderate risk of CVD compared to both MF and HF.  However, despite significant 
differences in EDD and cIMT, there were no significant differences in inflammatory 
biomarkers between the groups. Collectively, these findings suggest that non-invasive 
measurement of cIMT and brachial artery are more sensitive measures of vascular 
heath in children than inflammatory biomarkers.  
 In summary, i) there was a clustering of CVD risk factors in LF, ii) impaired 
EDD and increased cIMT were more prevalent in LF than HF and MF and iii) V̇O2max 
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was significantly and independently related to EDD and CIMT.  The beneficial effects 
of increased CRF on cardiovascular health are multifactorial but are primarily 
associated with risk factor modification and the positive direct effect of exercise on 
the vascular endothelium (Joyner & Green, 2009).  Increased CRF is associated with 
reductions in body weight and adiposity, TG, BP and improvements in insulin 
sensitivity in skeletal muscle (Ross et al., 2008).  Regular exercise training is 
associated with increases in shear stress that result in an up-regulation of eNOS and 
subsequent bioavailability of NO, which enhances EDD and exerts anti-inflammatory 
effects (Green et al., 2004) .  
Study 2 
Although V̇O2max is considered the gold standard measurement of CRF, it is 
not often attained in overweight/obese adolescents due to its effort dependency 
(Marinov et al., 2003).  The oxygen uptake efficiency slope (OUES) is highly correlated 
with V̇O2max and has been proposed as an alternative effort independent 
submaximal measure of CRF (Baba et al., 1996).  Study 2 examined the relation 
between OUES and vascular health and compared maximal and submaximal OUES in 
LF, MF and HF male adolescents. 
 A primary requisite for a submaximal measure of CRF is that it is independent 
of exercise intensity.  Findings from previous studies that have examined the relation 
between maximal and submaximal OUES have been equivocal with some reporting 
lower (Drinkard et al., 2007) or higher submaximal OUES values than maximal OUES 
(Marinov et al., 2003) while others found no difference between maximal and 
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submaximal OUES (Marinov et al., 2007).  In study 2, submaximal OUES calculated up 
to the VAT was significantly lower (6%) than maximal OUES.  However, similar to the 
findings of Akkerman et al., (2010) there was no significant difference in maximal and 
submaximal OUES values when expressed relative to body mass and BSA.  These 
findings suggest that when OUES is expressed relative to body mass and BSA it is a 
valid, effort independent submaximal measure of CRF.  Similar to the findings of 
previous studies, maximal and submaximal OUES were both significantly correlated 
to  V̇O2max, (Baba et al., 1996,  Marinov et al., 2007, Marinov et al., 2003, Breithaupt 
et al., 2012 Akkerman et al., 2010)  The fact that submaximal OUES is significantly 
correlated with V̇O2max means that this is a suitable surrogate for V̇O2max when 
such testing is not feasible or V̇O2max  cannot be attained.  
To date, no published studies have examined the relation between OUES 
and vascular health in children and adolescents.  In study 2, the relation between 
maximal OUES and submaximal OUES and vascular health was examined.  There was 
a significant inverse association between maximal and submaximal OUES expressed 
relative to body mass and cIMT.  There was a positive between maximal OUES and 
submaximal OUES values expressed relative to body mass and EDD.  Unsurprisingly, 
V̇O2max was also inversely related to cIMT and positively related to EDD.  While a 
significant independent association between both maximal OUES/kg and submaximal 
OUES/kg and EDD, a stronger association was found between V̇O2max (ml
.kg-1.min-1) 
and EDD. Furthermore, only V̇O2max was retained in a multiple regression analysis 
used to predict EDD that included maximal OUES/kg and submaximal OUES/kg.  
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Similarly, in healthy middle-aged adults V̇O2max (ml
.kg-1.min-1) was found to be the 
only significant predictor of large artery stiffness in a linear regression analysis that 
included both maximal and submaximal OUES (Arena et al., 2009).  The more robust 
relation observed between V̇O2max and EDD may be attributed to the fact that 
V̇O2max is considered the gold standard measurement of CRF and measures the 
maximum capacity of the respiratory, cardiovascular and musculoskeletal systems.  
While the OUES purportedly reflects the integrated function of the pulmonary, 
cardiac and skeletal muscle systems, little is known how the health of each of these 
physiologic systems independently contributes to the variation in OUES (Arena et al., 
2009). Furthermore, less variability is associated with V̇O2max compared to the 
measurement of submaximal OUES, which is dependent on VAT determination.  It is 
often not always possible to determine the VAT and in the present study it could not 
be identified in 27% of the participants.  The subjective nature of VAT measurement 
also means that it is subject to greater variability.  The findings of the current study 
suggest that while both submaximal and maximal OUES were significantly related to 
EDD they may not be a viable surrogate for V̇O2max in predicting vascular health in 
both healthy adolescents 
 Attainment of V̇O2max requires a plateau in oxygen uptake, defined as a 
change in V̇O2 < 2.0 ml.kg
-1.min-1 with increasing workload during the final minute of 
exercise (Rowland & Cunningham 1992).  In total, 32% of the cohort did not achieve a 
plateau in oxygen consumption.  Interestingly, a higher percentage of LF achieved a 
plateau in oxygen consumption (73.4%) than MF (68.2%) and HF (54.5).  This finding 
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is in agreement with Norman et al., (2005) who also found that a higher percentage 
of overweight/obese adolescents achieved a plateau in oxygen consumption 
compared to their non-overweight children (Norman et al., 2005).  In addition, to a 
plateau in oxygen consumption, a number of secondary criterion including a 
respiratory exchange ratio (RER) > 1.0, heart rate (HR) >200 bpm and volitional 
fatigue (RPE 18-20) were used to verify attainment of attainment of V̇O2max.  In 
study 2, attainment of at least two of the four criteria was required for the test to be 
considered maximal.  Based on these criteria, a maximal test was achieved by all HF, 
MF and LF participants.  In contrast, previous studies have found that a large 
proportion of both normal and overweight children do not achieve the criteria for 
V̇O2max (Marinov et al., 2003, Norman et al., 2005).  The findings of study 2 indicate 
that LF overweight/obese adolescents are capable of attaining V̇O2max during 
maximal exercise testing and that V̇O2max testing should be encouraged when 
assessing CRF in such populations where feasible.  
It has been recommended that OUES values should be adjusted for 
anthropometric variables such as body mass, BSA and FFM when comparing different 
study samples (Breithaupt et al., 2012).  In study, 64% of LF were overweight or 
obese.  There was no significant difference between the absolute maximal and 
submaximal OUES values between HF and LF.  This is in contrast to previous studies 
that reported higher absolute maximal and submaximal OUES values in obese 
compared to normal weight children (Marniov et al., 2003).  Maximal and 
submaximal OUES values expressed relative to body mass and BSA were significantly 
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higher in HF than MF and LF.  Previous studies have also reported significantly lower 
maximal and submaximal OUES expressed relative to body mass or BSA in overweight 
and obese children compared to healthy normal weight controls (Marinov et al., 
2003) (Breithaupt et al., 2012). 
The mean absolute maximal OUES and submaximal OUES values calculated in 
the present study were higher compared to other studies that examined the OUES in 
healthy normal weight 15 year old male adolescents (Akkerman et al., 2010, Marinov 
et al., 2007).  In obese adolescents with a mean age of 14.25 years, Breithaupt et al. 
(2012) found similar but slightly lower absolute maximal and submaximal OUES 
values than those found in study 2.  The higher values reported by Breithaupt et al.,  
(2012) and in the present study may be partially attributed to differences in body 
size.  In total, 26% of participants in the present study were classified as overweight. 
In addition, the mode of exercise testing may also help to explain the higher OUES 
values in study 2.  Other studies (Akkerman et al., 2010,  Marinov et al., 2007) used 
cycle ergometry to assess V̇O2max.  In contrast, Breithaupt et al., (2012) and the 
present study used treadmill exercise testing which is associated with a significantly 
higher V̇O2max value than cycle ergometry (Carter et al., 2000).  As OUES is highly 
correlated with V̇O2max, this may help explain the difference in OUES values reported 
between studies.  
In summary, maximal OUES and submaximal OUES were i) highly correlated 
with V̇O2max ii) significantly higher in HF than MF and LF, iii) positively related to EDD 
and iv) inversely related to cIMT. Performance of V̇O2max is not often feasible in 
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children and adolescents where maximal exercise testing is contraindicated or when 
performance may be impaired by pain shortness of breath or fatigue rather than 
exertion.  In such cases, the OUES should be used, as it is a valid submaximal 
independent effort measure of CRF when expressed relative to body weight and is 
significantly related to V̇O2max.  While OUES was significantly related to EDD, a more 
robust relation was observed between V̇O2max and EDD suggesting that V̇O2max 
should be the preferred method of CRF assessment in adolescents and that this 
testing should be encouraged, particularly with LF overweight/obese adolescents 
who are capable of attaining V̇O2max. However, the strong correlation observed 
between submaximal OUES means that this can serve as an alternative to V̇O2max 
when maximal exercise testing is not feasible. 
Study 3  
Currently, 81% of Irish children and 88% of Irish adolescents do not meet the 
current PA recommendations of 60 min of daily MVPA (Woods et al., 2010).  In 
addition, it is estimated that European children aged 12-18 years spend on average 9 
hours per day or 71% of their waking hours in sedentary behaviours (Ruiz et al., 
2011).  To date no published studies have simultaneously examined the effect of 
objectively measured PA and sedentary behaviour on both vascular structure and 
function in apparently healthy adolescents.  In study 3, PA and sedentary behaviours, 
selected CVD risk factors, cIMT and endothelial function were compared between LF, 
MF and HF healthy male adolescents.  In addition, the relation between PA 
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behaviours and vascular health and sedentary behaviours and vascular health was 
examined.  
Carotid IMT was significantly lower and EDD was significantly higher in HF 
than MF and in MF than LF.  In addition, similar differences in CVD risk factors were 
found between the 3 experimental groups with a large proportion of LF being 
overweight/obese, hypertensive, insulin resistant and having elevated TG.  PA 
behaviours were similar between MF and LF despite the significant differences in 
both vascular health measures and V̇O2max.  Similarly, with the exception of both 
total time and percentage of time spent in MVPA during waking hours, there was no 
significant difference in PA behaviours between HF and MF.  In contrast, all measured 
PA behaviours (standing, LIPA, LIPA including standing and MVPA) were significantly 
higher in HF than LF.  
The majority of evidence that has informed current PA guidelines has been based 
on the health-associated benefits of PA performed at a moderate intensity.  While 
low to moderate correlations were found between all PA behaviours including MVPA 
and selected CVD risk factors in study 3, the strongest associations were found 
between LIPA (including standing) and CVD risk factors.  A recent study involving 
1,731 adolescents aged 12-19 years found that after adjusting for confounders, each 
additional hour per day of low LIPA was associated with a 0.59 mmHg decrease in 
DBP and each additional hour per day of high LIPA was associated with a 1.67 mmHg 
lower DBP and 0.04 high HDL-C (Carson et al., 2013). The findings of Carson et al., 
(2013) and the present study are of considerable public health importance.  They 
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both indicate that increasing LIPA may be a more feasible strategy rather than 
increasing MVPA in the large proportion of adolescents who do not meet the current 
guidelines, and particularly in those who engage in minimal PA.  Furthermore, MVPA 
only accounts for a small proportion of waking hours among adolescents even if they 
are accumulating the recommended 60 min throughout the day (Tremblay et al., 
2007).  Conversely, LIPA accounts for the majority of a daily energy expenditure 
(Levine et al., 2006) and as a result there may be a greater opportunity to increase 
daily LIPA through activities involving light ambulatory movement.  
Relatively few studies have examined the relation between objectively 
measured PA and vascular health in children.  In the present study, there was a 
significant positive association between EDD and the total time spent in LIPA and 
MVPA during waking hours and also the percentage of time in LIPA and MVPA during 
waking hours.  Similarly, others have found an association between time spent in 
both MVPA (Hopkins et al., 2009) and habitual PA (Abbott et al., 2002) and the 
percent change in FMD in prepubertal children, .  The strongest association has been 
found between time spent in PA and brachial artery FMD in individuals in the lowest 
tertile for percent change in FMD, suggesting that children with the lowest FMD 
could benefit the most from increasing their PA.  
To examine the independent relation between PA and endothelial function, 
Pahkala et al., (2008) found that after adjusting for baseline brachial diameter, BMI, 
HDL-C, LDL-C, TG, hsCRP and SBP, maximum FMD/SRAUC was positively associated 
with leisure time PA in 13 year old boys (Pahkala et al., 2008).  In contrast, the 
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present study found that after adjusting for confounders, there was no significant 
relation between LIPA and MVPA and the percent change in EDD.  A weak but 
significant relation however, remained between both total time and percentage of 
waking hours spent in LIPA and MVPA and absolute change in EDD. 
With the exception of right far wall cIMT, no significant relation was found 
between cIMT and total time spent in MVPA and percentage of time spent in MVPA 
during waking hours.  Similarly others have reported no association between 
objectively measured MVPA and cIMT in children aged between 11-15 years (Melo et 
al., 2014, Ried-Larsen et al., 2013).  In contrast, both the total time and the 
percentage of time spent in LIPA during waking hours were significantly related to all 
measures of cIMT in study 3.  A weak but significant relation remained between the 
percentage of time spent in LIPA and right far wall cIMT after adjusting for potential 
confounders.  A greater emphasis should be placed within the current PA guidelines 
on LIPA rather than sole emphasis on MVPA, due to its independent and inverse 
association with vascular health.  
Current national guidelines place great attention on the importance of PA for 
optimizing health in children and adolescents with little or no emphasis on the 
importance of CRF.  This is surprising considering that CRF is one of the most 
important correlates of overall health status and is an considered one of the 
strongest predictors for CVD, and all-cause mortality (Lavie et al., 2012).  PA is a 
behaviour that when performed regularly at an appropriate intensity may result in 
improvements in CRF (Kaminsky et al., 2013).  In the present study, V̇O2max was 
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positively related to all measured PA behaviours.  However, CRF has a stronger 
physiological basis than PA (Kaminsky et al., 2013).  In study 3, V̇O2max (ml
.kg-1.min-1) 
was independently related to both the percentage change and the absolute change in 
EDD and left far wall cIMT.  These associations were more robust than the 
independent associations observed for PA and vascular health.  Stronger associations 
were also observed between V̇O2max and CVD risk factors in study 1 than those 
reported between PA behaviours and CVD risk factors in study 3.  This is in agreement 
with the findings of Rizzo et al., (2007) who also found a stronger association 
between V̇O2max and clustered CMD risk objectively than between objectively 
measured PA and clustered CMD in children and adolescents (Rizzo et al., 2007). 
In terms of measurement, V̇O2max is a more objective and reliable method of 
assessing CRF and has a lower measurement error than PA (Kaminsky et al., 2013).  In 
study 3, PA measurement compliance issues including non-wear time and incorrect 
positioning of the accelerometer meant that 34% of the study sample was excluded 
from the analysis.  Collectively these findings suggest that V̇O2max, in addition to 
being a direct measure of physiological health, is a more reliable measure of vascular 
health, particularly in adolescent populations.  
In study 3, a number of measures of sedentary behaviour were assessed. These 
included total time and percentage of time spent in sitting/lying during waking hours 
and both the number and duration of bouts spent in bouts < 20min, > 20min, > 30 
min and > 60 min. The majority of studies to date have only measured sedentary 
time. Therefore, the present study provides a more detailed insight into the 
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characteristics of sedentary behaviours undertake by male adolescents.  
Furthermore, previous studies examining the relation between sedentary behaviour 
and cardiovascular health have only measured risk factors to assess CV health profile 
in children and adolescents. While CVD risk factor profiles are useful to identify 
adolescents at CVD risk, the ability to measure the disease itself using non-invasive 
ultrasound provides more diagnostic information in terms of vascular health and 
disease progression.  In addition to CVD risk factors, the present study also examined 
measures of vascular health, enabling a more comprehensive examination of the 
relation between sedentary behaviour and cardiovascular health to be undertaken.  
Excessive sedentary behaviour has been found to reduce insulin sensitivity, impair 
metabolic function and attenuate endothelial function, all markers of ACVD  
(Tremblay et al., 2010).  Male adolescents spent on average 63% of their waking day 
sitting/lying.  This figure is slightly lower than those reported by Ruiz et al., (2011) 
who found that European children between the ages of 12-18 years spend on average 
9 h per day or 71% of their waking hours involved in sedentary behaviours (Ruiz et al., 
2011).  The different findings between studies may be due in part to the use of 
different accelerometers.  The ActivPAL activity inclinometer that was used in study 3 
can differentiate between sitting and standing.  In contrast, the Actigraph 
accelerometer used in the study by Ruiz et al., (2011) is unable to discriminate 
between sitting and standing which may help to explain the higher sedentary time 
values.  LF spent on average 68% of their waking day sitting/lying.  The percentage of 
time spent sitting/lying and the total sedentary hours during the waking day was 
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significantly lower in HF than MF and LF.  There was no significant difference in time 
spent sedentary between MF and LF.  
There is some evidence that excessive sedentary behaviour is associated with 
deleterious effects on vascular health in adults (Hamburg et al., 2008,  Demiot et al., 
2007).  Sedentary behavior induces hemodynamic alterations within the vasculature.  
Low shear stress reduces NO bioavailability (Thosar et al., 2012) and increases 
oxidative stress (Laufs et al., 2005).  In the present study, the percentage of waking 
day spent sitting/lying was inversely related with both the percent change and 
absolute change in EDD.  In contrast, in the only published study to examine 
sedentary behaviour and endothelial function in healthy prepubertal children 
Hopkins et al., (2012) found no association between brachial artery FMD and 
objectively measured total sedentary time with or without adjustment for potential 
confounders (Hopkins et al., 2012).  Similarly, the relation between sedentary time 
and EDD was no longer significant in study 3 after adjusting for SBP, sum of skinfolds, 
V̇O2max and pubertal stage.  
Findings from previous studies examining the independent relation between 
sedentary behaviour and cardiometabolic disease risk factors in children and 
adolescents have been equivocal with some studies reporting no association 
independent of PA while others reported an association between sedentary time and 
cardiometabolic disease risk factors in children independent of PA. (Tremblay 2014). 
The relation between sedentary time independent of MVPA and vascular health was 
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addressed in Study 3. Sedentary time was inversely related to percent change in EDD 
and positively related to cIMT after adjustment for MVPA.  
Exercise induced increases in shear stress and subsequent increase in NO 
bioavailability appear to be ephemeral (Thosar et al., 2012).  Long uninterrupted 
bouts of sedentary behaviour maintain a state of low shear stress, which prohibits an 
increase in NO bioavailability.  A recent study examining the effect of prolonged 
sitting and breaks in sitting time on endothelial function in 12 non-obese men found 
that 3 h of sitting resulted in a significant impairment in shear rate and FMD in the 
femoral artery (Thosar et al., 2015).  Similarly, both the number of sedentary bouts 
and time spent in sedentary bouts >20 min, >30 min and >60 min were inversely 
related to both the percentage change and absolute change in EDD in study 3.  Of 
these measures, the strongest association was found between both the number and 
duration of sedentary bouts > 30 min and measures of vascular health.  These 
findings suggest that uninterrupted sedentary behaviour of > 30 min can negatively 
impact vascular health in youth.  There was also a significant positive relation 
between both the percent change and absolute change in EDD and the number of 
sedentary bout < 20 min and the time spent in sedentary bouts < 20 min. Although no 
studies have examined the effect of breaking-up sedentary time on vascular health in 
children, the findings from study 3 suggest that interrupting sedentary time may have 
a beneficial effect on endothelial function in adolescents. 
In addition to its relation with EDD, total time sitting and lying and the 
percentage of the waking day spent sitting/lying was positively associated with cIMT 
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of the near and far wall of the left and right CCA.  These associations were no longer 
significant for right far wall cIMT but remained significant for left far wall cIMT 
independent of percent time in MVPA. When adjusted for other potential 
confounders including sum of skinfolds, pubertal stage and CRF, these associations 
were no longer significant.   Similarly, in the only previous published study to examine 
the relation between objectively measured sedentary time and cIMT, total sedentary 
time measured was not associated with far wall IMT of the CCA with or without 
adjusting for MVPA, CRF, BMI and waist circumference in children between the age of 
11 and 13 years (Melo et al., 2014). 
With the exception of the number of sedentary bouts <20 min and the duration 
of time spent in this sedentary category, all sedentary behaviours were inversely 
related to V̇O2max and all PA behaviours were positively related to V̇O2max.  In 
contrast to V̇O2max, after adjusting for all potential confounders, there was no 
significant relation between sedentary time and both EDD and cIMT, suggesting that 
V̇O2max is a better measure of vascular health than sedentary behaviour in 
adolescent males. 
 In summary, total time spent in PA behaviours was significantly higher and 
total sedentary time was significantly lower in HF than MF and LF.  A weak but 
independent association was found between the absolute change in EDD and both 
LIPA and MVPA.  Of all the sedentary number and bout duration indices measured in 
Study 3, those of  > 30 min showed the strongest relation between measures of 
vascular health.  The relation between sedentary behaviour and EDD remained 
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significant after adjustment for MVPA. However, it was no longer significant after 
adjusting for potential confounders that included pubertal stage, V̇O2max and 
adiposity in addition to MVPA.  While much of the recent focus has been on 
increasing MVPA, the results of the present study suggest that increasing LIPA should 
be promoted among adolescents, as it is positively associated with EDD, inversely 
associated with cIMT and significantly associated with a number of CVD risk factors.  
While significant and independent associations were found between PA and vascular 
health, the relation between V̇O2max and vascular health was more robust indicating 
that V̇O2max is a better measure of vascular health in male adolescents. 
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Study Limitations  
 There are a number of limitations associated with this research. Firstly, 
percentage body fat could not be determined in the study participants. In children 
and adolescents, the Slaughter equation (Slaughter et al., 1988) is commonly used to 
estimate percentage body fat. This equation requires skinfold measurement from the 
subscapular and triceps.  In the present study, the skinfold measurements were taken 
at the chest, abdomen and thigh which precluded the use of the Slaughter et al., 
(1988) equation.  Body composition was instead reported in terms of sum of 
skinfolds. Consequently, FFM could not be determined in the series of studies.  The 
expression of V̇O2max relative to FFM would have assisted in understanding the 
influence of adiposity and lean muscle mass in determining V̇O2max and its relation 
with vascular health.  
 Secondly, the cross sectional design of the series of studies did not allow cause 
and effect relationships to be determined. In addition, the lowest detection limit for 
hsCRP was 0.48 mg.L-1.  As hsCRP values are generally low in healthy children, exact 
hsCRP values could not be determined for those with a value below the limit of 
detection, and where therefore recorded as 0.48 mg/dL. Finally, a number of 
methodological and interpretive limitations are associated with brachial artery FMD 
technique.  These include the variability of FMD, the lack of a consensus on what 
defines normal FMD in adolescents, variability relating to protocol employed 
between studies and normalization for shear stress. 
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Future Directions 
This series of studies examined the relation between CRF, PA and sedentary 
behaviours and vascular health in apparently healthy male adolescents. Future 
research should determine the appropriate volume, intensity and type of exercise/PA 
needed to maintain optimal vascular health in children and adolescents.  
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 Chapter VII 
CONCLUSION 
This series of studies is the first to compare objectively measured indices of 
CRF, PA, and sedentary behaviour and vascular health in Irish adolescents.  ACVD risk 
factors including obese, overweight, hypertension, insulin resistance and elevated TG 
clustered in adolescent males with low CRF.  cIMT was significantly higher and EDD 
was significantly lower in LF than both MF and HF male adolescents.  Alarmingly, the 
majority of LF participants had advanced vascular aging of the carotid arteries and 
impaired endothelial function.   V̇O2max, OUES, PA and sedentary time were each 
significantly related to EDD and cIMT.  The adverse effect of low levels of CRF and PA 
behaviours and high levels of sedentary behaviour on vascular health may at least in 
part be due to the detrimental effect of the low levels of shear stress associated with 
each of these behaviours on the human vasculature. 
While OUES, PA and sedentary behaviours were all significantly related to 
vascular health, a stronger relation was observed between V̇O2max and markers of 
vascular health. Furthermore, V̇O2max but not all PA measured variables remained 
independently related to EDD and cIMT after adjusting for potential confounders. 
Collectively, these findings highlight the urgent need to develop of a unified strategy 
to increase CRF levels among post-primary children to combat the early development 
of subclinical ACVD.  The fact that EDD was normal in MF participants would indicate 
that this level of CRF is cardioprotective and the attainment of a moderate level of 
CRF among Irish post-primary school students, should be national priority.  
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APPLICATION FOR APPROVAL OF A PROJECT INVOLVING HUMAN 
PARTICIPANTS 
 
Application No. (office use only)  DCUREC/2011/   
 
Period of Approval (office use only) ....../....../...... to
 ....../....../.... 
 
This application form is to be used by researchers seeking ethics approval for individual 
projects and 120studies. The signed original and an electronic copy of your completed 
application must be submitted to the DCU Research Ethics Committee.   
Note: If your research requires approval from the Biosafety Committee, this approval 
should be in place prior to REC submission. Please attach the approval from the BSC to this 
submission. 
 
NB - The hard copy must be signed by the PI.  The electronic copy should consist of one file 
only, which incorporates all supplementary documentation.  The completed application 
must be proofread and spellchecked before submission to the REC.  All sections of the 
application form should be completed.  Applications which do not adhere to these 
requirements will not be accepted for review and will be returned directly to the applicant. 
 
Applications must be completed on the form; answers in the form of attachments will not be 
accepted, except where indicated.  No handwritten applications will be accepted.  Research 
must not commence until written approval has been received from the Research Ethics 
Committee. 
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PROJECT TITLE 
 
Comparison of cardiovascular disease risk factors and vascular health in low 
fit moderately fit and high fit Irish teenagers. 
 
PRINCIPAL INVESTIGATOR(S) Prof. Niall M. Moyna 
 
Please confirm that all supplementary information is included in your application (in both 
signed original and electronic copy). If questionnaire or interview questions are submitted in 
draft form, a copy of the final documentation must be submitted for final approval when 
available. 
 
 INCLUDED NOT APPLICABLE 
Bibliography    
Recruitment advertisement    
Plain language statement/Information Statement    
Informed Consent form    
Evidence of external approvals related to the research    
Questionnaire     
Interview Schedule    
Debriefing material    
Other    
Please note: 
1. Any amendments to the original approved proposal must receive prior REC approval. 
2. As a condition of approval investigators are required to document and report 
immediately to the Secretary of the Research Ethics Committee any adverse events, 
any issues which might negatively impact on the conduct of the research and/or any 
complaint from a participant relating to their participation in the study 
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1. ADMINISTRATIVE DETAILS 
 
THIS PROJECT IS:  Research Project  Funded Consultancy 
(tick as many as apply)  Practical Class  Clinical Trial 
  Student Research Project  
(please give details) 
 Other  - Please Describe:       
  ResearchMasters  Taught Masters 
  PhD  Undergraduate 
 
Project Start Date: Oct 1, 2011 Project End date:     May 31, 2014 
1.1 INVESTIGATOR CONTACT DETAILS  
PRINCIPAL INVESTIGATOR(S):  
TITLE SURNAME FIRST NAME PHONE FAX EMAIL 
Prof Moyna Niall 01 7008802 01 7008888 niall.moyna@dcu.ie 
 
OTHER INVESTIGATORS: 
TITLE SURNAME FIRST NAME PHONE FAX EMAIL 
Dr. Mc Caffrey (MD) Noel 087 2797597 01 7008888 noel.mccaffrey@dcu.ie 
Ms. Sheridan Sinead 086 3584725 01 7008888 sinead.sheridan9@mail.dcu.ie 
FACULTY/DEPARTMENT/SCHOOL/CENTRE: School of Health and Human Performance  
1.2 WILL THE RESEARCH BE UNDERTAKEN ON-SITE AT DUBLIN CITY UNIVERSITY 
 YES  NO The laboratory research will be undertaken in the Vascular Health Research 
Unit in Dublin City University.  Cardiovascular fitness will be estimated by 
having transition year students (15-17 years) undertake a multi-stage shuttle 
test in their own school. 
1.3 IS THIS PROTOCOL BEING SUBMITTED TO ANOTHER ETHICS COMMITTEE, OR HAS IT 
BEEN PREVIOUSLY SUBMITTED TO AN ETHICS COMMITTEE?) 
 YES  NO  
DECLARATION BY INVESTIGATORS 
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The information contained herein is, to the best of my knowledge and belief, accurate.  I have 
read the University’s current research ethics guidelines, and accept responsibility for the 
conduct of the procedures set out in the attached application in accordance with the 
guidelines, the University’s policy on Conflict of Interest and any other condition laid down by 
the Dublin City University Research Ethics Committee or its Sub-Committees.  I have 
attempted to identify all risks related to the research that may arise in conducting this 
research and acknowledge my obligations and the rights of the participants. 
If there any affiliation or financial interest for researcher(s) in this research or its outcomes or 
any other circumstances which might represent a perceived, potential or actual conflict of 
interest this should be declared in accordance with Dublin City University policy on Conflicts of 
Interest.  
I and my co-investigators or supporting staff have the appropriate qualifications, experience 
and facilities to conduct the research set out in the attached application and to deal with any 
emergencies and contingencies related to the research that may arise. 
Signature(s): 
Principal investigator(s):     8  July 2011 
 
Print name(s) in block letters:   Niall Moyna 8 July 2011 
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2. PROJECT OUTLINE  
2.2 LAY DESCRIPTION  
Despite a substantial decline in cardiovascular disease (CVD) death rates over the 
past two decades, CVD remains the leading cause of mortality in Ireland.  Moreover, 
recent data suggests that an increase in sedentary behaviours and concomitant 
decrease in physical activity and cardiorespiratory fitness are leading to an increase 
in some CVD risk factors such as diabetes mellitus, obesity, and metabolic syndrome 
in children.  The purpose of this study is to compare cardiovascular disease risk 
factors and sub-clinical atherosclerosis in low fit, moderately fit and high fit transition 
year students.  Students will undertake a multi-stage shuttle run (MSST) test to 
estimate their cardiorespiratory fitness level.  Based on the results of the MSST the 
students will be classified as low fit, moderately fit or high fit.  A random sample of 
low fit, moderately fit and high fit boys (n=90) and girls (n=90) will be selected to 
wear an accelerometer for 7 days to record their physical activity levels, and will 
make a single visit to the Vascular Health Research Unit in DCU.  During this visit, 
participants will undertake a treadmill exercise test to determine their aerobic fitness 
level (VO2max) and have their body composition assessed.  A small volume of blood 
will be taken to measure a variety of biomarkers in the blood (glucose, total 
cholesterol, HDL-C, LDL-C, insulin and hs-CRP) that are used to predict CVD risk.  
Evidence of CVD will be determined by using ultrasound to measure the thickness of 
the wall of the carotid artery in the neck, and the ability of the ability of the brachial 
artery in the arm to dilate (widen) after the blood flow in blocked for 5 minutes.  The 
study will provide health care professionals with information on the importance of 
physical activity in the primary prevention of CVD and other lifestyle mediated 
chronic disease in children. 
2.2 AIMS OF AND JUSTIFICATION FOR THE RESEARCH 
Cardiovascular disease refers to coronary heart disease, stroke and blood vessel 
disease, and is the leading cause of death in Ireland.  Atherosclerosis is the primary 
underlying cause of most CVD.  Although clinical heart disease occurs in middle-age 
and in older individuals, evidence of atherosclerotic disease and organ changes 
related to high blood pressure, and adult type II diabetes are now evident in 
childhood.  Results from autopsy studies of young individuals, indicate that the 
duration of risk factor burden is a major factor governing the development of 
atherosclerosis (2, 3, 4).  Cardiovascular disease risk factor levels for an individual 
tend to persist or track over time in a given rank within the distribution of the 
population.  Long term exposure to multiple CVD risk factors and lifestyle behaviours 
such as a high fat-high calorie diet, tobacco use and physical inactivity confers a 
lifelong burden of CVD risk resulting in the development of early systemic 
atherosclerosis.   
Although a profile of CVD risk factors is useful in predicting cardiovascular events, 
measurement of sub-clinical atherosclerosis by non-invasive imaging techniques such 
as echo-doppler studies of the carotid arteries or brachial artery reactivity provides a 
powerful approach to determine the extensiveness and severity of asymptomatic 
disease and potential future risk.  A recent analysis of 4380 members of 4 
longitudinal cohort studies, found that risk factor measurements (high [highest 
quintile] total cholesterol, triglycerides, blood pressure, and body mass index) 
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obtained at or after 9 years of age are predictive of sub-clinical atherosclerosis in 
adulthood.   
Recent evidence indicates that an alarming 81% of boys and girls attending Irish 
primary school and 88% of post primary pupils do not meet the current Department 
of Health and Children’s physical recommendations.  Furthermore, the study found 
that physically active children have a better health profile (based on 
cardiorespiratory fitness, BMI, blood pressure and waist/hip ratio) than those who 
are inactive.  The effect of low levels of physical activity on cardiorespiratory fitness, 
CVD risk factors and sub-clinical atherosclerosis in Irish children is unknown.  The aim 
of this study is to compare CVD risk factors and sub-clinical atherosclerosis in low fit, 
moderately fit and high fit adolescents.  It is hypothesized that there will be an 
inverse relation between physical activity levels, cardiorespiratory fitness levels and 
serum levels of glucose, total cholesterol, LDL-C, insulin, hs-CRP and subclinical 
cardiovascular disease.  
2.3  PROPOSED METHOD  
Study Overview 
The study will use a cross-sectional research design.  Transition year students who 
agree to participate will undertake a multi-stage shuttle test (MSST) during school 
hours.  Based on the results of the MSST the students will be classified as low fit, 
moderately fit or high fit.  A random sample of low fit, moderately fit and high fit 
boys and girls will be selected to wear an accelerometer for 7 days to record their 
physical activity levels, and will make a single visit to the Vascular Health Research 
Unit in DCU.  During this visit, a blood sample will be drawn, body composition will be 
assessed, and carotid intima media thickness (CIMT), endothelial function and 
aerobic fitness (VO2max) will be measured. 
Initial Contact with Schools 
A letter (Appendix 1) providing a brief summary of the research project will be sent 
to secondary school principles in the greater Dublin region.  Participants recruited for 
the study will be required to wear an accelerometer for 7 days prior to their visit to 
the Vascular Health Unit in DCU. 
SCHOOL VISIT 1:  Approximately 30 minutes in duration.  Sinead Sheridan (PhD 
student) will visit the schools that agree to participate to outline the purpose of the 
study and provide a brief summary of what is involved to all transition year students.  
Students will be provided with an informed consent to be signed by a 
parent/guardian, an assent form to be signed by themselves, and a Physical Activity 
Readiness Questionnaire (Appendix 3).   
SCHOOL VISIT 2: Approximately 60 minutes in duration.  Subjects will undertake a 
multi-stage shuttle test (MSST) during school hours.   
Multistage Shuttle Run Test: Subjects will run back and forth between two lines 
exactly 20 m apart, keeping in time with a series of audio signals (bleeps).  The initial 
speed will be 8.0 km/hr and will increase by 0.14 m.s-1 every minute.  The test will be 
terminated if a subject stops voluntarily, or is unable to maintain the set pace.  The 
total number of shuttle runs completed will be used to classify participants into the 
low, moderate and high fitness categories.  Fitness classification will be based on 
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data collected during a multistage fitness test on 2120 boys and 1964 girls as part of 
the Take Part Study.  A total of 90 boys (30 low fit, 30 moderately fit, and 30 high fit) 
and 90 girls (30 low fit, 30 moderately fit, and 30 high fit) aged 15-17 years will be 
randomly selected to wear an accelerometer and visit DCU. 
Measurement of Physical Activity: Subjects will wear a uni-axial activPAL 
accelerometer for 7 days prior to their visit to the Vascular Health Unit in Dublin City 
University.  Accelerometry count thresholding will be employed to quantify the 
amount of time spent in daily physical activity.  
VISIT TO THE VASCULAR HEALTH UNIT DCU:  Approximately 3 hours in duration.  
Subjects will arrive at the Vascular Health Unit following an overnight fast.  A blood 
sample (9 ml) will be drawn and body composition and pubertal status will be 
assessed.  Carotid intima media thickness (CIMT) and endothelial function will be 
measured using ultrasonography.  Finally, aerobic fitness (VO2max) will be measured. 
Pubertal status:  Pubertal status will be assessed by asking the subjects to self-report 
their current status, compared to standard graphical representations of pubertal 
Tanner stages.   
Cardiorespiratory fitness: A ramp treadmill protocol with open circuit spirometry will 
be used to measure VO2max.  During this assessment subjects will be fitted with a 
mouthpiece or facemask.  
Body composition: Height, weight, waist and hip circumferences will also be 
measured using standard procedures.  Skinfold callipers will be used to measure 
double thickness subcutaneous adipose tissue on the right side of the body.   
Blood sampling and assays: Blood samples will be obtained using standard 
venipuncture.  An individual trained in phlebotomy will draw the blood samples.  The 
total amount of blood taken will be approximately 9 ml.  Serum concentrations of 
blood lipids will be determined on an automated clinical chemistry analyser using 
spectrophotometric (lipids).  Serum concentrations of hs-CRP and insulin will be 
determined by immunoassay. Plasma glucose will be measured using a standard 
spectrophotometric assay.   
Carotid Intima- Media Thickness (CIMT): Thickness of the carotid intima-media will 
be assessed using a 12.0 MHz linear-array transducer (SonoSite, MicroMaxx).  
Recordings will be obtained with the subject resting in a supine position, with the 
head turned slightly to the contralateral side.  The common coronary artery, 
including the carotid bulb, will be visualized, and 2 longitudinal B-mode images of the 
left and the right common carotid arteries at end diastole will be recorded and 
electronically stored.  Measurements of CIMT will be conducted in the 10-mm linear 
segment proximal to the carotid bulb at 2 plaque-free sides twice in the near wall 
and twice in the far wall on both sides and combined as mean CIMT.  The 
combination of the readings from the near and far walls yields the strongest 
association with cardiovascular disease.  The artery will be scanned longitudinally 
without colour flow to assess the grey scale image and with colour flow to identify 
difficult anatomy and delineate irregularities in plaque. 
Endothelial Function: Endothelial dependent dilation will be determined in response 
to reactive hyperaemia following 5 min of lower arm occlusion.  A blood pressure 
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cuff will be placed on the left arm for blood pressure monitoring and another on the 
right lower arm for occlusion.  ECG leads will be attached to monitor heart rate.  
Subjects will rest for 10 min in a supine position.  Blood pressure will be determined 
during the final 2 minutes of the rest period.  Baseline blood flow and brachial artery 
diameter (SonoSite, MicroMaxx) will be recorded.  The right arm blood pressure cuff 
will then be inflated to approximately 220-230 mmHg and maintained at that 
pressure for 5 minutes.  The cuff will then be rapidly deflated after 5 min of 
occlusion.  Doppler blood flow measurement will be obtained during the first minute 
following cuff deflation.  Brachial artery diameter will be assessed at one and three 
minutes post occlusion.  Subjects will then rest for 15 minutes to eliminate 
endothelium dependent effects on brachial artery diameter.  After this period, 
endothelial independent dilation will be assessed.  Baseline blood flow and brachial 
artery diameter will be recorded and used as a baseline prior to sublingual 
nitroglycerine administration.  Glyceryl trinitrate (0.4mg) will be placed under the 
subjects tongue.  Doppler blood flow measurement will be obtained three minutes 
following the sublingual nitroglycerin administration and brachial artery diameter 
measurements will be assessed 3 and 5 minutes post glyceryl trinitrate 
administration.   
Data Analysis: Data will be analysed using SPSS (v17.0, SPSS Inc., IL).  A mixed model 
(gender x fitness level) ANOVA will be used to compare mean differences.  Pearson’s 
product-moment correlation coefficients were used to determine the relation 
between selected parameters.  A probability of p ≤ 0.05 was accepted for statistical 
significance.  
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2.4  PARTICIPANT PROFILE  
A total of 90 boys (30 low fit, 30 moderately fit, and 30 high fit) and 90 girls (30 low 
fit, 30 moderately fit, and 30 high fit) aged 15-17 years in transition year will be 
recruited from the participatory schools in the greater Dublin region. 
Inclusion criteria: 
 Transition year student  
 Aged 15-17 years 
 Clinically stable and in good health 
 Girls will be scheduled to visit DCU during the first 7 days of the follicular 
phase of their menstrual cycle. 
Exclusion criteria: 
Potential subjects will be excluded if: 
 They have not informed consent  
 Current smoker 
 Clinical conditions that may preclude them from exercise 
 Taking oral contraceptive pill 
 Systolic blood pressure >180 mmHg and/or diastolic blood pressure > 100 
mmHg   
The family physician and parents of study participants with high blood 
pressure or other adverse indicators will be contacted by Dr. Noel McCaffrey. 
2.5 MEANS BY WHICH PARTICIPANTS ARE TO BE RECRUITED  
A letter providing a brief summary of the research project will be sent to post-
primary school principals in the greater Dublin region.  Sinead Sheridan (PhD student) 
will visit the schools that agree to participate.  The purpose of the study will be 
outlined and a brief summary of what is involved will be explained to all transition 
year students.  The students will be provided with an informed consent to be signed 
by a parent/guardian.  In addition, they will sign an assent form and complete a 
Physical Activity Readiness Questionnaire (Appendex 1).  Perspective participants will 
be told that only a small number of them will be randomly selected to wear an 
accelerometer and visit DCU.   
2.6  PLEASE EXPLAIN WHEN, HOW, WHERE, AND TO WHOM RESULTS WILL BE 
DISSEMINATED, INCLUDING WHETHER PARTICIPANTS WILL BE PROVIDED WITH 
ANY INFORMATION AS TO THE FINDINGS OR OUTCOMES OF THE PROJECT? 
The results obtained will form the basis for a postgraduate thesis and will be 
presented at scientific meeting and published in scientific journals.  The identity of 
the individual participants will remain anonymous.  Information, as a group, will only 
be presented.  Participants will be provided with a report which will detail their 
results from participating in the study. 
2.7 OTHER APPROVALS REQUIRED Has permission to gain access to another location, 
organisation etc. been obtained?  Copies of letters of approval to be provided when 
available. 
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 YES  NO  NOT APPLICABLE 
 
Permission will be obtained from school principles (Appendix 1) 
 
2.8 HAS A SIMILAR PROPOSAL BEEN PREVIOUSLY APPROVED BY THE REC 
 
 YES  NO 
(If YES, please state both the REC Application Number and Project Title) 
 
 
3. RISK AND RISK MANAGEMENT 
 
3.1 ARE THE RISKS TO SUBJECTS AND/OR RESEARCHERS ASSOCIATED WITH YOUR 
PROJECT GREATER THAN THOSE ENCOUNTERED IN EVERYDAY LIFE? 
 YES  NO If YES, this proposal will be subject to full REC review 
If NO, this proposal may be processed by expedited administrative review 
3.2 DOES THE RESEARCH INVOLVE 
 YES NO 
 use of a questionnaire? (attach copy)?   
 interviews (attach interview questions)?   
 observation of participants without their knowledge?   
 participant observation (provide details in section 2)?   
 audio- or video-taping interviewees or events?   
 access to personal and/or confidential data (including student, patient or 
client data) without the participant’s specific consent? 
  
 administration of any stimuli, tasks, investigations or procedures which 
may be experienced by participants as physically or mentally painful, 
stressful or unpleasant during or after the research process? 
  
 performance of any acts which might diminish the self-esteem of 
participants or cause them to experience embarrassment, regret or 
depression? 
  
 investigation of participants involved in illegal activities?   
 procedures that involve deception of participants?   
 administration of any substance or agent?   
 use of non-treatment of placebo control conditions?   
 collection of body tissues or fluid samples?   
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 collection and/or testing of DNA samples?   
 participation in a clinical trial?   
 administration of ionising radiation to participants?   
3.3 POTENTIAL RISKS TO PARTICIPANTS AND RISK MANAGEMENT PROCEDURES (see 
Guidelines) 
1. Exercise testing is associated with a very small risk of abnormal heart rhythm, 
heart attack or death. Subjects heart activity will be continuously monitored 
using a 12 lead ECG and a physician will be present during exercise testing. 
2. Drawing blood is associated with slight pain and discomfort and can cause 
bruising where the needle is inserted.  An individual trained in phlebotomy will 
draw the blood samples.  A safe volume of approximately 9 ml of blood will be 
drawn.   
3. Restriction of blood flow for a period of 5 minutes is necessary to assess 
endothelial dependent and independent dilation.  This procedure may induce 
slight discomfort in the subject’s arm which will dissipate following the deflation 
of the blood pressure cuff.  The glyceryl trinitrate administered may cause a 
headache that may last for 5-10 minutes  
Alternatives to the risks: Endothelial dependent and independent dilation can only 
be determined by brachial artery reactivity and the administration of nitroglycerin.  
Blood samples are required to assess the subject’s cardiovascular biomarkers.    
3.4 ARE THERE LIKELY TO BE ANY BENEFITS (DIRECT OR INDIRECT) TO PARTICIPANTS 
FROM THIS RESEARCH? 
 YES  NO 
Participants will receive a copy of their results, detailing information 
on their vascular health, body composition and fitness levels.  
3.5 ARE THERE ANY SPECIFIC RISKS TO RESEARCHERS? (e.g. risk of infection or where 
research is undertaken at an off-campus location) 
 YES  NO 
Risk is associated with working with blood and 
handling needles. The research team has been 
immunized for hepatitis B.  Standard operating 
procedures for the handling of biological products 
exist within the School of Health and Human 
Performance. 
3.6 ADVERSE/UNEXPECTED OUTCOMES  
The School of Health and Human Performance has established an emergency 
protocol for adverse events.  In the unlikely event of a major adverse outcome, an 
ambulance will be called and the participant will be sent immediately to Beaumont 
Hospital.  Any minor adverse outcomes will be dealt with by the study physician who 
will then refer the participant, if required, to the VHI- swift care clinic in Swords for 
further attention. 
3.7 MONITORING  
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The research team will have meetings on a weekly basis to update on all aspects of 
the study.  All researchers involved in the study will be familiar with testing 
procedures and the safety statement prior to commencing data collection.  A 
number of practice sessions will be undertaken by all the research team to ensure 
proficiency and reliability in performing the data collection procedures.  
3.8 SUPPORT FOR PARTICIPANTS  
 This study does not require additional support for participants  
3.9 DO YOU PROPOSE TO OFFER PAYMENTS OR INCENTIVES TO PARTICIPANTS? 
 
 YES  NO (If YES, please provide further details.) 
 
4. INVESTIGATORS’ QUALIFICATIONS, EXPERIENCE AND SKILLS  
The PI (Niall Moyna) has extensive experience with measuring flow mediated 
dilation.  He initially learned the procedure in the Division of Cardiology at the 
University of Pittsburgh Centre, Pittsburgh, PA, USA and later established an 
endothelial function assessment laboratory in the Division of Nuclear Cardiology at 
Hartford Hospital, Connecticut, USA.  During the past 5 years, Prof Moyna and Dr. 
Cleona Gray, the Senior Vascular Technologist in the Vascular Lab at the Mater 
Hospital have trained a number of DCU graduate students in the measurement of 
carotid intima media thickness and flow mediated dilation.   
Dr. Noel McCaffrey is a physician with extensive experience in exercise related 
research. 
Sinead Sheridan recently completed the BSc Physical Education and Biology at Dublin 
City University.  She finished first in her class with a 1.1 honors degree.  Sinead is 
familiar with many of the procedures involved in fitness testing and she is currently 
learning the ultrasound procedure involved in measuring carotid intima media 
thickness and flow mediated dilation. 
 
5. CONFIDENTIALITY/ANONYMITY 
5.1 WILL THE IDENTITY OF THE PARTICIPANTS BE PROTECTED? 
 YES  NO 
(If NO, please explain) 
      
 IF YOU ANSWERED YES TO 5.1, PLEASE ANSWER THE FOLLOWING QUESTIONS: 
5.2 HOW WILL THE ANONYMITY OF THE PARTICIPANTS BE RESPECTED?  
Participant confidentiality is an important issue during data collection.  Participant’s 
identity and other personal information will not be revealed, published or used in 
other studies.  Participants will be assigned an ID number under which all personal 
information will be stored in a secure locked cabinet in the Vascular Health Research 
Unit in the School of Health and Human Performance in DCU and saved in a 
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password- protected in a computer in DCU.  The principal investigator and named 
collaborators listed on this ethics application will be able to access the data. 
5.3 LEGAL LIMITATIONS TO DATA CONFIDENTIALITY: (Have you included appropriate 
information in the plain language statement and consent form?  See Guidelines) 
 
 YES  NO 
(If NO, please advise how participants will be 
advised.) 
      
 
6 DATA/SAMPLE STORAGE, SECURITY AND DISPOSAL  
6.1 HOW WILL THE DATA/SAMPLES BE STORED? ( REC recommends that all data be 
stored on campus) 
Stored at DCU   
Stored at another site  (Please explain where and for 
what purpose) 
      
6.2 WHO WILL HAVE ACCESS TO DATA/SAMPLES? 
Access by named researchers only    
Access by people other than named researcher(s)  (Please explain who and for 
what purpose) 
Other  (Please explain) 
       
6.3 IF DATA/SAMPLES ARE TO BE DISPOSED OF, PLEASE EXPLAIN HOW, WHEN AND BY 
WHOM THIS WILL BE DONE? 
The data will be stored in a secure locked cabinet in the Vascular Health Research 
Unit in the School of Health and Human Performance in DCU and saved in a 
password- protected in a computer in DCU.  Data will be kept for a maximum of 5 
years following from the date of the publication of the research.  The principal 
investigator will be responsible for the security of the data.  Only the other 
investigators listed on this ethics application form will have access to the data.  The 
data will be shredded by the principal investigator after 5 years. 
 
7. FUNDING 
7.1 HOW IS THIS WORK BEING FUNDED? 
 Grant has been submitted to the Office of the Minister for Children and Youth Affairs 
- Research Scholarship Programme 
7.2 PROJECT GRANT NUMBER (If relevant and/or known) 
      
7.3 DOES THE PROJECT REQUIRE APPROVAL BEFORE CONSIDERATION FOR FUNDING 
BY A GRANTING BODY?  
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 YES  NO 
7.4 HOW WILL PARTICIPANTS BE INFORMED OF THE SOURCE OF THE FUNDING? 
Informed consent  
7.5 DO ANY OF THE RESEARCHERS, SUPERVISORS OR FUNDERS OF THIS PROJECT HAVE 
A PERSONAL, FINANCIAL OR COMMERCIAL INTEREST IN ITS OUTCOME THAT MIGHT 
COMPROMISE THE INDEPENDENCE AND INTEGRITY OF THE RESEARCH, OR BIAS THE 
CONDUCT OR RESULTS OF THE RESEARCH, OR UNDULY DELAY OR OTHERWISE 
AFFECT THEIR PUBLICATION? 
 
 YES  NO 
(If Yes, please specify how this conflict of interest will be 
addressed.) 
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8. PLAIN LANGUAGE STATEMENT  
DUBLIN CITY UNIVERSITY 
Plain Language Statement 
Project Title: Comparison of Cardiovascular Disease Risk Factors and 
Vascular Health in Low fit, Moderately Fit and High Fit Irish 
Teenagers 
Principal investigator   Professor Niall M. Moyna (Tel: 01-7008802; Fax 01-7008888) 
    Centre for Preventive Medicine 
    School of Health and Human Performance 
Email:     niall.moyna@dcu.ie 
I. Introduction to the Research Study 
Disease of the blood vessels that supply the heart and brain called cardiovascular disease 
(CVD) is the leading cause of death in Ireland.  Although the clinical events associated 
with CVD such as chest pain, heart attack and stroke normally occur when people get 
older there is now strong evidence that the disease process starts during childhood.  
Children who regularly eat a high fat-high diet, who smoke or who don’t get enough 
exercise have a high risk of getting heart disease early in life.  Researchers can now use 
simple and painless procedures to measure the health of blood vessels and the risk for 
developing CVD.  The aim of this study is to compare the health of blood vessels in low 
fit, moderately fit and high fit adolescent boys and girls. In addition, we will check to see 
how many CVD risk factors that low fit, moderately fit and high fit adolescent boys have.   
II. Involvement in the Research Study will require 
If you agree to allow your child to take part in the study, he/she will undertake a shuttle 
run test during school hours to assess their fitness level.  After your child had completed 
the shuttle run test he or she may be selected by chance to wear a small device called an 
accelerometer on their hip to record how much physical activity they get every day for 7 
days.   They will also make a single visit to DCU to undergo additional tests.  During the 
visit to DCU, i) a blood sample will be drawn, ii) their height, weight, and the amount of 
muscle and fat will be measured, iii) a picture will be taken of a blood vessel in their neck, 
iv) the health of a blood vessel in the arm will be assessed and v) they will undergo a 
fitness level on a treadmill.  Your child will be asked to fast for at least 12 hours and will 
not be allowed to exercise for at least 24 hours before the visit to DCU.   
 Researchers from Dublin City University will visit the school that your child is 
attending to administer the shuttle run test.  This test involves running back and 
forth between two lines exactly 20 metres apart while keeping in time with a series 
of audio signals.   
 Two tablespoons of blood will be taken to measure a variety of biomarkers in the 
blood that are used to predict the risk of CVD.  These include glucose and 
cholesterol.  Special skin calipers will be used to measure amount of muscle and fat.  
The blood samples and skin caliper measurements will be taken in a private room.  
A female researcher will measure height and weight and take the skinfold 
measurements in girls.  
 292 
 A special machine called an ultrasound will take a picture of a blood vessel in your 
child’s neck.  (figure A).  The health of a blood vessel in your child’s arm will be also 
measured using the ultrasound machine and involves two steps.  The first step will 
involve blocking the blood flow to your child’s lower arm for 5 minutes by inflating a 
blood pressure cuff, and then taking a picture when the blood pressure cuff in 
released.  The second step involves spraying a medicine called glyceryl trinitrate 
under your child’s tongue in order to widen the artery and then taking a picture 3 
minutes later (figure B).  
  
 
 
 
 
 
 
 
 
 
  Figure A       Figure B 
 Your child’s fitness will be assessed by having him/her walk/run on a treadmill while 
wearing a special headgear that is attached to a mouthpiece. 
III. Potential risks from involvement in the Research Study 
 Your child may experience some muscle soreness in his/her legs or nausea following 
exercise.   
 People who exercise have a very small risk of getting injured and having heart 
problems.  The chance of any of these happening in healthy young adolescent boys 
and girls is very low.   
 Drawing blood may cause a slight pain where the needle is inserted and can leave a 
bruise.  A person trained to take blood will be used to decrease these risks.  The 
amount of blood drawn is not harmful.   
 Stopping the flow of blood for a period of 5 minutes may induce slight discomfort in 
your child’s arm which will go away when the blood pressure cuff is deflated.  
 Gyceryl trinitrate, is a type of medicine called a nitrate that works by being converted 
in the body to a chemical called nitric oxide.  This chemical (nitric oxide) is also 
made naturally by the body and has the effect of making the veins and arteries 
relax and widen (dilate).  This makes it easier for the heart to pump blood around 
the body.  There is a very small chance that your child may get a headache that may 
last 5-10 minutes after glyceryl trinitrate is sprayed under his/her tongue. 
IV. Benefits from involvement in the Research Study 
Your child will receive a report summarizing the results of his/her tests undertaken 
during the study.  No other benefits have been promised.  
V. Arrangements to protect confidentiality of data  
 Your child’s identity and other personal information will not be revealed, published or 
used in further studies.  Your child will be assigned an ID number under which all 
personal information will be stored and saved in a password protected file in a computer 
at DCU.  The person is charge of the study (Prof. Niall Moyna), and the other researchers 
listed on this ethics application will have access to the data.  You need to be aware that 
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confidentiality of information provided can only be protected within the limitations of 
the law.  It is possible for data to be subject to subpoena, freedom of information claim 
or mandated reporting by some professions. 
VI. Advice as to whether or not data is to be destroyed after a minimum period  
 The original documentation will be stored for a maximum of 5 years.  Thereafter the 
documentation will be shredded. 
VII. Involvement in the Research Study is voluntary 
Involvement in this study is completely voluntary.  Your child may withdraw from the 
Research Study at any point.  There will be no penalty for withdrawing before all stages 
of the Research Study have been completed.   
If participants have concerns about this study and wish to contact an independent person, 
please contact: The Secretary, Dublin City University Research Ethics Committee, c/o 
Office of the Vice-President for Research, Dublin City University, Dublin 9.  Tel 01-
7008000 
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9. INFORMED CONSENT FORM  
 
DUBLIN CITY UNIVERSITY 
Informed Consent Form  
I.      Research Study Title  
Comparison of Cardiovascular Disease Risk Factors and Vascular Health in Low fit, 
Moderately Fit and High Fit Irish Teenagers  
Principle Investigator  
 Prof. Niall M. Moyna, Centre for Preventive Medicine, School of Health and Human 
Performance 
II. Purpose of the research 
To compare cardiovascular disease risk factors and sub-clinical atherosclerosis in low fit, 
moderately fit and high fit adolescents. 
III. Confirmation of particular requirements as highlighted in the Plain Language 
Statement 
Participant – please complete the following (Circle Yes or No for each question) 
I have read the Plain Language Statement (or had it read to me)   Yes 
 No  
I understand the information provided      Yes 
 No  
I have had an opportunity to ask questions and discuss this study    Yes 
 No  
I have received satisfactory answers to all my questions     Yes 
 No  
IV. Confirmation that involvement in the Research Study is voluntary 
Your child may withdraw from the Research Study at any point.   
V. Advice as to arrangements to be made to protect confidentiality of data, including that 
confidentiality of information provided is subject to legal limitations  
Your child’s and other personal information will not be revealed, published or used in 
further studies.  Your child will be assigned an ID number under which all personal 
information will be stored in a secure locked cabinet and saved in a password protected 
file in a computer at DCU.  The named investigators will have access to the data.  Data 
will be shredded after 5 years by Prof. Moyna. 
Confidentiality is insured, but you must be aware that confidentiality of information 
provided can only be protected within the limitations of the law.  It is possible for data 
to be subject to subpoena, freedom of information claim or mandated reporting by 
some professions. 
VI. Any other relevant information 
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If your child is in a dependent relationship with any of the researchers their involvement 
in the project will not affect ongoing assessment/grades/management or treatment of 
health at DCU.  
VII. Signature: 
I have read and understood the information in this form.  My questions and concerns 
have been answered by the researchers, and I have a copy of this consent form.  
Therefore, I consent to allow my child  take part in this research project 
 Participants Signature:         
 Name in Block Capitals:         
 Witness:           
 
 Date:            
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DUBLIN CITY UNIVERSITY 
ASSENT FORM FOR CHILDREN 
Study Title:  Comparison of Cardiovascular Disease Risk Factors and Vascular 
Health in Low fit, Moderately Fit and High Fit Irish Teenagers 
1. My physical education teacher has talked to me about being part of a 
research study.  
2. I have been told that researchers from Dublin City University (DCU) will visit 
my school and measure by fitness using a bleep test 
3. I have been told that I may be selected at random to visit the Vascular 
Research Unit at DCU to undergo additional tests.  I will also wear a small 
device called an accelerometer on my hip for 7 days to record my physical 
activity levels  
4. The visit to DCU will take place in the morning and will last for about 3 hours. 
5. I will not eat any food from 10 pm the previous evening.  I will be allowed to 
drink water. 
6. I will not do any exercise that makes me tired the day before the bleep test in 
school or the tests in DCU.   
7. I will have about 2 tablespoons of blood taken from a vein in my arm.  
Drawing blood may cause a slight pain where the needle is inserted and may 
leave a bruise on my arm that will clear up in a few days 
8. A special ultrasound machine will take a picture of an artery in my neck.  This 
will take about 15 minutes. 
9. The health of a blood vessel in my arm will also be measured using the 
ultrasound machine.  The first step will involve blocking the blood flow in my 
arm for 5 minutes using a blood pressure cuff and then taking a picture of my 
blood vessel when the cuff in released.  The second step involves spraying a 
chemical under my tongue and taking a picture image 3 minutes later.  This 
test will take about 45 minutes, 
10. Stopping the flow of blood in my arm for 5 minutes may feel a little 
uncomfortable.  The chemical that is sprayed under my tongue may cause a 
headache that may last for 5-10 minutes 
11. I will run on treadmill to see how fit I am.  During the test I will wear a nose 
clip on my nose and a mouthpiece in my mouth.  
12. I will be allowed to stop any of the tests whenever I want. 
13. I may feel tired or be out of breath when I am running on the treadmill and 
my legs may feel tired 
14. If I wish, I can stop doing the tests at any time.   
15. If I wish, I may choose not to take part in any of the tests. 
16. I know that the people in DCU, my physical education teacher and my 
parents/guardian will not be upset with me if I decide not to take part in this 
study, or if I wish to stop taking part in the study. 
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SIGNED: ________________________________________ DATE: __________
 (Participant’s name) 
SIGNED: ________________________________________ DATE:   __________ 
(Witness name) 
 
Appendix 1 
Dear Principal: 
I am a member of the Vascular Health Research Centre, in the School of Health and Human 
Performance at DCU.  We are planning to undertake a study that will evaluate both risk 
factors for cardiovascular disease (CVD) and subclinical CVD in transition year students. 
Despite a substantial decline in CVD death rates over the past two decades, CVD remains the 
leading cause of mortality in Irish men and women.  Results from autopsy studies of young 
individuals, mostly from accidental deaths or during military warfare indicate that the 
duration of risk factor burden is a major factor governing the development of CVD.  There is 
accumulating evidence that cardiovascular disease risk factor levels for an individual tend to 
persist or track over time in a given rank within the distribution of the population.  Long term 
exposure to multiple CVD risk factors and lifestyle behaviours such as a high fat-high calorie 
diet, tobacco use and physical inactivity confers a lifelong burden of CVD risk resulting in the 
development of early systemic CVD.   
The Children’s Sport Participation and Physical Activity study (CSPPA) is a recently published 
multi-centre study (I am a co-author) that examined physical activity levels in Irish children 
from 53 primary schools (n=1275) and 70 post primary schools (n=4122, 1st to 6th year, 12-
18 yr; 52% female).  Results from the study indicate that an alarming 81% of primary and 88% 
of post primary pupils do not meet the Department of Health and Children’s physical activity 
recommendations.  Furthermore, physically active children have a better health profile 
(based on cardiorespiratory fitness, BMI, blood pressure and waist/hip ratio) than those who 
are inactive.  The use of a non-invasive technique such as ultrasound to measure the 
thickness of the wall of the carotid artery in the neck, and the ability of the brachial artery in 
the arm to dilate following 5 minutes of occlusion are now commonly used to determine the 
severity of asymptomatic CVD and potential future risk.  The proposed study will evaluate 
physical activity levels, cardiovascular fitness, risk factors for cardiovascular disease, and 
subclinical CVD in low fit, moderately fit and high fit 15-17 year old Irish boys and girls. 
We are seeking your permission to contact the physical education teacher(s) 
If you would like more information please feel free to contact my office number - 01-
7008802.    
My email address: niall.moyna@dcu.ie 
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Kindest regards, 
_________________ 
Niall M. Moyna, PhD., FACSM 
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Appendix 2 
 
Ethical justification for blood sampling associated with human studies conducted within 
DCU. 
Completion instructions: 
This document is intended to prompt responses to a number of standard questions which 
generally need to be answered to justify the sampling of blood associated with human 
studies. 
The document is not meant to be an exhaustive exploration of the justification for such 
sampling and in specific situations.   Additional information may be required/ requested.   
Answers are expected to be brief but should also be informative.  See a sample completed 
form at the end.   
Queries should be directed to the Secretary of the Research Ethics Committee in the OVPR 
office.  
 
 
1) Briefly explain why blood sampling is required 
 
 
 
 
 
2) Outline the analyses, components or general applications to be investigated in 
subject blood (now and any future studies) 
 
 
 
 
 
 
 
To measure biomarkers that are used to predict the risk for cardiovascular disease. 
Serum total cholesterol, TG, LDL-C and HDL-C, and hs-CRP will be determined using 
enzymatic assays (Liquicolor, Human, Germany/Randox direct, Randox, Northern 
Ireland) and measured spectrophotometrically (MODULAR, Hitachi, Japan).  Glucose 
will be analysed using an automated YSI 2300 STAT PLUS analyser.  Serum insulin was 
determined by a dissociation enhanced lanthanide fluorescent immunoassay (DELFIA) 
using a commercially available kit (Perkinelmer, Wellesley MA, USA).    
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3) Are any alternatives available to substitute the venous sampling of blood?  yes/no.   
  
 
 
 
4) Will sampling require cannulation or direct vein puncture?   
 
 
 
 
 
5) Outline the minimum volume of original subject blood (i.e. not serum or plasma) 
required to measure the required components.   
  
 
 
6) Are steps being taken in the protocol to minimise the volume of blood samples 
being taken?   Yes 
  
 
  
 
 
 
7) Are steps included to minimise the number of blood samples/vein puncture being 
taken?  No 
 
 
8) Anticipated sampling methodology 
Volume of blood to be taken per sample 
 
9.0ml 
No 
9.0 ml 
Yes.  We have taken the minimum volume of blood that will allow us to measure the selected 
biomarkers 
Yes.  We are only taking 9 ml of blood (2 teaspoons) during a single venipuncture 
Direct vein puncture  
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Maximum number of samples to be taken per 
“sitting” 
 
1 
Maximum number of samples taken per day 
 
1 
 
 
Maximum number of samples to be taken over 
the course of the full study (if long duration study 
indicate the amount taken in an active 1 month 
period) 
 
1 
Maximum anticipate number of vein puncture 
episodes 
1 
Total volume of blood that will be taken from 
subject.  
 
9.0 ml 
 
9) I certify that:-  
 all persons sampling blood in this study are certified to do so through the school/unit 
where this work is being conducted  
 that all those manipulating the resultant samples are fully trained in the safe practice 
of handling blood  
 all persons handling this blood have received appropriate information according to 
current vaccination policy. 
 
 
Signature of Study PI   Date: 10 June 2011 
 
 
An original signed copy must accompany electronic submissions.  Alternatively, a PDF or 
other scanned version with a signature may be submitted 
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Appendix B 
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Appendix C 
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Appendix D 
V̇O2max Protocol (LF) 
Stage Time Speed Slope 
Warm Up 2:00 6.0 0.0 
1 1:00 7.0 0.0 
2 1:00 8.0 1.0 
3 1:00 8.0 2.0 
4 1:00 8.0 3.0 
5 1:00 8.0 4.0 
6 1:00 8.0 5.0 
7 1:00 8.0 6.0 
8 1:00 8.0 7.0 
9 1:00 8.0 8.0 
10 1:00 8.0 9.0 
11 99:00 8.0                9.0 
Recovery 5:00 5.0 0.0 
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V̇O2max Protocol (MF) 
Stage Time Speed Slope 
Warm Up 2:00 7.0 0.0 
1  1:00 8.0 0.0 
2 1:00 10.0 1.0 
3 1:00 10.0 2.0 
4 1:00 10.0 3.0 
5 1:00 10.0 4.0 
6 1:00 10.0 5.0 
7 1:00 10.0 6.0 
8 1:00 10.0 7.0 
9 1:00 10.0 8.0 
10 1:00 10.0 9.0 
11 99:00 10.0 10.0 
Recovery 5:00 5.5 0.0 
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V̇O2max Protocol (HF) 
Stage Time Speed Slope 
Warm Up 2:00 9.0 0.0 
1 1:00 11.0 0.0 
2 1:00 12.0/13.0 1.0 
3 1:00 12.0/13.0 2.0 
4 1:00 12.0/13.0 3.0 
5 1:00 12.0/13.0 4.0 
6 1:00 12.0/13.0 5.0 
7 1:00 12.0/13.0 6.0 
8 1:00 12.0/13.0 7.0 
9 1:00 12.0/13.0 8.0 
10 1:00 12.0/13.0 9.0 
11 99:00 12.0/13.0 9.0 
Recovery 5:00 6.0 0.0 
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Appendix E 
Data of graded maximal exercise test of individual participant used to calculate OUES  
 
Test 
VO2(ml/kg/min) VO2 (l/min) VO2(ml/min) VE LOG VE VO2(ml/min) 
0:01:20 36.30 2.58 2580.00 48.00 1.68 2580.00 : :4  9.6  .81 813.  56.8  .75 813.  
0:02:00 39.50 2.81 2811.00 55.20 1.74 2811.00 
0:02:20 48.00 3.41 3410.00 66.10 1.82 3410.00 
0:02:40 41.80 2.97 2973.00 57.50 1.76 2973.00 
0:03:00 44.60 3.18 3175.00 63.70 1.80 3175.00 
0:03:20 45.60 3.24 3239.00 66.10 1.82 3239.00 
0:03:40 46.90 3.33 3332.00 70.40 1.85 3332.00 
0:04:00 46.20 3.29 3285.00 69.40 1.84 3285.00 
0:04:20 49.40 3.51 3512.00 72.50 1.86 3512.00 
0:04:40 50.90 3.62 3618.00 74.80 1.87 3618.00 
0:05:00 47.30 3.36 3362.00 71.70 1.86 3362.00 
0:05:20 50.00 3.56 3555.00 73.30 1.87 3555.00 
0:05:40 53.00 3.77 3769.00 79.50 1.90 3769.00 
0:06:00 55.10 3.92 3921.00 92.70 1.97 3921.00 
0:06:20 54.40 3.87 3868.00 94.80 1.98 3868.00 
0:06:40 56.80 4.04 4036.00 94.70 1.98 4036.00 
0:07:00 55.00 3.91 3912.00 92.50 1.97 3912.00 
0:07:20 58.30 4.15 4147.00 100.40 2.00 4147.00 
0:07:40 57.40 4.08 4082.00 103.70 2.02 4082.00 
0:08:00 58.80 4.18 4180.00 106.60 2.03 4180.00 
0:08:20 60.50 4.30 4302.00 107.50 2.03 4302.00 
0:08:40 59.80 4.25 4250.00 108.10 2.03 4250.00 
0:09:00 62.00 4.41 4407.00 116.30 2.07 4407.00 
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0:09:20 64.80 4.61 4608.00 128.90 2.11 4608.00 
0:09:40 64.10 4.56 4561.00 128.80 2.11 4561.00 
0:10:00 64.60 4.59 4593.00 118.20 2.07 4593.00 
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